<SEC-DOCUMENT>0001493152-24-025724.txt : 20240701
<SEC-HEADER>0001493152-24-025724.hdr.sgml : 20240701
<ACCEPTANCE-DATETIME>20240701080024
ACCESSION NUMBER:		0001493152-24-025724
CONFORMED SUBMISSION TYPE:	8-K
PUBLIC DOCUMENT COUNT:		18
CONFORMED PERIOD OF REPORT:	20240628
ITEM INFORMATION:		Entry into a Material Definitive Agreement
ITEM INFORMATION:		Unregistered Sales of Equity Securities
ITEM INFORMATION:		Material Modifications to Rights of Security Holders
ITEM INFORMATION:		Financial Statements and Exhibits
FILED AS OF DATE:		20240701
DATE AS OF CHANGE:		20240701

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			Cingulate Inc.
		CENTRAL INDEX KEY:			0001862150
		STANDARD INDUSTRIAL CLASSIFICATION:	PHARMACEUTICAL PREPARATIONS [2834]
		ORGANIZATION NAME:           	03 Life Sciences
		IRS NUMBER:				863825535
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		8-K
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-40874
		FILM NUMBER:		241088213

	BUSINESS ADDRESS:	
		STREET 1:		1901 W. 47TH PLACE
		CITY:			KANSAS CITY
		STATE:			KS
		ZIP:			66205
		BUSINESS PHONE:		(913) 942-2300

	MAIL ADDRESS:	
		STREET 1:		1901 W. 47TH PLACE
		CITY:			KANSAS CITY
		STATE:			KS
		ZIP:			66205
</SEC-HEADER>
<DOCUMENT>
<TYPE>8-K
<SEQUENCE>1
<FILENAME>form8-k.htm
<TEXT>
<XBRL>
<?xml version='1.0' encoding='ASCII'?>
<html xmlns="http://www.w3.org/1999/xhtml" xmlns:xs="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:xbrldi="http://xbrl.org/2006/xbrldi" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xmlns:iso4217="http://www.xbrl.org/2003/iso4217" xmlns:ix="http://www.xbrl.org/2013/inlineXBRL" xmlns:ixt="http://www.xbrl.org/inlineXBRL/transformation/2015-02-26" xmlns:ixt-sec="http://www.sec.gov/inlineXBRL/transformation/2015-08-31" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:dei="http://xbrl.sec.gov/dei/2024" xmlns:ref="http://www.xbrl.org/2006/ref" xmlns:us-gaap="http://fasb.org/us-gaap/2024" xmlns:us-roles="http://fasb.org/us-roles/2024" xmlns:dtr-types="http://www.xbrl.org/dtr/type/2022-03-31" xmlns:country="http://xbrl.sec.gov/country/2024" xmlns:srt="http://fasb.org/srt/2024" xmlns:CING="http://cingulate.com/20240628">
<head>
     <title></title>
<meta http-equiv="Content-Type" content="text/html"/>
</head>
<!-- Field: Set; Name: xdx; ID: xdx_02D_US%2DGAAP%2D2024 -->
<!-- Field: Set; Name: xdx; ID: xdx_031_CING_cingulate.com_20240628 -->
<!-- Field: Set; Name: xdx; ID: xdx_04D_20240628_20240628 -->
<!-- Field: Set; Name: xdx; ID: xdx_059_edei%2D%2DAmendmentFlag_false -->
<!-- Field: Set; Name: xdx; ID: xdx_056_edei%2D%2DEntityCentralIndexKey_0001862150 -->
<!-- Field: Set; Name: xdx; ID: xdx_06B_USD_1_iso4217%2D%2DUSD -->
<!-- Field: Set; Name: xdx; ID: xdx_062_Shares_2_xbrli%2D%2Dshares -->
<!-- Field: Set; Name: xdx; ID: xdx_06D_USDPShares_3_iso4217%2D%2DUSD_xbrli%2D%2Dshares -->
<body>
<div style="display: none">
<ix:header>
 <ix:hidden>
  <ix:nonNumeric contextRef="AsOf2024-06-28" id="Fact000003" name="dei:AmendmentFlag">false</ix:nonNumeric>
  <ix:nonNumeric contextRef="AsOf2024-06-28" id="Fact000004" name="dei:EntityCentralIndexKey">0001862150</ix:nonNumeric>
  </ix:hidden>
 <ix:references>
  <link:schemaRef xlink:href="cing-20240628.xsd" xlink:type="simple"/>
  </ix:references>
 <ix:resources>
    <xbrli:context id="AsOf2024-06-28">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001862150</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2024-06-28</xbrli:startDate>
        <xbrli:endDate>2024-06-28</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2024-06-282024-06-28_custom_CommonStockParValue0.0001PerShareMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001862150</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">CING:CommonStockParValue0.0001PerShareMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2024-06-28</xbrli:startDate>
        <xbrli:endDate>2024-06-28</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2024-06-282024-06-28_custom_WarrantsExercisableForOneShareOfCommonStockMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001862150</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">CING:WarrantsExercisableForOneShareOfCommonStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2024-06-28</xbrli:startDate>
        <xbrli:endDate>2024-06-28</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:unit id="USD">
      <xbrli:measure>iso4217:USD</xbrli:measure>
    </xbrli:unit>
    <xbrli:unit id="Shares">
      <xbrli:measure>xbrli:shares</xbrli:measure>
    </xbrli:unit>
    <xbrli:unit id="USDPShares">
      <xbrli:divide>
        <xbrli:unitNumerator>
          <xbrli:measure>iso4217:USD</xbrli:measure>
        </xbrli:unitNumerator>
        <xbrli:unitDenominator>
          <xbrli:measure>xbrli:shares</xbrli:measure>
        </xbrli:unitDenominator>
      </xbrli:divide>
    </xbrli:unit>
  </ix:resources>
 </ix:header>
</div>


<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"></p>

<!-- Field: Rule-Page --><div style="margin-top: 0pt; margin-bottom: 0pt; width: 100%"><div style="border-top: Black 4pt solid; border-bottom: Black 1.5pt solid; font-size: 1pt">&#160;</div></div><!-- Field: /Rule-Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 18pt"><b>UNITED
STATES </b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 18pt"><b>SECURITIES
AND EXCHANGE COMMISSION</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 12pt"><b>Washington,
D.C. 20549</b></span><b> <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 18pt"><b>FORM
<span id="xdx_900_edei--DocumentType_c20240628__20240628_zxc1Ub9Rd4qh"><ix:nonNumeric contextRef="AsOf2024-06-28" id="Fact000009" name="dei:DocumentType">8-K</ix:nonNumeric></span></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>CURRENT
REPORT </b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Pursuant
to Section 13 or 15(d) of the Securities Exchange Act of 1934 </b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Date
of Report (Date of earliest event reported): <span id="xdx_906_edei--DocumentPeriodEndDate_c20240628__20240628_zKW7aGH5yBW2"><ix:nonNumeric contextRef="AsOf2024-06-28" format="ixt:datemonthdayyearen" id="Fact000010" name="dei:DocumentPeriodEndDate">June 28, 2024</ix:nonNumeric></span> </b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 18pt"><b><span id="xdx_907_edei--EntityRegistrantName_c20240628__20240628_zHOCLBaPFgK9"><ix:nonNumeric contextRef="AsOf2024-06-28" id="Fact000011" name="dei:EntityRegistrantName">CINGULATE,
INC.</ix:nonNumeric></span></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>(Exact
name of registrant as specified in its charter) </b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center; width: 32%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_904_edei--EntityIncorporationStateCountryCode_c20240628__20240628_zXe3QvCWG1P"><ix:nonNumeric contextRef="AsOf2024-06-28" format="ixt-sec:stateprovnameen" id="Fact000012" name="dei:EntityIncorporationStateCountryCode">Delaware</ix:nonNumeric></span></b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: center; width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center; width: 32%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span><span id="xdx_90C_edei--EntityFileNumber_c20240628__20240628_zenWkCmM53Hc"><ix:nonNumeric contextRef="AsOf2024-06-28" id="Fact000013" name="dei:EntityFileNumber">001-40874</ix:nonNumeric></span></span></b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: center; width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center; width: 32%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_905_edei--EntityTaxIdentificationNumber_c20240628__20240628_zN3xH5Yw2nX9"><ix:nonNumeric contextRef="AsOf2024-06-28" id="Fact000014" name="dei:EntityTaxIdentificationNumber">86-3825535</ix:nonNumeric></span></b></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(State
    or other jurisdiction</span></p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">of
    incorporation)</span></p></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(Commission</span></p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">File
    Number)</span></p></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(I.R.S.
    Employer</span></p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Identification
    Number)</span></p></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-left: auto; border-collapse: collapse; margin-right: auto">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span id="xdx_903_edei--EntityAddressAddressLine1_c20240628__20240628_zvl7qiXWLjDh" style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><ix:nonNumeric contextRef="AsOf2024-06-28" id="Fact000015" name="dei:EntityAddressAddressLine1">1901
                                            W. 47<sup>th</sup> Place</ix:nonNumeric></b></span></p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_90F_edei--EntityAddressCityOrTown_c20240628__20240628_zQx7LTuRKtn5"><ix:nonNumeric contextRef="AsOf2024-06-28" id="Fact000016" name="dei:EntityAddressCityOrTown">Kansas
    City</ix:nonNumeric></span>, <span id="xdx_907_edei--EntityAddressStateOrProvince_c20240628__20240628_zPfTvdm9IhQj"><ix:nonNumeric contextRef="AsOf2024-06-28" id="Fact000017" name="dei:EntityAddressStateOrProvince">KS</ix:nonNumeric></span> <span id="xdx_900_edei--EntityAddressPostalZipCode_c20240628__20240628_zqcNjrdefgFh"><ix:nonNumeric contextRef="AsOf2024-06-28" id="Fact000018" name="dei:EntityAddressPostalZipCode">66205</ix:nonNumeric></span></b></span></p></td>
    </tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(Address
    of principal executive offices) (Zip Code)</span></td>
    </tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span style="text-decoration: underline"><span id="xdx_90B_edei--CityAreaCode_c20240628__20240628_zXSggBmcGmgc"><ix:nonNumeric contextRef="AsOf2024-06-28" id="Fact000019" name="dei:CityAreaCode">(913)</ix:nonNumeric></span>
<span id="xdx_90D_edei--LocalPhoneNumber_c20240628__20240628_zV1hxx10vKJb"><ix:nonNumeric contextRef="AsOf2024-06-28" id="Fact000020" name="dei:LocalPhoneNumber">942-2300</ix:nonNumeric></span></span></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(Registrant&#8217;s
telephone number, including area code)</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(Former
name or former address, if changed since last report)</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Check
the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under
any of the following provisions:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_906_edei--WrittenCommunications_c20240628__20240628_zuByVyWfrslc"><ix:nonNumeric contextRef="AsOf2024-06-28" format="ixt:booleanfalse" id="Fact000021" name="dei:WrittenCommunications">&#9744;</ix:nonNumeric></span></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Written
    communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_900_edei--SolicitingMaterial_c20240628__20240628_zA3NmtkPe8x8"><ix:nonNumeric contextRef="AsOf2024-06-28" format="ixt:booleanfalse" id="Fact000022" name="dei:SolicitingMaterial">&#9744;</ix:nonNumeric></span></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Soliciting
    material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_90F_edei--PreCommencementTenderOffer_c20240628__20240628_zPUrMcssD53l"><ix:nonNumeric contextRef="AsOf2024-06-28" format="ixt:booleanfalse" id="Fact000023" name="dei:PreCommencementTenderOffer">&#9744;</ix:nonNumeric></span></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Pre-commencement
    communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_906_edei--PreCommencementIssuerTenderOffer_c20240628__20240628_zrgeMPSVbS7i"><ix:nonNumeric contextRef="AsOf2024-06-28" format="ixt:booleanfalse" id="Fact000024" name="dei:PreCommencementIssuerTenderOffer">&#9744;</ix:nonNumeric></span></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Pre-commencement
    communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Securities
registered pursuant to Section 12(b) of the Act:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center; width: 38%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Title
    of each class</b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: center; width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center; width: 20%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Trading
    Symbol(s)</b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: center; width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center; width: 38%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Name
    of each exchange on which registered</b></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_90D_edei--Security12bTitle_c20240628__20240628__us-gaap--StatementClassOfStockAxis__custom--CommonStockParValue0.0001PerShareMember_zL1sMkS7ri8i"><ix:nonNumeric contextRef="From2024-06-282024-06-28_custom_CommonStockParValue0.0001PerShareMember" id="Fact000025" name="dei:Security12bTitle">Common
    Stock, par value $0.0001 per share</ix:nonNumeric></span></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_903_edei--TradingSymbol_c20240628__20240628__us-gaap--StatementClassOfStockAxis__custom--CommonStockParValue0.0001PerShareMember_zciL9plMgX0g"><ix:nonNumeric contextRef="From2024-06-282024-06-28_custom_CommonStockParValue0.0001PerShareMember" id="Fact000026" name="dei:TradingSymbol">CING</ix:nonNumeric></span></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_90D_edei--SecurityExchangeName_c20240628__20240628__us-gaap--StatementClassOfStockAxis__custom--CommonStockParValue0.0001PerShareMember_zDo4vvncFpZf"><ix:nonNumeric contextRef="From2024-06-282024-06-28_custom_CommonStockParValue0.0001PerShareMember" format="ixt-sec:exchnameen" id="Fact000027" name="dei:SecurityExchangeName">The
    Nasdaq Stock Market LLC</ix:nonNumeric></span></span></p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(Nasdaq
    Capital Market)</span></p></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_903_edei--Security12bTitle_c20240628__20240628__us-gaap--StatementClassOfStockAxis__custom--WarrantsExercisableForOneShareOfCommonStockMember_z6wx87Dq3jDl"><ix:nonNumeric contextRef="From2024-06-282024-06-28_custom_WarrantsExercisableForOneShareOfCommonStockMember" id="Fact000028" name="dei:Security12bTitle">Warrants,
    exercisable for one share of common stock</ix:nonNumeric></span></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_902_edei--TradingSymbol_c20240628__20240628__us-gaap--StatementClassOfStockAxis__custom--WarrantsExercisableForOneShareOfCommonStockMember_zFTgA3huBExi"><ix:nonNumeric contextRef="From2024-06-282024-06-28_custom_WarrantsExercisableForOneShareOfCommonStockMember" id="Fact000029" name="dei:TradingSymbol">CINGW</ix:nonNumeric></span></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_908_edei--SecurityExchangeName_c20240628__20240628__us-gaap--StatementClassOfStockAxis__custom--WarrantsExercisableForOneShareOfCommonStockMember_z5kaNKBBVs0f"><ix:nonNumeric contextRef="From2024-06-282024-06-28_custom_WarrantsExercisableForOneShareOfCommonStockMember" format="ixt-sec:exchnameen" id="Fact000030" name="dei:SecurityExchangeName">The
    Nasdaq Stock Market LLC</ix:nonNumeric></span></span></p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(Nasdaq
    Capital Market)</span></p></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Indicate
by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (&#167; 230.405
of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (&#167; 240.12b-2 of this chapter).</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Emerging
growth company <span id="xdx_90C_edei--EntityEmergingGrowthCompany_c20240628__20240628_zdtmGN96kny5"><ix:nonNumeric contextRef="AsOf2024-06-28" format="ixt:booleantrue" id="Fact000031" name="dei:EntityEmergingGrowthCompany">&#9746;</ix:nonNumeric></span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">If
an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying
with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. <span id="xdx_909_edei--EntityExTransitionPeriod_c20240628__20240628_zIE1jLeQkGbg"><ix:nonNumeric contextRef="AsOf2024-06-28" format="ixt:booleanfalse" id="Fact000032" name="dei:EntityExTransitionPeriod">&#9744;</ix:nonNumeric></span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<!-- Field: Rule-Page --><div style="margin-top: 0pt; margin-bottom: 0pt; width: 100%"><div style="border-top: Black 1.5pt solid; border-bottom: Black 4pt solid; font-size: 1pt">&#160;</div></div><!-- Field: /Rule-Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 100%">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.75in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Item
    1.01</b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Entry
    Into a Material Definitive Agreement.</b></span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
June 28, 2024, Cingulate, Inc. (the &#8220;<b><i>Company</i></b>&#8221;) entered into an inducement offer letter agreement (the &#8220;<b><i>Inducement
Letter</i></b>&#8221;) with certain holders (the &#8220;<b><i>Holders</i></b>&#8221;) of certain of its existing warrants to purchase
up to an aggregate of 3,187,500 shares of the Company&#8217;s common stock, par value $0.0001 per share (&#8220;<b><i>Common Stock</i></b>&#8221;)
issued to the Holders on February 6, 2024 (the &#8220;<b><i>Existing Warrants</i></b>&#8221;).</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Pursuant
to the Inducement Letter, the Holders agreed to exercise for cash its Existing Warrants at a reduced exercise price of $0.585 per share
in consideration for the Company&#8217;s agreement to issue in a private placement (i) new series C common stock purchase warrants (the
&#8220;<b><i>New Series C Warrants</i></b>&#8221;) to purchase an aggregate of 4,250,000 shares of Common Stock (the &#8220;<b><i>New
Series C Warrant Shares</i></b>&#8221;) and (ii) new series D common stock purchase warrants (the &#8220;<b><i>New Series D Warrants</i></b>&#8221;
and together with the New Series C Warrants, the &#8220;<b><i>New Warrants</i></b>&#8221;) to purchase an aggregate of 2,125,000 shares
of Common Stock (the &#8220;<b><i>New Series D Warrant Shares</i></b>&#8221; and together with the New Series C Warrant Shares, the (&#8220;<b><i>New
Warrant Shares</i></b>&#8221;), as described below.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
closing of the transactions contemplated pursuant to the Inducement Letter is expected to occur on or about July 1, 2024 (the &#8220;<b><i>Closing
Date</i></b>&#8221;), subject to satisfaction of customary closing conditions. The Company expects to receive aggregate gross proceeds
of approximately $1.86 million from the exercise of the Existing Warrants by the Holders, before deducting placement agent fees and other
offering expenses payable by the Company. The Company intends to use the net proceeds from the offering for continued research and development
and commercialization activities of CTx-1301, and for working capital, capital expenditures and general corporate purposes.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company engaged H.C. Wainwright &amp; Co., LLC (the &#8220;<b><i>Placement Agent</i></b>&#8221;) to act as its exclusive placement agent
in connection with the transactions summarized above and has agreed to pay the Placement Agent a cash fee equal to 8.0% of the
aggregate gross proceeds received from the Holders&#8217; exercise of its Existing Warrants pursuant to that certain engagement letter,
by and between the Company and the Placement Agent, dated as of December 27, 2023 (as amended, the &#8220;<b><i>Engagement Letter</i></b>&#8221;).
Pursuant to the Engagement Letter, the Company agreed to reimburse the Placement Agent for its expenses in connection with the exercise
of the Existing Warrants and the issuance of the New Warrants of: (i) $50,000 for fees and expenses of the Placement Agent&#8217;s
counsel, (ii) $35,000 for its non-accountable expenses and (iii) and $15,950 for its clearing costs. The Company also agreed
to issue to the Placement Agent or its designees warrants (the &#8220;<b><i>Placement Agent Warrants</i></b>&#8221;) to purchase up to
255,000 shares of Common Stock (the &#8220;<b><i>Placement Agent Warrant Shares</i></b>&#8221;). The Placement Agent Warrants
will have substantially the same terms as the New Series C Warrants, except that the Placement Agent Warrants will have an exercise price
equal to $0.7313.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
issuance of the shares of Common Stock underlying the Existing Warrants has been registered pursuant to an existing post-effective registration
statement on Form S-1 (File No. 333-276502), declared effective by the Securities and Exchange Commission (the &#8220;<b><i>SEC</i></b>&#8221;)
April 2, 2024.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company has agreed to file a registration statement on Form S-3 providing for the resale of the New Warrant Shares (the &#8220;<b><i>Resale
Registration Statement</i></b>&#8221;), as soon as reasonable practicable after the Closing Date (and in any event within 30 calendar
days of the date of the Inducement Letter), and to use commercially reasonable efforts to cause the Resale Registration Statement to
be declared effective by the SEC within 60 days following the date of the Inducement Letter (or within 90 calendar days in case of &#8220;full
review&#8221; of the Resale Registration Statement by the SEC) and to keep the Resale Registration Statement effective at all times until
the Holders no longer own any New Warrants or New Warrant Shares.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Pursuant
to the Inducement Letter, the Company agreed not to issue any shares of Common Stock or Common Stock equivalents or to file any other
registration statement with the SEC (in each case, subject to certain exceptions) until twenty (20) days after the Closing Date. The
Company has also agreed not to effect or agree to effect any Variable Rate Transaction (as defined in the Inducement Letter) until one
(1) year after the Closing Date (subject to certain exceptions).</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 2 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 100%">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Terms
of the New Warrants</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Duration
and Exercise Price</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Each
New Warrant will have an exercise price equal to $0.585 per share. The New Series C Warrants will be exercisable on or after the date
of the Stockholder Approval (as defined below) until the five (5) year anniversary of the initial exercise date. The New Series D Warrants
will be exercisable on or after the date of the Stockholder Approval until the two (2) year anniversary of the initial exercise date.
The exercise price and number of New Warrant Shares issuable upon exercise of the New Warrants is subject to appropriate adjustment in
the event of stock dividends, stock splits, subsequent rights offerings, pro rata distributions, reorganizations, or similar events affecting
the Common Stock and the exercise price.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Stockholder
Approval</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Pursuant
to Nasdaq Listing Rule 5635(d), the exercise of the New Warrants is subject to stockholder approval (the &#8220;<b><i>Stockholder Approval</i></b>&#8221;).
The Company agreed to convene a stockholders&#8217; meeting on or before 90 days following the Closing Date, to obtain such approval.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Exercisability</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Subject
to the receipt of the Stockholder Approval, the New Warrants will be exercisable, at the option of each holder, in whole or in part,
by delivering a duly executed exercise notice accompanied by payment in full for the number of shares of Common Stock purchased upon
such exercise (except in the case of a cashless exercise as discussed below). A holder (together with its affiliates) may not exercise
any portion of such holder&#8217;s New Warrants to the extent that the holder would own more than 4.99% (or, at the election of the holder,
9.99%) of the outstanding Common Stock immediately after exercise, except that upon prior notice from the holder to the Company, the
holder may increase or decrease the amount of ownership of outstanding stock after exercising the holder&#8217;s New Warrants up to 9.99%
of the number of shares of Common Stock outstanding immediately after giving effect to the exercise, as such percentage ownership is
determined in accordance with the terms of the New Warrants, provided that any increase will not be effective until 61 days following
notice to the Company.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Cashless
Exercise</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">If,
at the time a holder exercises its New Warrants, a registration statement registering the resale of the New Warrant Shares by the holder
under the Securities Act of 1933, as amended (the &#8220;<b><i>Securities Act</i></b>&#8221;) is not then effective or available, then
in lieu of making the cash payment otherwise contemplated to be made upon such exercise in payment of the aggregate exercise price, the
holder may elect instead to receive upon such exercise (either in whole or in part), the net number of shares of Common Stock determined
according to a formula set forth in the New Warrants.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>&#160;</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Rights
as a Stockholder</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Except
as otherwise provided in the New Warrants or by virtue of the holder&#8217;s ownership of shares of Common Stock, such holder of New
Warrants does not have the rights or privileges of a holder of Common Stock, including any voting rights, until such holder exercises
such holder&#8217;s New Warrants. The New Warrants will provide that the holders of the New Warrants have the right to participate in
distributions or dividends paid on shares of Common Stock.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Fundamental
Transactions</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">If
at any time the New Warrants are outstanding, the Company, either directly or indirectly, in one or more related transactions effect
a Fundamental Transaction (as defined in the New Warrants), a holder of New Warrants will be entitled to receive, the number of shares
of Common Stock of the successor or acquiring corporation or of the Company, if the Company is the surviving corporation, and any additional
consideration receivable as a result of the Fundamental Transaction by such holder of the number of shares of Common Stock for which
the New Warrants are exercisable immediately prior to the Fundamental Transaction. As an alternative, and at the holder&#8217;s option
in the event of a Fundamental Transaction, exercisable at any time concurrently with, or within 30 days after, the consummation of the
Fundamental Transaction (or, if later, the date of the public announcement of the applicable fundamental transaction), the Company shall
purchase the unexercised portion of the New Warrants from the holder by paying to the holder an amount of cash equal to the Black Scholes
Value (as defined in the New Warrants) of the remaining unexercised portion of the New Warrants on the date of the consummation of such
Fundamental Transaction.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 3 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 100%">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>&#160;</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Waivers
and Amendments</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
New Warrants may be modified or amended, or the provisions of the New Warrants waived with the Company&#8217;s and the holder&#8217;s
written consent.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
forms of Inducement Letter, the New Warrant and the Placement Agent Warrant are attached as Exhibits 10.1, 4.1 and 4.2, respectively.
The descriptions of the terms of the Inducement Letter, the New Warrants and the Placement Agent Warrants are not intended to be complete
and are qualified in their entirety by reference to such exhibits. The Inducement Letter contains customary representations, warranties
and covenants by the Company which were made only for the purposes of such agreements and as of specific dates, were solely for the benefit
of the parties to such agreements and may be subject to limitations agreed upon by the contracting parties.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company issued a press release on June 28, 2024 announcing the entering into of the Inducement Letter which press release is attached
as Exhibit 99.1 hereto.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.75in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Item
    3.02</b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Unregistered
    Sales of Equity Securities.</b></span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
New Warrants, Placement Agent Warrants, New Warrant Shares and Placement Agent Warrant Shares have not been registered under the Securities
Act and were offered pursuant to the exemption from registration provided in Section 4(a)(2) under the Securities Act, and Rule 506(b)
promulgated thereunder.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
description of the New Warrants and the Placement Agent Warrants under Item 1.01 of this Form 8-K is incorporated by reference herein.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">On June 10, 2024, the Company issued 139,821
shares of Common Stock to a consultant at a value of $0.704 per share. Such issuance was exempt from registration under Section 4(a)(2)
under the Securities Act.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.75in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Item
    3.03</b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Material
    Modifications to Rights of Security Holders.</b></span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
disclosure set forth under Item 1.01 of this Current Report on Form 8-K is incorporated herein by reference into this Item 3.03 in its
entirety.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.75in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Item
    9.01</b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Financial
    Statements and Exhibits.</b></span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(d)
Exhibits.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; width: 0.75in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Exhibit
    No.</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.1in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Description</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.1</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="text-decoration: underline"><a href="ex4-1.htm">Form of New Warrant.</a></span></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.2</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="ex4-2.htm">Form of Placement Agent Warrant.</a></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.1</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="text-decoration: underline"><a href="ex10-1.htm">Form of Inducement Letter.</a></span></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">99.1</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="text-decoration: underline"><a href="ex99-1.htm">Press Release of the Company, dated June 28, 2024.</a></span></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">104</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Cover
    Page Interactive Data File (embedded within the Inline XBRL document).</span></td></tr>
  </table>

<!-- Field: Page; Sequence: 4 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 100%">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>SIGNATURES</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Pursuant
to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by
the undersigned hereunto duly authorized.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Date:
    July 1, 2024</span></td>
    <td colspan="2" style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>CINGULATE,
    INC.</b></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 50%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 5%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 45%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">By:</span></td>
    <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>/s/
    Shane J. Schaffer</i></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Name:</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Shane
    J. Schaffer</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Title:
    </span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Chief
    Executive Officer</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 5; Options: Last -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p>


<!-- Field: Set; Name: xdx; ID: xdx_08B_extensions -->
<!-- eJx1kUFuwjAQRU/AHUZRlxE4Vouq7GgEqCoUBIh2a5JJa5F4orGhcKTeso4DoovWsmSNZt7/f+QoiqMpTXSFDO9PqxlssG4q5RBWWCKjydFPZM8vKfh3hR/aOlbGhfIKZuQZ9MxDX8rcN8LoUVssUhDDgXwcyHtIRCqHMJpHvbafkSl1gcZpVYEyBSyZGtboFJ87hY06kaH6HKy2yFaTSSHpi679DVIkEl7pqL6I9xZmsyzqxeH0oinTofFT45ND05IwrrD2drajbzekyQ/WUZ2+KW6Xs+MTcq6t2lU4IV4YXH8qxkXpF63JrB3l+znWO2SPJkLKRIwuqa4KMeBNA0piIINgWxmgEvIgBLZV+iPHL5+l4q2qDij6QohkiRyi/OPecRDAGBrFcGxZuOtoaPxnhQxXzx9OrJsk -->
</body>
</html>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-4
<SEQUENCE>2
<FILENAME>ex4-1.htm
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Exhibit
4.1</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">NEITHER
THE OFFER AND SALE OF THIS SECURITY NOR THE SECURITIES FOR WHICH THIS SECURITY IS EXERCISABLE HAVE BEEN REGISTERED WITH THE SECURITIES
AND EXCHANGE COMMISSION OR THE SECURITIES COMMISSION OF ANY STATE IN RELIANCE UPON AN EXEMPTION FROM REGISTRATION UNDER THE SECURITIES
ACT OF 1933, AS AMENDED (THE &ldquo;SECURITIES ACT&rdquo;), AND, ACCORDINGLY, THIS SECURITY MAY NOT BE OFFERED OR SOLD EXCEPT PURSUANT
TO AN EFFECTIVE REGISTRATION STATEMENT UNDER THE SECURITIES ACT OR PURSUANT TO AN AVAILABLE EXEMPTION FROM, OR IN A TRANSACTION NOT SUBJECT
TO, THE REGISTRATION REQUIREMENTS OF THE SECURITIES ACT AND IN ACCORDANCE WITH APPLICABLE STATE SECURITIES LAWS. THIS SECURITY AND THE
SECURITIES ISSUABLE UPON EXERCISE OF THIS SECURITY MAY BE PLEDGED IN CONNECTION WITH A BONA FIDE MARGIN ACCOUNT OR OTHER LOAN SECURED
BY SUCH SECURITIES.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>SERIES
[C] [D] COMMON STOCK PURCHASE WARRANT</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase"><B>CINGULATE
INC.</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase"><B></B></FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 50%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Warrant
    Shares: ___________</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 50%; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Issue
    Date: July 1, 2024</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">THIS
SERIES [C] [D] COMMON STOCK PURCHASE WARRANT (the &ldquo;<U>Warrant</U>&rdquo;) certifies that, for value received__________ or its assigns
(the &ldquo;<U>Holder</U>&rdquo;) is entitled, upon the terms and subject to the limitations on exercise and the conditions hereinafter
set forth, at any time on or after the Stockholder Approval Date (as defined below) (the &ldquo;<U>Initial Exercise Date</U>&rdquo;)
and on or prior to 5:00 p.m. (New York City time) on the date that is the ___<SUP>1</SUP> of the Initial Exercise Date, provided that,
if such date is not a Trading Day, insert the immediately following Trading Day (the &ldquo;<U>Termination Date</U>&rdquo;) but not thereafter,
to subscribe for and purchase from Cingulate Inc., a Delaware corporation (the &ldquo;<U>Company</U>&rdquo;), up to _____shares (as subject
to adjustment hereunder, the &ldquo;<U>Warrant Shares</U>&rdquo;) of Common Stock. The purchase price of one share of Common Stock under
this Warrant shall be equal to the Exercise Price, as defined in Section 2(b).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Section
1</U>. <U>Definitions</U>. In addition to the terms defined elsewhere in this Warrant, the following terms have the meanings
indicated in this Section 1:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Affiliate</U>&rdquo;
means any Person that, directly or indirectly through one or more intermediaries, controls or is controlled by or is under common control
with a Person, as such terms are used in and construed under Rule 405 under the Securities Act.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<!-- Field: Rule-Page --><DIV STYLE="margin-top: 0pt; margin-bottom: 0pt; width: 25%"><DIV STYLE="font-size: 1pt; border-top: Black 1.5pt solid">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><SUP>1
</SUP><U>Series C New Warrants</U>: five (5) year anniversary. <U>Series D New Warrants</U>: two (2) year anniversary</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 1; Options: NewSection; Value: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->1<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white">&ldquo;<U>Bid
Price</U>&rdquo; means, for any date, the price determined by the first of the following clauses that applies: (a) if the Common Stock
is then listed or quoted on a Trading Market, the bid price of the Common Stock for the time in question (or the nearest preceding date)
on the Trading Market on which the Common Stock is then listed or quoted as reported by Bloomberg L.P. (&ldquo;Bloomberg&rdquo;) (based
on a Trading Day from 9:30 a.m. (New York City time) to 4:02 p.m. (New York City time)), (b) if OTCQB or OTCQX is not a Trading Market,
the volume weighted average price of the Common Stock for such date (or the nearest preceding date) on OTCQB or OTCQX as applicable,
(c) if the Common Stock is not then listed or quoted for trading on OTCQB or OTCQX and if prices for the Common Stock are then reported
on the Pink Open Market (or a similar organization or agency succeeding to its functions of reporting prices), the most recent bid price
per share of the Common Stock so reported, or (d) in all other cases, the fair market value of a share of Common Stock as determined
by an independent appraiser selected in good faith by the Holders of a majority in interest of the Warrants then outstanding and reasonably
acceptable to the Company, the reasonable fees and expenses of which shall be paid by the Company.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Board
of Directors</U>&rdquo; means the board of directors of the Company.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Commission</U>&rdquo;
means the United States Securities and Exchange Commission.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Common
Stock</U>&rdquo; means the common stock of the Company, par value $0.0001 per share, and any other class of securities into which such
securities may hereafter be reclassified or changed.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Common
Stock Equivalents</U>&rdquo; means any securities of the Company or the Subsidiaries which would entitle the holder thereof to acquire
at any time Common Stock, including, without limitation, any debt, preferred stock, right, option, warrant or other instrument that is
at any time convertible into or exercisable or exchangeable for, or otherwise entitles the holder thereof to receive, Common Stock.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Exchange
Act</U>&rdquo; means the Securities Exchange Act of 1934, as amended, and the rules and regulations promulgated thereunder.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Letter
Agreement</U>&rdquo; means that certain letter agreement between the initial Holder hereof and the Company, dated as of June 28, 2024,
pursuant to which such initial Holder agreed to exercise one or more warrants to purchase shares of Common Stock and the Company agreed
to issue to the initial Holder of this Warrant.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Person</U>&rdquo;
means an individual or corporation, partnership, trust, incorporated or unincorporated association, joint venture, limited liability
company, joint stock company, government (or an agency or subdivision thereof) or other entity of any kind.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Rule
144</U>&rdquo; means Rule 144 promulgated by the Commission pursuant to the Securities Act, as such Rule may be amended or interpreted
from time to time, or any similar rule or regulation hereafter adopted by the Commission having substantially the same purpose and effect
as such Rule.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 2; Value: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->2<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Securities
Act</U>&rdquo; means the Securities Act of 1933, as amended, and the rules and regulations promulgated thereunder.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Stockholder
Approval</U>&rdquo; means such approval as may be required by the applicable rules and regulations of the Nasdaq Stock Market (or any
successor entity) from the shareholders of the Company with respect to issuance of all of the Warrants and the Warrant Shares upon the
exercise thereof.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Stockholder
Approval Date</U>&rdquo; means the date on which Stockholder Approval is received and deemed effective under Delaware law.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Subsidiaries</U>&rdquo;
means the subsidiaries of the Company set forth in the SEC Reports and shall, where applicable, also include any direct or indirect subsidiary
of the Company formed or acquired after the date hereof.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Trading
Day</U>&rdquo; means a day on which the Common Stock is traded on a Trading Market.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Trading
Market</U>&rdquo; means any of the following markets or exchanges on which the Common Stock is listed or quoted for trading on the date
in question: the NYSE American, the Nasdaq Capital Market, the Nasdaq Global Market, the Nasdaq Global Select Market or the New York
Stock Exchange (or any successors to any of the foregoing).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Transfer
Agent</U>&rdquo; means Computershare Trust Company, N.A., the current transfer agent of the Company, with a mailing address of 480 Washington
Blvd 26th Floor, Jersey City, NJ 07310, and any successor transfer agent of the Company.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white">&ldquo;<U>VWAP</U>&rdquo;
means, for any date, the price determined by the first of the following clauses that applies: (a) if the Common Stock is then listed
or quoted on a Trading Market, the daily volume weighted average price of the Common Stock for such date (or the nearest preceding date)
on the Trading Market on which the Common Stock is then listed or quoted as reported by Bloomberg (based on a Trading Day from 9:30 a.m.
(New York City time) to 4:02 p.m. (New York City time)), (b) if OTCQB or OTCQX is not a Trading Market, the volume weighted average price
of the Common Stock for such date (or the nearest preceding date) on OTCQB or OTCQX as applicable, (c) if the Common Stock is not then
listed or quoted for trading on OTCQB or OTCQX and if prices for the Common Stock are then reported on The Pink Open Market (or a similar
organization or agency succeeding to its functions of reporting prices), the most recent bid price per share of the Common Stock so reported,
or (d) in all other cases, the fair market value of a share of Common Stock as determined by an independent appraiser selected in good
faith by the Holders of a majority in interest of the Warrants then outstanding and reasonably acceptable to the Company, the reasonable
fees and expenses of which shall be paid by the Company.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white">&ldquo;<U>Warrants</U>&rdquo;
means this Warrant and other Common Stock purchase warrants issued by the Company pursuant to the Letter Agreement.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 3; Value: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->3<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Section
2</U>. <U>Exercise</U>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">a)
<U>Exercise of Warrant</U>. Exercise of the purchase rights represented by this Warrant may be made, in whole or in part, at any time
or times on or after the Initial Exercise Date and on or before the Termination Date by delivery to the Company of a duly executed PDF
copy submitted by e-mail (or e-mail attachment) of the Notice of Exercise in the form attached hereto as <U>Annex A</U> (the &ldquo;<U>Notice
of Exercise</U>&rdquo;). Within the earlier of (i) one (1) Trading Day and (ii) the number of Trading Days comprising the Standard Settlement
Period (as defined in Section 2(d)(i) herein) following the date of exercise as aforesaid, the Holder shall deliver the aggregate Exercise
Price for the Warrant Shares specified in the applicable Notice of Exercise by wire transfer or cashier&rsquo;s check drawn on a United
States bank, in either case in immediately available funds, unless the cashless exercise procedure specified in Section 2(c) below is
specified in the applicable Notice of Exercise. No ink-original Notice of Exercise shall be required, nor shall any medallion guarantee
(or other type of guarantee or notarization) of any Notice of Exercise be required. The Company shall have no obligation to inquire with
respect to or otherwise confirm the authenticity of the signature(s) contained on any Notice of Exercise nor the authority of the person
so executing such Notice of Exercise. Notwithstanding anything herein to the contrary, the Holder shall not be required to physically
surrender this Warrant to the Company until the Holder has purchased all of the Warrant Shares available hereunder and the Warrant has
been exercised in full, in which case, the Holder shall surrender this Warrant to the Company for cancellation within three (3) Trading
Days of the date on which the final Notice of Exercise is delivered to the Company. Partial exercises of this Warrant resulting in purchases
of a portion of the total number of Warrant Shares available hereunder shall have the effect of lowering the outstanding number of Warrant
Shares purchasable hereunder in an amount equal to the applicable number of Warrant Shares purchased. The Holder and the Company shall
maintain records showing the number of Warrant Shares purchased and the date of such purchases. The Company shall deliver any objection
to any Notice of Exercise within one (1) Trading Day of receipt of such notice. <B>The Holder and any assignee, by acceptance of this
Warrant, acknowledges and agrees that, by reason of the provisions of this paragraph, following the purchase of a portion of the Warrant
Shares hereunder, the number of Warrant Shares available for purchase hereunder at any given time may be less than the amount stated
on the face hereof.</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">b)
<U>Exercise Price</U>. The exercise price per share of Common Stock under this Warrant shall be <B>$0.585</B>, subject to adjustment
hereunder (the &ldquo;<U>Exercise Price</U>&rdquo;).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 4; Value: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->4<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">c)
<U>Cashless Exercise</U>. If at the time of exercise hereof there is no effective registration statement registering, or the prospectus
contained therein is not available for the resale of the Warrant Shares by the Holder, then this Warrant may also be exercised, in whole
or in part, at such time by means of a &ldquo;cashless exercise&rdquo; in which the Holder shall be entitled to receive a number of Warrant
Shares equal to the quotient obtained by dividing [(A-B) (X)] by (A), where:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; width: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(A)</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">=</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">as
    applicable: (i) the VWAP on the Trading Day immediately preceding the date of the applicable Notice of Exercise if such Notice of
    Exercise is (1) both executed and delivered pursuant to Section 2(a) hereof on a day that is not a Trading Day or (2) both executed
    and delivered pursuant to Section 2(a) hereof on a Trading Day prior to the opening of &ldquo;regular trading hours&rdquo; (as defined
    in Rule 600(b) of Regulation NMS promulgated under the federal securities laws) on such Trading Day, (ii) at the option of the Holder,
    either (y) the VWAP on the Trading Day immediately preceding the date of the applicable Notice of Exercise or (z) the Bid Price of
    the Common Stock on the principal Trading Market as reported by <U>Bloomberg</U> as of the time of the Holder&rsquo;s execution of
    the applicable Notice of Exercise if such Notice of Exercise is executed during &ldquo;regular trading hours&rdquo; on a Trading
    Day and is delivered within two (2) hours thereafter (including until two (2) hours after the close of &ldquo;regular trading hours&rdquo;
    on a Trading Day) pursuant to Section 2(a) hereof or (iii) the VWAP on the date of the applicable Notice of Exercise if the date
    of such Notice of Exercise is a Trading Day and such Notice of Exercise is both executed and delivered pursuant to Section 2(a) hereof
    after the close of &ldquo;regular trading hours&rdquo; on such Trading Day;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(B)</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">=</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
    Exercise Price of this Warrant, as adjusted hereunder; and</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(X)</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">=</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
    number of Warrant Shares that would be issuable upon exercise of this Warrant in accordance with the terms of this Warrant if such
    exercise were by means of a cash exercise rather than a cashless exercise.</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white">If
Warrant Shares are issued in such a cashless exercise, the parties acknowledge and agree that in accordance with Section 3(a)(9) of the
Securities Act, the holding period of the Warrant Shares being issued may be tacked on to the holding period of this Warrant. The Company
agrees not to take any position contrary to this Section 2(c).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">d)
<U>Mechanics of Exercise</U>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1.5in; text-align: justify; text-indent: 0.5in">i. <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Delivery
of Warrant Shares Upon Exercise</U>. The Company shall cause the Warrant Shares purchased hereunder to be transmitted by the Transfer
Agent to the Holder by crediting the account of the Holder&rsquo;s or its designee&rsquo;s balance account with the Depository Trust
Company through its Deposit or Withdrawal at Custodian system (&ldquo;<U>DWAC</U>&rdquo;) if the Company&rsquo;s transfer agent is then
a participant in such system and either (A) there is an effective registration statement permitting the issuance of the Warrant Shares
to or resale of the Warrant Shares by the Holder or (B) the Warrant Shares are eligible for resale by the Holder without volume or manner-of-sale
limitations pursuant to Rule 144 (assuming cashless exercise of the Warrants), and otherwise by physical delivery of a certificate, registered
in the Company&rsquo;s share register in the name of the Holder or its designee, for the number of Warrant Shares to which the Holder
is entitled pursuant to such exercise to the address specified by the Holder in the Notice of Exercise by the date that is earlier of
(i) one (1) Trading Day after the delivery to the Company of the Notice of Exercise and (ii) the number of Trading Days comprising the
Standard Settlement Period after the delivery to the Company of the Notice of Exercise (such date, the &ldquo;<U>Warrant Share Delivery
Date</U>&rdquo;). Upon delivery of the Notice of Exercise, the Holder shall be deemed for all corporate purposes to have become the holder
of record of the Warrant Shares with respect to which this Warrant has been exercised, irrespective of the date of delivery of the Warrant
Shares, provided that payment of the aggregate Exercise Price (other than in the case of a cashless exercise) is received within the
earlier of (i) one (1) Trading Day and (ii) the number of Trading Days comprising the Standard Settlement Period following delivery of
the Notice of Exercise. If the Company fails for any reason to deliver to the Holder the Warrant Shares subject to a Notice of Exercise
by the Warrant Share Delivery Date, the Company shall pay to the Holder, in cash, as liquidated damages and not as a penalty, for each
$1,000 of Warrant Shares subject to such exercise (based on the VWAP of the Common Stock on the date of the applicable Notice of Exercise),
$10 per Trading Day (increasing to $20 per Trading Day on the third Trading Day after the Warrant Share Delivery Date) for each Trading
Day after such Warrant Share Delivery Date until such Warrant Shares are delivered or Holder rescinds such exercise. The Company agrees
to maintain a transfer agent that is a participant in the FAST program so long as this Warrant remains outstanding and exercisable. As
used herein, &ldquo;<U>Standard Settlement Period</U>&rdquo; means the standard settlement period, expressed in a number of Trading Days,
on the Company&rsquo;s primary Trading Market with respect to the Common Stock as in effect on the date of the delivery of the Notice
of Exercise.</FONT></P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1.5in; text-align: justify; text-indent: -9pt"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1.5in; text-align: justify; text-indent: -9pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>




<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1.5in; text-align: justify; text-indent: -9pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">ii.
<U>Delivery of New Warrants Upon Exercise</U>. If this Warrant shall have been exercised in part, the Company shall, at the request of
a Holder and upon surrender of this Warrant, at the time of delivery of the Warrant Shares, deliver to the Holder a new Warrant evidencing
the rights of the Holder to purchase the unpurchased Warrant Shares remaining available under this Warrant, which new Warrant shall in
all other respects be identical with this Warrant.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">iii.
<U>Rescission Rights</U>. If the Company fails to cause the Transfer Agent to transmit to the Holder the Warrant Shares pursuant to Section
2(d)(i) by the Warrant Share Delivery Date, then the Holder will have the right to rescind such exercise.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 5; Value: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->5<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">iv.
<U>Compensation for Buy-In on Failure to Timely Deliver Warrant Shares Upon Exercise</U>. In addition to any other rights available to
the Holder, if the Company fails to cause the Transfer Agent to transmit to the Holder the Warrant Shares in accordance with the provisions
of Section 2(d)(i) above pursuant to an exercise on or before the Warrant Share Delivery Date, and if after such date the Holder is required
by its broker to purchase (in an open market transaction or otherwise) or the Holder&rsquo;s brokerage firm otherwise purchases, shares
of Common Stock to deliver in satisfaction of a sale by the Holder of the Warrant Shares which the Holder anticipated receiving upon
such exercise (a &ldquo;<U>Buy-In</U>&rdquo;), then the Company shall (A) pay in cash to the Holder the amount, if any, by which (x)
the Holder&rsquo;s total purchase price (including reasonable and customary brokerage commissions, if any) for the shares of Common Stock
so purchased exceeds (y) the amount obtained by multiplying (1) the number of Warrant Shares that the Company was required to deliver
to the Holder in connection with the exercise at issue times (2) the price at which the sell order giving rise to such purchase obligation
was executed, and (B) at the option of the Holder, either reinstate the portion of the Warrant and equivalent number of Warrant Shares
for which such exercise was not honored (in which case such exercise shall be deemed rescinded) or deliver to the Holder the number of
shares of Common Stock that would have been issued had the Company timely complied with its exercise and delivery obligations hereunder.
For example, if the Holder purchases Common Stock having a total purchase price of $11,000 to cover a Buy-In with respect to an attempted
exercise of shares of Common Stock with an aggregate sale price giving rise to such purchase obligation of $10,000, under clause (A)
of the immediately preceding sentence the Company shall be required to pay the Holder $1,000. The Holder shall provide the Company written
notice indicating the amounts payable to the Holder in respect of the Buy-In and, upon request of the Company, evidence of the amount
of such loss. Nothing herein shall limit a Holder&rsquo;s right to pursue any other remedies available to it hereunder, at law or in
equity including, without limitation, a decree of specific performance and/or injunctive relief with respect to the Company&rsquo;s failure
to timely deliver shares of Common Stock upon exercise of the Warrant as required pursuant to the terms hereof.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">v.
<U>No Fractional Shares or Scrip</U>. No fractional shares or scrip representing fractional shares shall be issued upon the exercise
of this Warrant. As to any fraction of a share which the Holder would otherwise be entitled to purchase upon such exercise, the Company
shall, at its election, either pay a cash adjustment in respect of such final fraction in an amount equal to such fraction multiplied
by the Exercise Price or round up to the next whole share.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">vi.
<U>Charges, Taxes and Expenses</U>. Issuance of Warrant Shares shall be made without charge to the Holder for any issue or transfer tax
or other incidental expense in respect of the issuance of such Warrant Shares, all of which taxes and expenses shall be paid by the Company,
and such Warrant Shares shall be issued in the name of the Holder or in such name or names as may be directed by the Holder; <U>provided</U>,
<U>however</U>, that in the event that Warrant Shares are to be issued in a name other than the name of the Holder, this Warrant when
surrendered for exercise shall be accompanied by the assignment form attached hereto as <U>Annex B</U> (the &ldquo;<U>Assignment Form</U>&rdquo;)
duly executed by the Holder and the Company may require, as a condition thereto, the payment of a sum sufficient to reimburse it for
any transfer tax incidental thereto. The Company shall pay all Transfer Agent fees required for same-day processing of any Notice of
Exercise and all fees to the Depository Trust Company (or another established clearing corporation performing similar functions) required
for same-day electronic delivery of the Warrant Shares.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 6; Value: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->6<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">vii. <U>Closing
of Books</U>. The Company will not close its stockholder books or records in any manner which prevents the timely exercise of this
Warrant, pursuant to the terms hereof.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">e)
<U>Beneficial Ownership Limitations</U>. The Company shall not effect any exercise of this Warrant, and a Holder shall not have the right
to exercise any portion of this Warrant, pursuant to Section 2 or otherwise, to the extent that after giving effect to such issuance
after exercise as set forth on the applicable Notice of Exercise, the Holder (together with the Holder&rsquo;s Affiliates, and any other
Persons acting as a group together with the Holder or any of the Holder&rsquo;s Affiliates (such Persons, &ldquo;<U>Attribution Parties</U>&rdquo;)),
would beneficially own in excess of the Beneficial Ownership Limitation (as defined below). For purposes of the foregoing sentence, the
number of shares of Common Stock beneficially owned by the Holder and its Affiliates and Attribution Parties shall include the number
of shares of Common Stock issuable upon exercise of this Warrant with respect to which such determination is being made, but shall exclude
the number of shares of Common Stock which would be issuable upon (i) exercise of the remaining, nonexercised portion of this Warrant
beneficially owned by the Holder or any of its Affiliates or Attribution Parties and (ii) exercise or conversion of the unexercised or
nonconverted portion of any other securities of the Company (including, without limitation, any other Common Stock Equivalents) subject
to a limitation on conversion or exercise analogous to the limitation contained herein beneficially owned by the Holder or any of its
Affiliates or Attribution Parties. Except as set forth in the preceding sentence, for purposes of this Section 2(e), beneficial ownership
shall be calculated in accordance with Section 13(d) of the Exchange Act and the rules and regulations promulgated thereunder, it being
acknowledged by the Holder that the Company is not representing to the Holder that such calculation is in compliance with Section 13(d)
of the Exchange Act and the Holder is solely responsible for any schedules required to be filed in accordance therewith and the calculations
required under this Section 2(e). To the extent that the limitation contained in this Section 2(e) applies, the determination of whether
this Warrant is exercisable (in relation to other securities owned by the Holder together with any Affiliates and Attribution Parties)
and of which portion of this Warrant is exercisable shall be in the sole discretion of the Holder, and the submission of a Notice of
Exercise shall be deemed to be the Holder&rsquo;s determination of whether this Warrant is exercisable (in relation to other securities
owned by the Holder together with any Affiliates and Attribution Parties) and of which portion of this Warrant is exercisable, in each
case subject to the Beneficial Ownership Limitation, and the Company shall have no obligation to verify or confirm the accuracy of such
determination. In addition, a determination as to any group status as contemplated above shall be determined in accordance with Section
13(d) of the Exchange Act and the rules and regulations promulgated thereunder. For purposes of this Section 2(e), in determining the
number of outstanding shares of Common Stock, a Holder may rely on the number of outstanding shares of Common Stock as reflected in (A)
the Company&rsquo;s most recent periodic or annual report filed with the Commission, as the case may be, (B) a more recent public announcement
by the Company or (C) a more recent written notice by the Company or the Transfer Agent setting forth the number of shares of Common
Stock outstanding. Upon the written or oral request of a Holder, the Company shall within one (1) Trading Day confirm orally and in writing
to the Holder the number of shares of Common Stock then outstanding. In any case, the number of outstanding shares of Common Stock shall
be determined after giving effect to the conversion or exercise of securities of the Company, including this Warrant, by the Holder or
its Affiliates or Attribution Parties since the date as of which such number of outstanding shares of Common Stock was reported. The
&ldquo;<U>Beneficial Ownership Limitation</U>&rdquo; shall be [4.99%]/[9.99] of the number of shares of the Common Stock outstanding
immediately after giving effect to the issuance of shares of Common Stock issuable upon exercise of this Warrant. The Holder, upon notice
to the Company, may increase or decrease the Beneficial Ownership Limitation provisions of this Section 2(e), provided that the Beneficial
Ownership Limitation in no event exceeds 9.99% of the number of shares of the Common Stock outstanding immediately after giving effect
to the issuance of shares of Common Stock upon exercise of this Warrant held by the Holder and the provisions of this Section 2(e) shall
continue to apply. Any increase in the Beneficial Ownership Limitation will not be effective until the 61<SUP>st</SUP> day after such
notice is delivered to the Company. The provisions of this Section 2(e) shall be construed and implemented in a manner otherwise than
in strict conformity with the terms of this Section 2(e) to correct this Section 2(e) (or any portion hereof) which may be defective
or inconsistent with the intended Beneficial Ownership Limitation herein contained or to make changes or supplements necessary or desirable
to properly give effect to such limitation. The limitations contained in this Section 2(e) shall apply to a successor holder of this
Warrant.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 7; Value: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->7<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Section
3</U>. <U>Certain Adjustments</U>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">a)
<U>Stock Dividends and Splits</U>. If the Company, at any time while this Warrant is outstanding: (i) pays a stock dividend or otherwise
makes a distribution or distributions on shares of its Common Stock or any other equity or equity equivalent securities payable in shares
of Common Stock (which, for avoidance of doubt, shall not include any shares of Common Stock issued by the Company upon exercise of this
Warrant), (ii) subdivides outstanding shares of Common Stock into a larger number of shares, (iii) combines (including by way of reverse
stock split) outstanding shares of Common Stock into a smaller number of shares, or (iv) issues by reclassification of shares of the
Common Stock any shares of capital stock of the Company, then in each case the Exercise Price shall be multiplied by a fraction of which
the numerator shall be the number of shares of Common Stock (excluding treasury shares, if any) outstanding immediately before such event
and of which the denominator shall be the number of shares of Common Stock outstanding immediately after such event, and the number of
shares issuable upon exercise of this Warrant shall be proportionately adjusted such that the aggregate Exercise Price of this Warrant
shall remain unchanged. Any adjustment made pursuant to this Section 3(a) shall become effective immediately after the record date for
the determination of stockholders entitled to receive such dividend or distribution and shall become effective immediately after the
effective date in the case of a subdivision, combination or re-classification.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>




<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">b)
<U>Subsequent Rights Offerings</U>. In addition to any adjustments pursuant to Section 3(a) above, if at any time while this Warrant
is outstanding the Company grants, issues or sells any Common Stock Equivalents or rights to purchase stock, warrants, securities or
other property pro rata to the record holders of any class of shares of Common Stock (the &ldquo;<U>Purchase Rights</U>&rdquo;), then
the Holder will be entitled to acquire, upon the terms applicable to such Purchase Rights, the aggregate Purchase Rights which the Holder
could have acquired if the Holder had held the number of shares of Common Stock acquirable upon complete exercise of this Warrant (without
regard to any limitations on exercise hereof, including without limitation, the Beneficial Ownership Limitation) immediately before the
date on which a record is taken for the grant, issuance or sale of such Purchase Rights, or, if no such record is taken, the date as
of which the record holders of shares of Common Stock are to be determined for the grant, issue or sale of such Purchase Rights (<U>provided</U>,
<U>however</U>, that to the extent that the Holder&rsquo;s right to participate in any such Purchase Right would result in the Holder
exceeding the Beneficial Ownership Limitation, then the Holder shall not be entitled to participate in such Purchase Right to such extent
(or beneficial ownership of such shares of Common Stock as a result of such Purchase Right to such extent) and such Purchase Right to
such extent shall be held in abeyance for the Holder until such time, if ever, as its right thereto would not result in the Holder exceeding
the Beneficial Ownership Limitation); provided, that such Purchase Right shall terminate on, and shall not be held in abeyance for any
period subsequent to the Termination Date.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">c)
<U>Pro Rata Distributions</U>. During such time as this Warrant is outstanding, if the Company shall declare or make any dividend or
other distribution of its assets (or rights to acquire its assets) to holders of shares of Common Stock, by way of return of capital
or otherwise (including, without limitation, any distribution of cash, stock or other securities, property or options by way of a dividend,
spin off, reclassification, corporate rearrangement, scheme of arrangement or other similar transaction) (a &ldquo;<U>Distribution</U>&rdquo;),
at any time after the issuance of this Warrant, then, in each such case, the Holder shall be entitled to participate in such Distribution
to the same extent that the Holder would have participated therein if the Holder had held the number of shares of Common Stock acquirable
upon complete exercise of this Warrant (without regard to any limitations on exercise hereof, including without limitation, the Beneficial
Ownership Limitation) immediately before the date of which a record is taken for such Distribution, or, if no such record is taken, the
date as of which the record holders of shares of Common Stock are to be determined for the participation in such Distribution (<U>provided</U>,
<U>however</U>, that to the extent that the Holder&rsquo;s right to participate in any such Distribution would result in the Holder exceeding
the Beneficial Ownership Limitation, then the Holder shall not be entitled to participate in such Distribution to such extent (or in
the beneficial ownership of any shares of Common Stock as a result of such Distribution to such extent) and the portion of such Distribution
shall be held in abeyance for the benefit of the Holder until such time, if ever, as its right thereto would not result in the Holder
exceeding the Beneficial Ownership Limitation); provided, that such Purchase Right shall terminate on, and shall not be held in abeyance
for any period subsequent to the Termination Date.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 8; Value: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->8<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">d)
<U>Fundamental Transaction</U>. If, at any time while this Warrant is outstanding, (i) the Company (and all of its Subsidiaries, taken
as a whole), directly or indirectly, in one or more related transactions effects any merger or consolidation of the Company with or into
another Person (other than for the purpose of changing the Company&rsquo;s name and/or the jurisdiction of incorporation of the Company
or a holding company for the Company), (ii) the Company, directly or indirectly, effects any sale, lease, license, assignment, transfer,
conveyance or other disposition of all or substantially all of its assets in one or a series of related transactions, (iii) any, direct
or indirect, purchase offer, tender offer or exchange offer (whether by the Company or another Person) is completed pursuant to which
holders of the outstanding equity securities of the Company having voting power, including the power to vote on the election of directors
of the Company, are permitted to sell, tender or exchange their securities for other securities, cash or property and has been accepted
by the holders of the outstanding securities representing more than 50% of the aggregate voting power, including the power to vote on
the election of directors of the Company, of the issued and outstanding equity securities of the Company, (iv) the Company, directly
or indirectly, in one or more related transactions effects any reclassification, reorganization or recapitalization of the Common Stock
or any compulsory share exchange pursuant to which the Common Stock is effectively converted into or exchanged for other securities,
cash or property, or (v) the Company, directly or indirectly, in one or more related transactions consummates a stock or share purchase
agreement or other business combination (including, without limitation, a reorganization, recapitalization, spin-off, merger or scheme
of arrangement) with another Person or group of Persons whereby such other Person or group acquires securities representing more than
50% of the aggregate voting power, including the power to vote on the election of directors of the Company, of the issued and outstanding
equity securities of the Company (each a &ldquo;<U>Fundamental Transaction</U>&rdquo;), then, upon any subsequent exercise of this Warrant,
the Holder shall have the right to receive, for each Warrant Share that would have been issuable upon such exercise immediately prior
to the occurrence of such Fundamental Transaction, at the option of the Holder (without regard to any limitation in Section 2(d) on the
exercise of this Warrant), the number of shares of Common Stock of the successor or acquiring corporation or of the Company, if it is
the surviving corporation, and any additional consideration (the &ldquo;<U>Alternate Consideration</U>&rdquo;) receivable as a result
of such Fundamental Transaction by a holder of the number of shares of Common Stock for which this Warrant is exercisable immediately
prior to such Fundamental Transaction (without regard to any limitation in Section 2(e) on the exercise of this Warrant). For purposes
of any such exercise, the determination of the Exercise Price shall be appropriately adjusted to apply to such Alternate Consideration
based on the amount of Alternate Consideration issuable in respect of one share of Common Stock in such Fundamental Transaction, and
the Company shall apportion the Exercise Price among the Alternate Consideration in a reasonable manner reflecting the relative value
of any different components of the Alternate Consideration. If holders of Common Stock are given any choice as to the securities, cash
or property to be received in a Fundamental Transaction, then the Holder shall be given the same choice as to the Alternate Consideration
it receives upon any exercise of this Warrant following such Fundamental Transaction. Notwithstanding anything to the contrary, in the
event of a Fundamental Transaction (other than (x) any stock split or reverse stock split, (y) any transaction effected solely for the
purpose of changing the jurisdiction of incorporation of the Company, or (z) any holding company reorganization or parent-subsidiary
merger not requiring stockholder approval pursuant to Sections 251(g) or 253 of the Delaware General Corporation Law (or any successor
provisions thereof)), and for the avoidance of doubt, the Fundamental Transaction is approved by the Company&rsquo;s board of directors
and within the control of the Company, the Company or any Successor Entity (as defined below) shall, at the Holder&rsquo;s option, exercisable
at any time concurrently with, or within 30 days after, the consummation of the Fundamental Transaction (or, if later, the date of the
public announcement of the applicable Fundamental Transaction), purchase this Warrant from the Holder by paying to the Holder an amount
of cash equal to the Black Scholes Value (as defined below) of the remaining unexercised portion of this Warrant on the date of the consummation
of such Fundamental Transaction; provided, however, if the Fundamental Transaction is not within the Company&rsquo;s control, including
not approved by the Company&rsquo;s Board of Directors, Holder shall only be entitled to receive from the Company or any Successor Entity,
as of the date of consummation of such Fundamental Transaction, the same type or form of consideration (and in the same proportion),
at the Black Scholes Value of the unexercised portion of this Warrant, that is being offered and paid to the holders of Common Stock
of the Company in connection with the Fundamental Transaction, whether that consideration be in the form of cash, stock or any combination
thereof, or whether the holders of Common Stock are given the choice to receive from among alternative forms of consideration in connection
with the Fundamental Transaction; provided, further, that if holders of Common Stock of the Company are not offered or paid any consideration
in such Fundamental Transaction, such holders of Common Stock will be deemed to have received common stock of the Successor Entity (which
Successor Entity may be the Company following such Fundamental Transaction) in such Fundamental Transaction. &ldquo;<U>Black Scholes
Value</U>&rdquo; means the value of this Warrant based on the Black Scholes Option Pricing Model obtained from the &ldquo;OV&rdquo; function
on Bloomberg determined as of the day of consummation of the applicable Fundamental Transaction for pricing purposes and reflecting (A)
a risk-free interest rate corresponding to the U.S. Treasury rate for a period equal to the time between the date of the public announcement
of the applicable Fundamental Transaction and the Termination Date, (B) an expected volatility equal to the 100 day volatility obtained
from the HVT function on Bloomberg (determined utilizing a 365-day annualization factor) as of the Trading Day immediately following
the public announcement of the applicable Fundamental Transaction, (C) the underlying price per share used in such calculation shall
be the sum of the price per share being offered in cash, if any, plus the value of any non-cash consideration, if any, being offered
in such Fundamental Transaction, (D) a remaining option time equal to the time between the date of the public announcement of the applicable
Fundamental Transaction and the Termination Date and (E) a zero cost of borrow. The payment of the Black Scholes Value will be made by
wire transfer of immediately available funds within five (5) Trading Days of the Holder&rsquo;s election (or, if later, on the effective
date of the Fundamental Transaction). The Company shall require any successor entity in a Fundamental Transaction in which the Company
is not the survivor (the &ldquo;<U>Successor Entity</U>&rdquo;) to assume in writing all of the obligations of the Company under this
Warrant and the other Transaction Documents in accordance with the provisions of this Section 3(d) pursuant to written agreements in
form and substance reasonably satisfactory to the Holder and approved by the Holder (without unreasonable delay) prior to such Fundamental
Transaction and shall, at the option of the Holder, deliver to the Holder in exchange for this Warrant a security of the Successor Entity
evidenced by a written instrument substantially similar in form and substance to this Warrant which is exercisable for a corresponding
number of shares of capital stock of such Successor Entity (or its parent entity) equivalent to the shares of Common Stock acquirable
and receivable upon exercise of this Warrant (without regard to any limitations on the exercise of this Warrant) prior to such Fundamental
Transaction, and with an exercise price which applies the exercise price hereunder to such shares of capital stock (but taking into account
the relative value of the shares of Common Stock pursuant to such Fundamental Transaction and the value of such shares of capital stock,
such number of shares of capital stock and such exercise price being for the purpose of protecting the economic value of this Warrant
immediately prior to the consummation of such Fundamental Transaction), and which is reasonably satisfactory in form and substance to
the Holder. Upon the occurrence of any such Fundamental Transaction, the Successor Entity shall succeed to, and be substituted for (so
that from and after the date of such Fundamental Transaction, the provisions of this Warrant and the other Transaction Documents referring
to the &ldquo;Company&rdquo; shall refer instead to the Successor Entity), and may exercise every right and power of the Company and
shall assume all of the obligations of the Company under this Warrant and the other Transaction Documents with the same effect as if
such Successor Entity had been named as the Company herein. For the avoidance of doubt, the Holder shall be entitled to the benefits
of the provisions of this Section 3(e) regardless of whether the Company has sufficient authorized shares of Common Stock for the issuance
of Warrant Shares.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 9; Value: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->9<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">e)
<U>Calculations</U>. All calculations under this Section 3 shall be made to the nearest cent or the nearest 1/100th of a share, as the
case may be. For purposes of this Section 3, the number of shares of Common Stock deemed to be issued and outstanding as of a given date
shall be the sum of the number of shares of Common Stock (excluding treasury shares, if any) issued and outstanding.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">f)
<U>Notice to Holder</U>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">i.
<U>Adjustment to Exercise Price</U>. Whenever the Exercise Price is adjusted pursuant to any provision of this Section 3, the Company
shall promptly deliver to the Holder by email a notice setting forth the Exercise Price after such adjustment and any resulting adjustment
to the number of Warrant Shares and setting forth a brief statement of the facts requiring such adjustment.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">ii.
<U>Notice to Allow Exercise by Holder</U>. If (A) the Company shall declare a dividend (or any other distribution in whatever form) on
the Common Stock, (B) the Company shall declare a special nonrecurring cash dividend on or a redemption of the Common Stock, (C) the
Company shall authorize the granting to all holders of the Common Stock rights or warrants to subscribe for or purchase any shares of
capital stock of any class or of any rights, (D) the approval of any stockholders of the Company shall be required in connection with
any reclassification of the Common Stock, any consolidation or merger to which the Company (and all of its Subsidiaries, taken as a whole)
is a party, any sale or transfer of all or substantially all of the assets of the Company, or any compulsory share exchange whereby the
Common Stock is converted into other securities, cash or property, or (E) the Company shall authorize the voluntary or involuntary dissolution,
liquidation or winding up of the affairs of the Company, then, in each case, the Company shall cause to be delivered by email to the
Holder at its last email or other address as it shall appear upon the Warrant Register of the Company, at least 20 calendar days prior
to the applicable record or effective date hereinafter specified, a notice stating (x) the date on which a record is to be taken for
the purpose of such dividend, distribution, redemption, rights or warrants, or if a record is not to be taken, the date as of which the
holders of the Common Stock of record to be entitled to such dividend, distributions, redemption, rights or warrants are to be determined
or (y) the date on which such reclassification, consolidation, merger, sale, transfer or share exchange is expected to become effective
or close, and the date as of which it is expected that holders of the Common Stock of record shall be entitled to exchange their shares
of the Common Stock for securities, cash or other property deliverable upon such reclassification, consolidation, merger, sale, transfer
or share exchange; provided that the failure to deliver such notice or any defect therein or in the delivery thereof shall not affect
the validity of the corporate action required to be specified in such notice. To the extent that any notice provided in this Warrant
constitutes, or contains, material, non-public information regarding the Company or any of the Subsidiaries, the Company shall simultaneously
file such notice with the Commission pursuant to a Current Report on Form 8-K. The Holder shall remain entitled to exercise this Warrant
during the period commencing on the date of such notice to the effective date of the event triggering such notice except as may otherwise
be expressly set forth herein.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 10; Value: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->10<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Section
4</U>. <U>Transfer of Warrant</U>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">a)
<U>Transferability</U>. Subject to compliance with any applicable securities laws and the conditions set forth in Section 4(d) hereof,
this Warrant and all rights hereunder (including, without limitation, any registration rights) are transferable, in whole or in part,
upon surrender of this Warrant at the principal office of the Company or its designated agent, together with a written assignment of
this Warrant substantially in the form attached hereto duly executed by the Holder or its agent or attorney and funds sufficient to pay
any transfer taxes payable upon the making of such transfer. Upon such surrender and, if required, such payment, the Company shall execute
and deliver a new Warrant or Warrants in the name of the assignee or assignees, as applicable, and in the denomination or denominations
specified in such instrument of assignment, and shall issue to the assignor a new Warrant evidencing the portion of this Warrant not
so assigned, and this Warrant shall promptly be cancelled. Notwithstanding anything herein to the contrary, the Holder shall not be required
to physically surrender this Warrant to the Company unless the Holder has assigned this Warrant in full, in which case, the Holder shall
surrender this Warrant to the Company within three (3) Trading Days of the date on which the Holder delivers a duly executed Assignment
Form to the Company assigning this Warrant in full. The Warrant, if properly assigned in accordance herewith, may be exercised by a new
holder for the purchase of Warrant Shares without having a new Warrant issued.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>




<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">b)
<U>New Warrants</U>. This Warrant may be divided or combined with other Warrants upon presentation hereof at the aforesaid office of
the Company, together with a written notice specifying the names and denominations in which new Warrants are to be issued, signed by
the Holder or its agent or attorney. Subject to compliance with Section 4(a), as to any transfer which may be involved in such division
or combination, the Company shall execute and deliver a new Warrant or Warrants in exchange for the Warrant or Warrants to be divided
or combined in accordance with such notice. All Warrants issued on transfers or exchanges shall be dated the initial issuance date of
this Warrant and shall be identical with this Warrant except as to the number of Warrant Shares issuable pursuant thereto.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">c)
<U>Warrant Register</U>. The Company shall register this Warrant, upon records to be maintained by the Company for that purpose (the
&ldquo;<U>Warrant Register</U>&rdquo;), in the name of the record Holder hereof from time to time. The Company may deem and treat the
registered Holder of this Warrant as the absolute owner hereof for the purpose of any exercise hereof or any distribution to the Holder,
and for all other purposes, absent actual notice to the contrary.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">d)
<U>Transfer Restrictions</U>. If, at the time of the surrender of this Warrant in connection with any transfer of this Warrant, the transfer
of this Warrant shall not be either (i) registered pursuant to an effective registration statement under the Securities Act and under
applicable state securities or blue sky laws or (ii) eligible for resale without volume or manner-of-sale restrictions or current public
information requirements pursuant to Rule 144, the Company may require, as a condition of allowing such transfer, that the Holder or
transferee of this Warrant, as the case may be, provides to the Company an opinion of counsel, the form and substance of which opinion
shall be reasonably satisfactory to the Company, to the effect that the transfer of this Warrant does not require registration under
the Securities Act.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">e)
<U>Representation by the Holder</U>. The Holder, by the acceptance hereof, represents and warrants that it is acquiring this Warrant
and, upon any exercise hereof, will acquire the Warrant Shares issuable upon such exercise, for its own account and not with a view to
or for distributing or reselling such Warrant Shares or any part thereof in violation of the Securities Act or any applicable state securities
law, except pursuant to sales registered or exempted under the Securities Act.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 11; Value: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->11<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Section
5</U>. <U>Miscellaneous</U>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">a)
<U>No Rights as Stockholder Until Exercise; No Settlement in Cash</U>. This Warrant does not entitle the Holder to any voting rights,
dividends or other rights as a stockholder of the Company prior to the exercise hereof as set forth in Section 2(d)(i), except as expressly
set forth in Section 3. Without limiting any rights of a Holder to receive Warrant Shares on a &ldquo;cashless exercise&rdquo; pursuant
to Section 2(c) or to receive cash payments pursuant to Section 2(d)(i) and Section 2(d)(iv) herein, in no event shall the Company be
required to net cash settle an exercise of this Warrant.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">b)
<U>Loss, Theft, Destruction or Mutilation of Warrant</U>. The Company covenants that upon receipt by the Company of evidence reasonably
satisfactory to it of the loss, theft, destruction or mutilation of this Warrant or any stock certificate relating to the Warrant Shares,
and in case of loss, theft or destruction, of indemnity or security reasonably satisfactory to it (which, in the case of the Warrant,
shall not include the posting of any bond), and upon surrender and cancellation of such Warrant or stock certificate, if mutilated, the
Company will make and deliver a new Warrant or stock certificate of like tenor and dated as of such cancellation, in lieu of such Warrant
or stock certificate.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">c)
<U>Saturdays, Sundays, Holidays, etc</U>. If the last or appointed day for the taking of any action or the expiration of any right required
or granted herein shall not be a Trading Day, then such action may be taken or such right may be exercised on the next succeeding Trading
Day.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">d)
<U>Authorized Shares</U>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1in; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company covenants that during the period the Warrant is outstanding, it will reserve from its authorized and unissued Common Stock a
sufficient number of shares to provide for the issuance of the Warrant Shares upon the exercise of any purchase rights under this Warrant.
The Company further covenants that its issuance of this Warrant shall constitute full authority to its officers who are charged with
the duty of issuing the necessary Warrant Shares upon the exercise of the purchase rights under this Warrant. The Company will take such
reasonable action as may be necessary to assure that such Warrant Shares may be issued as provided herein without violation of any applicable
law or regulation, or of any requirements of the Trading Market upon which the Common Stock may be listed. The Company covenants that
all Warrant Shares which may be issued upon the exercise of the purchase rights represented by this Warrant will, upon exercise of the
purchase rights represented by this Warrant and payment for such Warrant Shares in accordance herewith, be duly authorized, validly issued,
fully paid and nonassessable and free from all taxes, liens and charges created by the Company in respect of the issue thereof (other
than taxes in respect of any transfer occurring contemporaneously with such issue).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1in; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 12; Value: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->12<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1in; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Except
and to the extent as waived or consented to by the Holder, the Company shall not by any action, including, without limitation, amending
its certificate of incorporation or through any reorganization, transfer of assets, consolidation, merger, dissolution, issue or sale
of securities or any other voluntary action, avoid or seek to avoid the observance or performance of any of the terms of this Warrant,
but will at all times in good faith assist in the carrying out of all such terms and in the taking of all such actions as may be necessary
or appropriate to protect the rights of Holder as set forth in this Warrant against impairment. Without limiting the generality of the
foregoing, the Company will (i) not increase the par value of any Warrant Shares above the amount payable therefor upon such exercise
immediately prior to such increase in par value, (ii) take such action as may be necessary or appropriate in order that the Company may
validly and legally issue fully paid and nonassessable Warrant Shares upon the exercise of this Warrant and (iii) use commercially reasonable
efforts to obtain all such authorizations, exemptions or consents from any public regulatory body having jurisdiction thereof, as may
be, necessary to enable the Company to perform its obligations under this Warrant.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Before
taking any action which would result in an adjustment in the number of Warrant Shares for which this Warrant is exercisable or in the
Exercise Price, the Company shall obtain all such authorizations or exemptions thereof, or consents thereto, as may be necessary from
any public regulatory body or bodies having jurisdiction thereof.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">e)
<U>Jurisdiction</U>. All questions concerning the construction, validity, enforcement and interpretation of this Warrant shall be governed
by and construed and enforced in accordance with the internal laws of the State of New York, without regard to the principles of conflicts
of law thereof. The Company and, by accepting this Warrant, the Holder each agrees that all legal proceedings concerning the interpretations,
enforcement and defense of the transactions contemplated by this Warrant (whether brought against the Company or the Holder or their
respective affiliates, directors, officers, shareholders, partners, members, employees or agents) shall be commenced exclusively in the
state and federal courts sitting in the City of New York. The Company and, by accepting this Warrant, the Holder each hereby irrevocably
submits to the exclusive jurisdiction of the state and federal courts sitting in the City of New York, Borough of Manhattan for the adjudication
of any dispute hereunder or in connection herewith or with any transaction contemplated hereby or discussed herein, and hereby irrevocably
waives, and agrees not to assert in any suit, action or proceeding, any claim that it is not personally subject to the jurisdiction of
any such court, that such suit, action or proceeding is improper or is an inconvenient venue for such proceeding. The Company and, by
accepting this Warrant, the Holder each hereby irrevocably waives personal service of process and consents to process being served in
any such suit, action or proceeding by mailing a copy thereof via registered or certified mail or overnight delivery (with evidence of
delivery) to it at the address in effect for notices to it under this Warrant and agrees that such service shall constitute good and
sufficient service of process and notice thereof. Nothing contained herein shall be deemed to limit in any way any right to serve process
in any other manner permitted by law. If the Company or the Holder shall commence an action, suit or proceeding to enforce any provisions
of this Warrant, the prevailing party in such action, suit or proceeding shall be reimbursed by the other party for their reasonable
attorneys&rsquo; fees and other costs and expenses incurred with the investigation, preparation and prosecution of such action or proceeding.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 13; Value: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->13<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">f)
<U>Restrictions</U>. The Holder acknowledges that the Warrant Shares acquired upon the exercise of this Warrant, if not registered, and
the Holder does not utilize cashless exercise, will have restrictions upon resale imposed by state and federal securities laws.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">g)
<U>Nonwaiver and Expenses</U>. No course of dealing or any delay or failure to exercise any right hereunder on the part of Holder shall
operate as a waiver of such right or otherwise prejudice the Holder&rsquo;s rights, powers or remedies. Without limiting any other provision
of this Warrant, if the Company willfully and knowingly fails to comply with any provision of this Warrant or the Letter Agreement, which
results in any material damages to the Holder, the Company shall pay to the Holder such amounts as shall be sufficient to cover any costs
and expenses including, but not limited to, reasonable attorneys&rsquo; fees, including those of appellate proceedings, incurred by the
Holder in collecting any amounts due pursuant hereto or in otherwise enforcing any of its rights, powers or remedies hereunder.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">h)
<U>Notices</U>. Any and all notices or other communications or deliveries to be provided by the Holder hereunder including, without limitation,
any Notice of Exercise, shall be in writing and delivered personally, by email or sent by a nationally recognized overnight courier service,
addressed to the Company, at 1901 W. 47th Place, Kansas City, KS 66205, Attention: Shane J. Schaffer, CEO, email address: sschaffer@cingulate.com,
or such other email address or address as the Company may specify for such purposes by notice to the Holder. Any and all notices or other
communications or deliveries to be provided by the Company hereunder shall be in writing and delivered personally, by email, or sent
by a nationally recognized overnight courier service addressed to the Holder at the email address or address of the Holder appearing
on the books of the Company. Any notice or other communication or deliveries hereunder shall be deemed given and effective on the earliest
of (i) the time of transmission, if such notice or communication is delivered via email at the email address set forth in this Section
prior to 5:30 p.m. (New York City time) on any date, (ii) the next Trading Day after the time of transmission, if such notice or communication
is delivered via email at the email address set forth in this Section on a day that is not a Trading Day or later than 5:30 p.m. (New
York City time) on any Trading Day, (iii) the second Trading Day following the date of mailing, if sent by U.S. nationally recognized
overnight courier service, or (iv) upon actual receipt by the party to whom such notice is required to be given. To the extent that any
notice provided by the Company hereunder constitutes, or contains, material, non-public information regarding the Company or any subsidiaries,
the Company shall simultaneously file such notice with the Commission pursuant to a Current Report on Form 8-K.</FONT></P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">i)
<U>Limitation of Liability</U>. No provision hereof, in the absence of any affirmative action by the Holder to exercise this Warrant
to purchase Warrant Shares, and no enumeration herein of the rights or privileges of the Holder, shall give rise to any liability of
the Holder for the purchase price of any Common Stock or as a stockholder of the Company, whether such liability is asserted by the Company
or by creditors of the Company.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 14; Value: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->14<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">j)
<U>Remedies</U>. The Holder, in addition to being entitled to exercise all rights granted by law, including recovery of damages, will
be entitled to specific performance of its rights under this Warrant. The Company agrees that monetary damages would not be adequate
compensation for any loss incurred by reason of a breach by it of the provisions of this Warrant and hereby agrees to waive and not to
assert the defense in any action for specific performance that a remedy at law would be adequate.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">k)
<U>Successors and Assigns</U>. Subject to applicable securities laws, this Warrant and the rights and obligations evidenced hereby shall
inure to the benefit of and be binding upon the successors and permitted assigns of the Company and the successors and permitted assigns
of Holder. The provisions of this Warrant are intended to be for the benefit of any Holder from time to time of this Warrant and shall
be enforceable by such Holder or holder of Warrant Shares.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">l)
<U>Amendment</U>. This Warrant may be modified or amended or the provisions hereof waived with the written consent of the Company, on
the one hand and the Holder, on the other hand.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">m)
<U>Severability</U>. Wherever possible, each provision of this Warrant shall be interpreted in such manner as to be effective and valid
under applicable law, but if any provision of this Warrant shall be prohibited by or invalid under applicable law, such provision shall
be ineffective to the extent of such prohibition or invalidity, without invalidating the remainder of such provisions or the remaining
provisions of this Warrant.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">n)
<U>Headings</U>. The headings used in this Warrant are for the convenience of reference only and shall not, for any purpose, be deemed
a part of this Warrant.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">o)
<U>Electronic Signatures</U>. Electronically scanned and transmitted signatures, including by email attachment, shall be deemed originals
for all purposes of this Warrant.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">********************</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>&nbsp;</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>(Signature
Page Follows)</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>&nbsp;</I></FONT></P>


<!-- Field: Page; Sequence: 15; Value: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->15<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">IN
WITNESS WHEREOF, the Company has caused this Warrant to be executed by its officer thereunto duly authorized as of the date first above
indicated.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 2.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>CINGULATE
    INC.</B></FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="padding-bottom: 1.5pt; font: 10pt Times New Roman, Times, Serif; width: 50%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 5%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">By:</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; width: 45%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Name:</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Shane
    J. Schaffer</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Title:</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Chief
    Executive Officer</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B></B></FONT></P>


<!-- Field: Page; Sequence: 16; Value: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->16<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><U>Annex
A</U></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>NOTICE
OF EXERCISE</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase">To:</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase"><B>CINGULATE
    INC.</B></FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(1)
The undersigned hereby elects to purchase ________ Warrant Shares of the Company pursuant to the terms of the attached Warrant (only
if exercised in full), and tenders herewith payment of the exercise price in full, together with all applicable transfer taxes, if any.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(2)
Payment shall take the form of (check applicable box):</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1.5in; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">[
] in lawful money of the United States; or</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1.5in; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1.5in; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">[
] if permitted the cancellation of such number of Warrant Shares as is necessary, in accordance with the formula set forth in subsection
2(c), to exercise this Warrant with respect to the maximum number of Warrant Shares purchasable pursuant to the cashless exercise procedure
set forth in subsection 2(c).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1.5in; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(3)
Please issue said Warrant Shares in the name of the undersigned or in such other name as is specified below:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(4)
<U>Accredited Investor</U>. The undersigned is an &ldquo;accredited investor&rdquo; as defined in Regulation D promulgated under the
Securities Act of 1933, as amended.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">_______________________________</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Warrant Shares shall be delivered to the following DWAC Account Number:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">_______________________________</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">_______________________________</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">_______________________________</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase">[SIGNATURE
OF HOLDER]</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Name
of Investing Entity: ________________________________________________________________________</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>Signature
of Authorized Signatory of Investing Entity</I>: _________________________________________________</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Name
of Authorized Signatory: ___________________________________________________________________</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Title
of Authorized Signatory: ____________________________________________________________________</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Date:
________________________________________________________________________________________</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>


<!-- Field: Page; Sequence: 17 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><U>Annex
B</U></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-weight: normal">ASSIGNMENT
FORM</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font: normal 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>(To
assign the foregoing Warrant, execute this form and supply required information. Do not use this form to exercise the Warrant to purchase
shares.)</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 10.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>&nbsp;</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">FOR
VALUE RECEIVED, the foregoing Warrant and all rights evidenced thereby are hereby assigned to</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 10.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 40%; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Name:</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 60%; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U></U>_____________________________________________</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(Please
    Print)</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U></U></FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Address:</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify">_____________________________________________</TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(Please
                                            Print)</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify">&nbsp;</TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Phone
Number:</FONT></P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Email
    Address:</FONT></P></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"></P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">_____________________________________________</FONT></P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">_____________________________________________</FONT></P></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><P STYLE="margin-top: 0; margin-bottom: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Dated: _______________ __, ______</FONT></P>
                                                                              <P STYLE="margin-top: 0; margin-bottom: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Holder&rsquo;s
    Signature:_______________________<U></U></FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify">&nbsp;</TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Holder&rsquo;s
    Address:________________________<U></U></FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 18; Options: Last -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>









<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"></P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-4.2
<SEQUENCE>3
<FILENAME>ex4-2.htm
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Exhibit
4.2</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">NEITHER
THE OFFER AND SALE OF THIS SECURITY NOR THE SECURITIES FOR WHICH THIS SECURITY IS EXERCISABLE HAVE BEEN REGISTERED WITH THE SECURITIES
AND EXCHANGE COMMISSION OR THE SECURITIES COMMISSION OF ANY STATE IN RELIANCE UPON AN EXEMPTION FROM REGISTRATION UNDER THE SECURITIES
ACT OF 1933, AS AMENDED (THE &ldquo;SECURITIES ACT&rdquo;), AND, ACCORDINGLY, THIS SECURITY MAY NOT BE OFFERED OR SOLD EXCEPT PURSUANT
TO AN EFFECTIVE REGISTRATION STATEMENT UNDER THE SECURITIES ACT OR PURSUANT TO AN AVAILABLE EXEMPTION FROM, OR IN A TRANSACTION NOT SUBJECT
TO, THE REGISTRATION REQUIREMENTS OF THE SECURITIES ACT AND IN ACCORDANCE WITH APPLICABLE STATE SECURITIES LAWS. THIS SECURITY AND THE
SECURITIES ISSUABLE UPON EXERCISE OF THIS SECURITY MAY BE PLEDGED IN CONNECTION WITH A BONA FIDE MARGIN ACCOUNT OR OTHER LOAN SECURED
BY SUCH SECURITIES.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>PLACEMENT
AGENT COMMON STOCK PURCHASE WARRANT</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase"><B>CINGULATE
INC. </B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" BORDER="0" STYLE="width: 100%; margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">
<TR STYLE="vertical-align: top">
  <TD STYLE="text-align: justify; width: 50%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Warrant Shares:</FONT></TD>
  <TD STYLE="text-align: justify; width: 50%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"> Issue Date: July 1, 2024</FONT></TD></TR>
</TABLE>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">THIS
PLACEMENT AGENT COMMON STOCK PURCHASE WARRANT (the &ldquo;<U>Warrant</U>&rdquo;) certifies that, for value received ____________ or its
assigns (the &ldquo;<U>Holder</U>&rdquo;) is entitled, upon the terms and subject to the limitations on exercise and the conditions hereinafter
set forth, at any time on or after the Stockholder Approval Date (as defined below) (the &ldquo;<U>Initial Exercise Date</U>&rdquo;)
and on or prior to 5:00 p.m. (New York City time) on the date that is the five (5) year anniversary of the Initial Exercise Date, provided
that, if such date is not a Trading Day, insert the immediately following Trading Day (the &ldquo;<U>Termination Date</U>&rdquo;) but
not thereafter, to subscribe for and purchase from Cingulate Inc., a Delaware corporation (the &ldquo;<U>Company</U>&rdquo;), up to __________
shares (as subject to adjustment hereunder, the &ldquo;<U>Warrant Shares</U>&rdquo;) of Common Stock. The purchase price of one share
of Common Stock under this Warrant shall be equal to the Exercise Price, as defined in Section 2(b). This Warrant is issued pursuant
to that certain Engagement Agreement, by and between the Company and H.C. Wainwright &amp; Co., LLC, dated as of December 27, 2023, as
amended.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Section
1</U>. <U>Definitions</U>. In addition to the terms defined elsewhere in this Warrant, the following terms have the meanings indicated
in this Section 1:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Affiliate</U>&rdquo;
means any Person that, directly or indirectly through one or more intermediaries, controls or is controlled by or is under common control
with a Person, as such terms are used in and construed under Rule 405 under the Securities Act.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 1; Options: NewSection -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->1<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white">&ldquo;<U>Bid
Price</U>&rdquo; means, for any date, the price determined by the first of the following clauses that applies: (a) if the Common Stock
is then listed or quoted on a Trading Market, the bid price of the Common Stock for the time in question (or the nearest preceding date)
on the Trading Market on which the Common Stock is then listed or quoted as reported by Bloomberg L.P. (&ldquo;Bloomberg&rdquo;) (based
on a Trading Day from 9:30 a.m. (New York City time) to 4:02 p.m. (New York City time)), (b) if OTCQB or OTCQX is not a Trading Market,
the volume weighted average price of the Common Stock for such date (or the nearest preceding date) on OTCQB or OTCQX as applicable,
(c) if the Common Stock is not then listed or quoted for trading on OTCQB or OTCQX and if prices for the Common Stock are then reported
on the Pink Open Market (or a similar organization or agency succeeding to its functions of reporting prices), the most recent bid price
per share of the Common Stock so reported, or (d) in all other cases, the fair market value of a share of Common Stock as determined
by an independent appraiser selected in good faith by the Holders of a majority in interest of the Warrants then outstanding and reasonably
acceptable to the Company, the reasonable fees and expenses of which shall be paid by the Company.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Board
of Directors</U>&rdquo; means the board of directors of the Company.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Commission</U>&rdquo;
means the United States Securities and Exchange Commission.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Common
Stock</U>&rdquo; means the common stock of the Company, par value $0.0001 per share, and any other class of securities into which such
securities may hereafter be reclassified or changed.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Common
Stock Equivalents</U>&rdquo; means any securities of the Company or the Subsidiaries which would entitle the holder thereof to acquire
at any time Common Stock, including, without limitation, any debt, preferred stock, right, option, warrant or other instrument that is
at any time convertible into or exercisable or exchangeable for, or otherwise entitles the holder thereof to receive, Common Stock.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Exchange
Act</U>&rdquo; means the Securities Exchange Act of 1934, as amended, and the rules and regulations promulgated thereunder.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Letter
Agreement</U>&rdquo; means that certain letter agreement between the initial Holder hereof and the Company, dated as of June 28, 2024,
pursuant to which such initial Holder agreed to exercise one or more warrants to purchase shares of Common Stock and the Company agreed
to issue to the initial Holder of this Warrant.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Person</U>&rdquo;
means an individual or corporation, partnership, trust, incorporated or unincorporated association, joint venture, limited liability
company, joint stock company, government (or an agency or subdivision thereof) or other entity of any kind.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Rule
144</U>&rdquo; means Rule 144 promulgated by the Commission pursuant to the Securities Act, as such Rule may be amended or interpreted
from time to time, or any similar rule or regulation hereafter adopted by the Commission having substantially the same purpose and effect
as such Rule.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Securities
Act</U>&rdquo; means the Securities Act of 1933, as amended, and the rules and regulations promulgated thereunder.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 2 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->2<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Stockholder
Approval</U>&rdquo; means such approval as may be required by the applicable rules and regulations of the Nasdaq Stock Market (or any
successor entity) from the shareholders of the Company with respect to issuance of all of the Warrants and the Warrant Shares upon the
exercise thereof.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Stockholder
Approval Date</U>&rdquo; means the date on which Stockholder Approval is received and deemed effective under Delaware law.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Subsidiaries</U>&rdquo;
means the subsidiaries of the Company set forth in the SEC Reports and shall, where applicable, also include any direct or indirect subsidiary
of the Company formed or acquired after the date hereof.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Trading
Day</U>&rdquo; means a day on which the Common Stock is traded on a Trading Market.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Trading
Market</U>&rdquo; means any of the following markets or exchanges on which the Common Stock is listed or quoted for trading on the date
in question: the NYSE American, the Nasdaq Capital Market, the Nasdaq Global Market, the Nasdaq Global Select Market or the New York
Stock Exchange (or any successors to any of the foregoing).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Transfer
Agent</U>&rdquo; means Computershare Trust Company, N.A., the current transfer agent of the Company, with a mailing address of 480 Washington
Blvd 26th Floor, Jersey City, NJ 07310, and any successor transfer agent of the Company.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white">&ldquo;<U>VWAP</U>&rdquo;
means, for any date, the price determined by the first of the following clauses that applies: (a) if the Common Stock is then listed
or quoted on a Trading Market, the daily volume weighted average price of the Common Stock for such date (or the nearest preceding date)
on the Trading Market on which the Common Stock is then listed or quoted as reported by Bloomberg (based on a Trading Day from 9:30 a.m.
(New York City time) to 4:02 p.m. (New York City time)), (b) if OTCQB or OTCQX is not a Trading Market, the volume weighted average price
of the Common Stock for such date (or the nearest preceding date) on OTCQB or OTCQX as applicable, (c) if the Common Stock is not then
listed or quoted for trading on OTCQB or OTCQX and if prices for the Common Stock are then reported on The Pink Open Market (or a similar
organization or agency succeeding to its functions of reporting prices), the most recent bid price per share of the Common Stock so reported,
or (d) in all other cases, the fair market value of a share of Common Stock as determined by an independent appraiser selected in good
faith by the Holders of a majority in interest of the Warrants then outstanding and reasonably acceptable to the Company, the reasonable
fees and expenses of which shall be paid by the Company.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white">&ldquo;<U>Warrants</U>&rdquo;
means this Warrant and other Common Stock purchase warrants issued by the Company pursuant to the Letter Agreement.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 3 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->3<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Section
2</U>. <U>Exercise</U>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">a)
<U>Exercise of Warrant</U>. Exercise of the purchase rights represented by this Warrant may be made, in whole or in part, at any time
or times on or after the Initial Exercise Date and on or before the Termination Date by delivery to the Company of a duly executed PDF
copy submitted by e-mail (or e-mail attachment) of the Notice of Exercise in the form attached hereto as <U>Annex A</U> (the &ldquo;<U>Notice
of Exercise</U>&rdquo;). Within the earlier of (i) one (1) Trading Day and (ii) the number of Trading Days comprising the Standard Settlement
Period (as defined in Section 2(d)(i) herein) following the date of exercise as aforesaid, the Holder shall deliver the aggregate Exercise
Price for the Warrant Shares specified in the applicable Notice of Exercise by wire transfer or cashier&rsquo;s check drawn on a United
States bank, in either case in immediately available funds, unless the cashless exercise procedure specified in Section 2(c) below is
specified in the applicable Notice of Exercise. No ink-original Notice of Exercise shall be required, nor shall any medallion guarantee
(or other type of guarantee or notarization) of any Notice of Exercise be required. The Company shall have no obligation to inquire with
respect to or otherwise confirm the authenticity of the signature(s) contained on any Notice of Exercise nor the authority of the person
so executing such Notice of Exercise. Notwithstanding anything herein to the contrary, the Holder shall not be required to physically
surrender this Warrant to the Company until the Holder has purchased all of the Warrant Shares available hereunder and the Warrant has
been exercised in full, in which case, the Holder shall surrender this Warrant to the Company for cancellation within three (3) Trading
Days of the date on which the final Notice of Exercise is delivered to the Company. Partial exercises of this Warrant resulting in purchases
of a portion of the total number of Warrant Shares available hereunder shall have the effect of lowering the outstanding number of Warrant
Shares purchasable hereunder in an amount equal to the applicable number of Warrant Shares purchased. The Holder and the Company shall
maintain records showing the number of Warrant Shares purchased and the date of such purchases. The Company shall deliver any objection
to any Notice of Exercise within one (1) Trading Day of receipt of such notice. <B>The Holder and any assignee, by acceptance of this
Warrant, acknowledges and agrees that, by reason of the provisions of this paragraph, following the purchase of a portion of the Warrant
Shares hereunder, the number of Warrant Shares available for purchase hereunder at any given time may be less than the amount stated
on the face hereof.</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">b)
<U>Exercise Price</U>. The exercise price per share of Common Stock under this Warrant shall be <B>$0.7313</B>, subject to adjustment
hereunder (the &ldquo;<U>Exercise Price</U>&rdquo;).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">c)
<U>Cashless Exercise</U>. If at the time of exercise hereof there is no effective registration statement registering, or the prospectus
contained therein is not available for the resale of the Warrant Shares by the Holder, then this Warrant may also be exercised, in whole
or in part, at such time by means of a &ldquo;cashless exercise&rdquo; in which the Holder shall be entitled to receive a number of Warrant
Shares equal to the quotient obtained by dividing [(A-B) (X)] by (A), where:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 4 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->4<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 1in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(A)
    = </FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">as
    applicable: (i) the VWAP on the Trading Day immediately preceding the date of the applicable Notice of Exercise if such Notice of
    Exercise is (1) both executed and delivered pursuant to Section 2(a) hereof on a day that is not a Trading Day or (2) both executed
    and delivered pursuant to Section 2(a) hereof on a Trading Day prior to the opening of &ldquo;regular trading hours&rdquo; (as defined
    in Rule 600(b) of Regulation NMS promulgated under the federal securities laws) on such Trading Day, (ii) at the option of the Holder,
    either (y) the VWAP on the Trading Day immediately preceding the date of the applicable Notice of Exercise or (z) the Bid Price of
    the Common Stock on the principal Trading Market as reported by <U>Bloomberg</U> as of the time of the Holder&rsquo;s execution of
    the applicable Notice of Exercise if such Notice of Exercise is executed during &ldquo;regular trading hours&rdquo; on a Trading
    Day and is delivered within two (2) hours thereafter (including until two (2) hours after the close of &ldquo;regular trading hours&rdquo;
    on a Trading Day) pursuant to Section 2(a) hereof or (iii) the VWAP on the date of the applicable Notice of Exercise if the date
    of such Notice of Exercise is a Trading Day and such Notice of Exercise is both executed and delivered pursuant to Section 2(a) hereof
    after the close of &ldquo;regular trading hours&rdquo; on such Trading Day;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(B)
    = </FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
    Exercise Price of this Warrant, as adjusted hereunder; and </FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(X)
    = </FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
    number of Warrant Shares that would be issuable upon exercise of this Warrant in accordance with the terms of this Warrant if such
    exercise were by means of a cash exercise rather than a cashless exercise.</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white">If
Warrant Shares are issued in such a cashless exercise, the parties acknowledge and agree that in accordance with Section 3(a)(9) of the
Securities Act, the holding period of the Warrant Shares being issued may be tacked on to the holding period of this Warrant. The Company
agrees not to take any position contrary to this Section 2(c).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 5 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->5<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">d)
<U>Mechanics of Exercise</U>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">i.
<U>Delivery of Warrant Shares Upon Exercise</U>. The Company shall cause the Warrant Shares purchased hereunder to be transmitted by
the Transfer Agent to the Holder by crediting the account of the Holder&rsquo;s or its designee&rsquo;s balance account with the Depository
Trust Company through its Deposit or Withdrawal at Custodian system (&ldquo;<U>DWAC</U>&rdquo;) if the Company&rsquo;s transfer agent
is then a participant in such system and either (A) there is an effective registration statement permitting the issuance of the Warrant
Shares to or resale of the Warrant Shares by the Holder or (B) the Warrant Shares are eligible for resale by the Holder without volume
or manner-of-sale limitations pursuant to Rule 144 (assuming cashless exercise of the Warrants), and otherwise by physical delivery of
a certificate, registered in the Company&rsquo;s share register in the name of the Holder or its designee, for the number of Warrant
Shares to which the Holder is entitled pursuant to such exercise to the address specified by the Holder in the Notice of Exercise by
the date that is earlier of (i) one (1) Trading Day after the delivery to the Company of the Notice of Exercise and (ii) the number of
Trading Days comprising the Standard Settlement Period after the delivery to the Company of the Notice of Exercise (such date, the &ldquo;<U>Warrant
Share Delivery Date</U>&rdquo;). Upon delivery of the Notice of Exercise, the Holder shall be deemed for all corporate purposes to have
become the holder of record of the Warrant Shares with respect to which this Warrant has been exercised, irrespective of the date of
delivery of the Warrant Shares, provided that payment of the aggregate Exercise Price (other than in the case of a cashless exercise)
is received within the earlier of (i) one (1) Trading Day and (ii) the number of Trading Days comprising the Standard Settlement Period
following delivery of the Notice of Exercise. If the Company fails for any reason to deliver to the Holder the Warrant Shares subject
to a Notice of Exercise by the Warrant Share Delivery Date, the Company shall pay to the Holder, in cash, as liquidated damages and not
as a penalty, for each $1,000 of Warrant Shares subject to such exercise (based on the VWAP of the Common Stock on the date of the applicable
Notice of Exercise), $10 per Trading Day (increasing to $20 per Trading Day on the third Trading Day after the Warrant Share Delivery
Date) for each Trading Day after such Warrant Share Delivery Date until such Warrant Shares are delivered or Holder rescinds such exercise.
The Company agrees to maintain a transfer agent that is a participant in the FAST program so long as this Warrant remains outstanding
and exercisable. As used herein, &ldquo;<U>Standard Settlement Period</U>&rdquo; means the standard settlement period, expressed in a
number of Trading Days, on the Company&rsquo;s primary Trading Market with respect to the Common Stock as in effect on the date of the
delivery of the Notice of Exercise.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">ii.
<U>Delivery of New Warrants Upon Exercise</U>. If this Warrant shall have been exercised in part, the Company shall, at the request of
a Holder and upon surrender of this Warrant, at the time of delivery of the Warrant Shares, deliver to the Holder a new Warrant evidencing
the rights of the Holder to purchase the unpurchased Warrant Shares remaining available under this Warrant, which new Warrant shall in
all other respects be identical with this Warrant.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">iii.
<U>Rescission Rights</U>. If the Company fails to cause the Transfer Agent to transmit to the Holder the Warrant Shares pursuant to Section
2(d)(i) by the Warrant Share Delivery Date, then the Holder will have the right to rescind such exercise.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 6 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->6<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">iv.
<U>Compensation for Buy-In on Failure to Timely Deliver Warrant Shares Upon Exercise</U>. In addition to any other rights available to
the Holder, if the Company fails to cause the Transfer Agent to transmit to the Holder the Warrant Shares in accordance with the provisions
of Section 2(d)(i) above pursuant to an exercise on or before the Warrant Share Delivery Date, and if after such date the Holder is required
by its broker to purchase (in an open market transaction or otherwise) or the Holder&rsquo;s brokerage firm otherwise purchases, shares
of Common Stock to deliver in satisfaction of a sale by the Holder of the Warrant Shares which the Holder anticipated receiving upon
such exercise (a &ldquo;<U>Buy-In</U>&rdquo;), then the Company shall (A) pay in cash to the Holder the amount, if any, by which (x)
the Holder&rsquo;s total purchase price (including reasonable and customary brokerage commissions, if any) for the shares of Common Stock
so purchased exceeds (y) the amount obtained by multiplying (1) the number of Warrant Shares that the Company was required to deliver
to the Holder in connection with the exercise at issue times (2) the price at which the sell order giving rise to such purchase obligation
was executed, and (B) at the option of the Holder, either reinstate the portion of the Warrant and equivalent number of Warrant Shares
for which such exercise was not honored (in which case such exercise shall be deemed rescinded) or deliver to the Holder the number of
shares of Common Stock that would have been issued had the Company timely complied with its exercise and delivery obligations hereunder.
For example, if the Holder purchases Common Stock having a total purchase price of $11,000 to cover a Buy-In with respect to an attempted
exercise of shares of Common Stock with an aggregate sale price giving rise to such purchase obligation of $10,000, under clause (A)
of the immediately preceding sentence the Company shall be required to pay the Holder $1,000. The Holder shall provide the Company written
notice indicating the amounts payable to the Holder in respect of the Buy-In and, upon request of the Company, evidence of the amount
of such loss. Nothing herein shall limit a Holder&rsquo;s right to pursue any other remedies available to it hereunder, at law or in
equity including, without limitation, a decree of specific performance and/or injunctive relief with respect to the Company&rsquo;s failure
to timely deliver shares of Common Stock upon exercise of the Warrant as required pursuant to the terms hereof.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">v.
<U>No Fractional Shares or Scrip</U>. No fractional shares or scrip representing fractional shares shall be issued upon the exercise
of this Warrant. As to any fraction of a share which the Holder would otherwise be entitled to purchase upon such exercise, the Company
shall, at its election, either pay a cash adjustment in respect of such final fraction in an amount equal to such fraction multiplied
by the Exercise Price or round up to the next whole share.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">vi.
<U>Charges, Taxes and Expenses</U>. Issuance of Warrant Shares shall be made without charge to the Holder for any issue or transfer tax
or other incidental expense in respect of the issuance of such Warrant Shares, all of which taxes and expenses shall be paid by the Company,
and such Warrant Shares shall be issued in the name of the Holder or in such name or names as may be directed by the Holder; <U>provided</U>,
<U>however</U>, that in the event that Warrant Shares are to be issued in a name other than the name of the Holder, this Warrant when
surrendered for exercise shall be accompanied by the assignment form attached hereto as <U>Annex B</U> (the &ldquo;<U>Assignment Form</U>&rdquo;) duly
executed by the Holder and the Company may require, as a condition thereto, the payment of a sum sufficient to reimburse it for any transfer
tax incidental thereto. The Company shall pay all Transfer Agent fees required for same-day processing of any Notice of Exercise and
all fees to the Depository Trust Company (or another established clearing corporation performing similar functions) required for same-day
electronic delivery of the Warrant Shares.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 7 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->7<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">vii.
<U>Closing of Books</U>. The Company will not close its stockholder books or records in any manner which prevents the timely exercise
of this Warrant, pursuant to the terms hereof.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">e)
<U>Beneficial Ownership Limitations</U>. The Company shall not effect any exercise of this Warrant, and a Holder shall not have the right
to exercise any portion of this Warrant, pursuant to Section 2 or otherwise, to the extent that after giving effect to such issuance
after exercise as set forth on the applicable Notice of Exercise, the Holder (together with the Holder&rsquo;s Affiliates, and any other
Persons acting as a group together with the Holder or any of the Holder&rsquo;s Affiliates (such Persons, &ldquo;<U>Attribution Parties</U>&rdquo;)),
would beneficially own in excess of the Beneficial Ownership Limitation (as defined below). For purposes of the foregoing sentence, the
number of shares of Common Stock beneficially owned by the Holder and its Affiliates and Attribution Parties shall include the number
of shares of Common Stock issuable upon exercise of this Warrant with respect to which such determination is being made, but shall exclude
the number of shares of Common Stock which would be issuable upon (i) exercise of the remaining, nonexercised portion of this Warrant
beneficially owned by the Holder or any of its Affiliates or Attribution Parties and (ii) exercise or conversion of the unexercised or
nonconverted portion of any other securities of the Company (including, without limitation, any other Common Stock Equivalents) subject
to a limitation on conversion or exercise analogous to the limitation contained herein beneficially owned by the Holder or any of its
Affiliates or Attribution Parties. Except as set forth in the preceding sentence, for purposes of this Section 2(e), beneficial ownership
shall be calculated in accordance with Section 13(d) of the Exchange Act and the rules and regulations promulgated thereunder, it being
acknowledged by the Holder that the Company is not representing to the Holder that such calculation is in compliance with Section 13(d)
of the Exchange Act and the Holder is solely responsible for any schedules required to be filed in accordance therewith and the calculations
required under this Section 2(e). To the extent that the limitation contained in this Section 2(e) applies, the determination of whether
this Warrant is exercisable (in relation to other securities owned by the Holder together with any Affiliates and Attribution Parties)
and of which portion of this Warrant is exercisable shall be in the sole discretion of the Holder, and the submission of a Notice of
Exercise shall be deemed to be the Holder&rsquo;s determination of whether this Warrant is exercisable (in relation to other securities
owned by the Holder together with any Affiliates and Attribution Parties) and of which portion of this Warrant is exercisable, in each
case subject to the Beneficial Ownership Limitation, and the Company shall have no obligation to verify or confirm the accuracy of such
determination. In addition, a determination as to any group status as contemplated above shall be determined in accordance with Section
13(d) of the Exchange Act and the rules and regulations promulgated thereunder. For purposes of this Section 2(e), in determining the
number of outstanding shares of Common Stock, a Holder may rely on the number of outstanding shares of Common Stock as reflected in (A)
the Company&rsquo;s most recent periodic or annual report filed with the Commission, as the case may be, (B) a more recent public announcement
by the Company or (C) a more recent written notice by the Company or the Transfer Agent setting forth the number of shares of Common
Stock outstanding. Upon the written or oral request of a Holder, the Company shall within one (1) Trading Day confirm orally and in writing
to the Holder the number of shares of Common Stock then outstanding. In any case, the number of outstanding shares of Common Stock shall
be determined after giving effect to the conversion or exercise of securities of the Company, including this Warrant, by the Holder or
its Affiliates or Attribution Parties since the date as of which such number of outstanding shares of Common Stock was reported. The
&ldquo;<U>Beneficial Ownership Limitation</U>&rdquo; shall be 4.99% of the number of shares of the Common Stock outstanding immediately
after giving effect to the issuance of shares of Common Stock issuable upon exercise of this Warrant. The Holder, upon notice to the
Company, may increase or decrease the Beneficial Ownership Limitation provisions of this Section 2(e), provided that the Beneficial Ownership
Limitation in no event exceeds 9.99% of the number of shares of the Common Stock outstanding immediately after giving effect to the issuance
of shares of Common Stock upon exercise of this Warrant held by the Holder and the provisions of this Section 2(e) shall continue to
apply. Any increase in the Beneficial Ownership Limitation will not be effective until the 61<SUP>st</SUP> day after such notice is delivered
to the Company. The provisions of this Section 2(e) shall be construed and implemented in a manner otherwise than in strict conformity
with the terms of this Section 2(e) to correct this Section 2(e) (or any portion hereof) which may be defective or inconsistent with
the intended Beneficial Ownership Limitation herein contained or to make changes or supplements necessary or desirable to properly give
effect to such limitation. The limitations contained in this Section 2(e) shall apply to a successor holder of this Warrant.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 8 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->8<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Section
3</U>. <U>Certain Adjustments</U>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">a)
<U>Stock Dividends and Splits</U>. If the Company, at any time while this Warrant is outstanding: (i) pays a stock dividend or otherwise
makes a distribution or distributions on shares of its Common Stock or any other equity or equity equivalent securities payable in shares
of Common Stock (which, for avoidance of doubt, shall not include any shares of Common Stock issued by the Company upon exercise of this
Warrant), (ii) subdivides outstanding shares of Common Stock into a larger number of shares, (iii) combines (including by way of reverse
stock split) outstanding shares of Common Stock into a smaller number of shares, or (iv) issues by reclassification of shares of the
Common Stock any shares of capital stock of the Company, then in each case the Exercise Price shall be multiplied by a fraction of which
the numerator shall be the number of shares of Common Stock (excluding treasury shares, if any) outstanding immediately before such event
and of which the denominator shall be the number of shares of Common Stock outstanding immediately after such event, and the number of
shares issuable upon exercise of this Warrant shall be proportionately adjusted such that the aggregate Exercise Price of this Warrant
shall remain unchanged. Any adjustment made pursuant to this Section 3(a) shall become effective immediately after the record date for
the determination of stockholders entitled to receive such dividend or distribution and shall become effective immediately after the
effective date in the case of a subdivision, combination or re-classification.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">b)
<U>Subsequent Rights Offerings</U>. In addition to any adjustments pursuant to Section 3(a) above, if at any time while this Warrant
is outstanding the Company grants, issues or sells any Common Stock Equivalents or rights to purchase stock, warrants, securities or
other property pro rata to the record holders of any class of shares of Common Stock (the &ldquo;<U>Purchase Rights</U>&rdquo;), then
the Holder will be entitled to acquire, upon the terms applicable to such Purchase Rights, the aggregate Purchase Rights which the Holder
could have acquired if the Holder had held the number of shares of Common Stock acquirable upon complete exercise of this Warrant (without
regard to any limitations on exercise hereof, including without limitation, the Beneficial Ownership Limitation) immediately before the
date on which a record is taken for the grant, issuance or sale of such Purchase Rights, or, if no such record is taken, the date as
of which the record holders of shares of Common Stock are to be determined for the grant, issue or sale of such Purchase Rights (<U>provided</U>,
<U>however</U>, that to the extent that the Holder&rsquo;s right to participate in any such Purchase Right would result in the Holder
exceeding the Beneficial Ownership Limitation, then the Holder shall not be entitled to participate in such Purchase Right to such extent
(or beneficial ownership of such shares of Common Stock as a result of such Purchase Right to such extent) and such Purchase Right to
such extent shall be held in abeyance for the Holder until such time, if ever, as its right thereto would not result in the Holder exceeding
the Beneficial Ownership Limitation); provided, that such Purchase Right shall terminate on, and shall not be held in abeyance for any
period subsequent to the Termination Date.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">c)
<U>Pro Rata Distributions</U>. During such time as this Warrant is outstanding, if the Company shall declare or make any dividend or
other distribution of its assets (or rights to acquire its assets) to holders of shares of Common Stock, by way of return of capital
or otherwise, other than cash (including, without limitation, any distribution of stock or other securities, property or options by way
of a dividend, spin off, reclassification, corporate rearrangement, scheme of arrangement or other similar transaction) (a &ldquo;<U>Distribution</U>&rdquo;),
at any time after the issuance of this Warrant, then, in each such case, the Holder shall be entitled to participate in such Distribution
to the same extent that the Holder would have participated therein if the Holder had held the number of shares of Common Stock acquirable
upon complete exercise of this Warrant (without regard to any limitations on exercise hereof, including without limitation, the Beneficial
Ownership Limitation) immediately before the date of which a record is taken for such Distribution, or, if no such record is taken, the
date as of which the record holders of shares of Common Stock are to be determined for the participation in such Distribution (<U>provided</U>,
<U>however</U>, that to the extent that the Holder&rsquo;s right to participate in any such Distribution would result in the Holder exceeding
the Beneficial Ownership Limitation, then the Holder shall not be entitled to participate in such Distribution to such extent (or in
the beneficial ownership of any shares of Common Stock as a result of such Distribution to such extent) and the portion of such Distribution
shall be held in abeyance for the benefit of the Holder until such time, if ever, as its right thereto would not result in the Holder
exceeding the Beneficial Ownership Limitation); provided, that such Purchase Right shall terminate on, and shall not be held in abeyance
for any period subsequent to the Termination Date.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 9 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->9<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">d)
<U>Fundamental Transaction</U>. If, at any time while this Warrant is outstanding, (i) the Company (and all of its Subsidiaries, taken
as a whole), directly or indirectly, in one or more related transactions effects any merger or consolidation of the Company with or into
another Person (other than for the purpose of changing the Company&rsquo;s name and/or the jurisdiction of incorporation of the Company
or a holding company for the Company), (ii) the Company, directly or indirectly, effects any sale, lease, license, assignment, transfer,
conveyance or other disposition of all or substantially all of its assets in one or a series of related transactions, (iii) any, direct
or indirect, purchase offer, tender offer or exchange offer (whether by the Company or another Person) is completed pursuant to which
holders of the outstanding equity securities of the Company having voting power, including the power to vote on the election of directors
of the Company, are permitted to sell, tender or exchange their securities for other securities, cash or property and has been accepted
by the holders of the outstanding securities representing more than 50% of the aggregate voting power, including the power to vote on
the election of directors of the Company, of the issued and outstanding equity securities of the Company, (iv) the Company, directly
or indirectly, in one or more related transactions effects any reclassification, reorganization or recapitalization of the Common Stock
or any compulsory share exchange pursuant to which the Common Stock is effectively converted into or exchanged for other securities,
cash or property, or (v) the Company, directly or indirectly, in one or more related transactions consummates a stock or share purchase
agreement or other business combination (including, without limitation, a reorganization, recapitalization, spin-off, merger or scheme
of arrangement) with another Person or group of Persons whereby such other Person or group acquires securities representing more than
50% of the aggregate voting power, including the power to vote on the election of directors of the Company, of the issued and outstanding
equity securities of the Company (each a &ldquo;<U>Fundamental Transaction</U>&rdquo;), then, upon any subsequent exercise of this Warrant,
the Holder shall have the right to receive, for each Warrant Share that would have been issuable upon such exercise immediately prior
to the occurrence of such Fundamental Transaction, at the option of the Holder (without regard to any limitation in Section 2(d) on the
exercise of this Warrant), the number of shares of Common Stock of the successor or acquiring corporation or of the Company, if it is
the surviving corporation, and any additional consideration (the &ldquo;<U>Alternate Consideration</U>&rdquo;) receivable as a result
of such Fundamental Transaction by a holder of the number of shares of Common Stock for which this Warrant is exercisable immediately
prior to such Fundamental Transaction (without regard to any limitation in Section 2(e) on the exercise of this Warrant). For purposes
of any such exercise, the determination of the Exercise Price shall be appropriately adjusted to apply to such Alternate Consideration
based on the amount of Alternate Consideration issuable in respect of one share of Common Stock in such Fundamental Transaction, and
the Company shall apportion the Exercise Price among the Alternate Consideration in a reasonable manner reflecting the relative value
of any different components of the Alternate Consideration. If holders of Common Stock are given any choice as to the securities, cash
or property to be received in a Fundamental Transaction, then the Holder shall be given the same choice as to the Alternate Consideration
it receives upon any exercise of this Warrant following such Fundamental Transaction. Notwithstanding anything to the contrary, in the
event of a Fundamental Transaction (other than (x) any stock split or reverse stock split, (y) any transaction effected solely for the
purpose of changing the jurisdiction of incorporation of the Company, or (z) any holding company reorganization or parent-subsidiary
merger not requiring stockholder approval pursuant to Sections 251(g) or 253 of the Delaware General Corporation Law (or any successor
provisions thereof)), and for the avoidance of doubt, the Fundamental Transaction is approved by the Company&rsquo;s board of directors
and within the control of the Company, the Company or any Successor Entity (as defined below) shall, at the Holder&rsquo;s option, exercisable
at any time concurrently with, or within 30 days after, the consummation of the Fundamental Transaction (or, if later, the date of the
public announcement of the applicable Fundamental Transaction), purchase this Warrant from the Holder by paying to the Holder an amount
of cash equal to the Black Scholes Value (as defined below) of the remaining unexercised portion of this Warrant on the date of the consummation
of such Fundamental Transaction; provided, however, if the Fundamental Transaction is not within the Company&rsquo;s control, including
not approved by the Company&rsquo;s Board of Directors, Holder shall only be entitled to receive from the Company or any Successor Entity,
as of the date of consummation of such Fundamental Transaction, the same type or form of consideration (and in the same proportion),
at the Black Scholes Value of the unexercised portion of this Warrant, that is being offered and paid to the holders of Common Stock
of the Company in connection with the Fundamental Transaction, whether that consideration be in the form of cash, stock or any combination
thereof, or whether the holders of Common Stock are given the choice to receive from among alternative forms of consideration in connection
with the Fundamental Transaction; provided, further, that if holders of Common Stock of the Company are not offered or paid any consideration
in such Fundamental Transaction, such holders of Common Stock will be deemed to have received common stock of the Successor Entity (which
Successor Entity may be the Company following such Fundamental Transaction) in such Fundamental Transaction. &ldquo;<U>Black Scholes
Value</U>&rdquo; means the value of this Warrant based on the Black Scholes Option Pricing Model obtained from the &ldquo;OV&rdquo; function
on Bloomberg determined as of the day of consummation of the applicable Fundamental Transaction for pricing purposes and reflecting (A)
a risk-free interest rate corresponding to the U.S. Treasury rate for a period equal to the time between the date of the public announcement
of the applicable Fundamental Transaction and the Termination Date, (B) an expected volatility equal to the 100 day volatility obtained
from the HVT function on Bloomberg (determined utilizing a 365-day annualization factor) as of the Trading Day immediately following
the public announcement of the applicable Fundamental Transaction, (C) the underlying price per share used in such calculation shall
be the sum of the price per share being offered in cash, if any, plus the value of any non-cash consideration, if any, being offered
in such Fundamental Transaction, (D) a remaining option time equal to the time between the date of the public announcement of the applicable
Fundamental Transaction and the Termination Date and (E) a zero cost of borrow. The payment of the Black Scholes Value will be made by
wire transfer of immediately available funds within five (5) Trading Days of the Holder&rsquo;s election (or, if later, on the effective
date of the Fundamental Transaction). The Company shall require any successor entity in a Fundamental Transaction in which the Company
is not the survivor (the &ldquo;<U>Successor Entity</U>&rdquo;) to assume in writing all of the obligations of the Company under this
Warrant and the other Transaction Documents in accordance with the provisions of this Section 3(d) pursuant to written agreements in
form and substance reasonably satisfactory to the Holder and approved by the Holder (without unreasonable delay) prior to such Fundamental
Transaction and shall, at the option of the Holder, deliver to the Holder in exchange for this Warrant a security of the Successor Entity
evidenced by a written instrument substantially similar in form and substance to this Warrant which is exercisable for a corresponding
number of shares of capital stock of such Successor Entity (or its parent entity) equivalent to the shares of Common Stock acquirable
and receivable upon exercise of this Warrant (without regard to any limitations on the exercise of this Warrant) prior to such Fundamental
Transaction, and with an exercise price which applies the exercise price hereunder to such shares of capital stock (but taking into account
the relative value of the shares of Common Stock pursuant to such Fundamental Transaction and the value of such shares of capital stock,
such number of shares of capital stock and such exercise price being for the purpose of protecting the economic value of this Warrant
immediately prior to the consummation of such Fundamental Transaction), and which is reasonably satisfactory in form and substance to
the Holder. Upon the occurrence of any such Fundamental Transaction, the Successor Entity shall succeed to, and be substituted for (so
that from and after the date of such Fundamental Transaction, the provisions of this Warrant and the other Transaction Documents referring
to the &ldquo;Company&rdquo; shall refer instead to the Successor Entity), and may exercise every right and power of the Company and
shall assume all of the obligations of the Company under this Warrant and the other Transaction Documents with the same effect as if
such Successor Entity had been named as the Company herein. For the avoidance of doubt, the Holder shall be entitled to the benefits
of the provisions of this Section 3(e) regardless of whether the Company has sufficient authorized shares of Common Stock for the issuance
of Warrant Shares.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 10 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->10<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">e)
<U>Calculations</U>. All calculations under this Section 3 shall be made to the nearest cent or the nearest 1/100th of a share, as the
case may be. For purposes of this Section 3, the number of shares of Common Stock deemed to be issued and outstanding as of a given date
shall be the sum of the number of shares of Common Stock (excluding treasury shares, if any) issued and outstanding.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">f)
<U>Notice to Holder</U>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">i.
<U>Adjustment to Exercise Price</U>. Whenever the Exercise Price is adjusted pursuant to any provision of this Section 3, the Company
shall promptly deliver to the Holder by email a notice setting forth the Exercise Price after such adjustment and any resulting adjustment
to the number of Warrant Shares and setting forth a brief statement of the facts requiring such adjustment.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">ii.
<U>Notice to Allow Exercise by Holder</U>. If (A) the Company shall declare a dividend (or any other distribution in whatever form) on
the Common Stock, (B) the Company shall declare a special nonrecurring cash dividend on or a redemption of the Common Stock, (C) the
Company shall authorize the granting to all holders of the Common Stock rights or warrants to subscribe for or purchase any shares of
capital stock of any class or of any rights, (D) the approval of any stockholders of the Company shall be required in connection with
any reclassification of the Common Stock, any consolidation or merger to which the Company (and all of its Subsidiaries, taken as a whole)
is a party, any sale or transfer of all or substantially all of the assets of the Company, or any compulsory share exchange whereby the
Common Stock is converted into other securities, cash or property, or (E) the Company shall authorize the voluntary or involuntary dissolution,
liquidation or winding up of the affairs of the Company, then, in each case, the Company shall cause to be delivered by email to the
Holder at its last email or other address as it shall appear upon the Warrant Register of the Company, at least 20 calendar days prior
to the applicable record or effective date hereinafter specified, a notice stating (x) the date on which a record is to be taken for
the purpose of such dividend, distribution, redemption, rights or warrants, or if a record is not to be taken, the date as of which the
holders of the Common Stock of record to be entitled to such dividend, distributions, redemption, rights or warrants are to be determined
or (y) the date on which such reclassification, consolidation, merger, sale, transfer or share exchange is expected to become effective
or close, and the date as of which it is expected that holders of the Common Stock of record shall be entitled to exchange their shares
of the Common Stock for securities, cash or other property deliverable upon such reclassification, consolidation, merger, sale, transfer
or share exchange; provided that the failure to deliver such notice or any defect therein or in the delivery thereof shall not affect
the validity of the corporate action required to be specified in such notice. To the extent that any notice provided in this Warrant
constitutes, or contains, material, non-public information regarding the Company or any of the Subsidiaries, the Company shall simultaneously
file such notice with the Commission pursuant to a Current Report on Form 8-K. The Holder shall remain entitled to exercise this Warrant
during the period commencing on the date of such notice to the effective date of the event triggering such notice except as may otherwise
be expressly set forth herein.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 11 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->11<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Section
4</U>. <U>Transfer of Warrant</U>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">a)
<U>Transferability</U>. Subject to compliance with any applicable securities laws and the conditions set forth in Section 4(d) hereof,
this Warrant and all rights hereunder (including, without limitation, any registration rights) are transferable, in whole or in part,
upon surrender of this Warrant at the principal office of the Company or its designated agent, together with a written assignment of
this Warrant substantially in the form attached hereto duly executed by the Holder or its agent or attorney and funds sufficient to pay
any transfer taxes payable upon the making of such transfer. Upon such surrender and, if required, such payment, the Company shall execute
and deliver a new Warrant or Warrants in the name of the assignee or assignees, as applicable, and in the denomination or denominations
specified in such instrument of assignment, and shall issue to the assignor a new Warrant evidencing the portion of this Warrant not
so assigned, and this Warrant shall promptly be cancelled. Notwithstanding anything herein to the contrary, the Holder shall not be required
to physically surrender this Warrant to the Company unless the Holder has assigned this Warrant in full, in which case, the Holder shall
surrender this Warrant to the Company within three (3) Trading Days of the date on which the Holder delivers a duly executed Assignment
Form to the Company assigning this Warrant in full. The Warrant, if properly assigned in accordance herewith, may be exercised by a new
holder for the purchase of Warrant Shares without having a new Warrant issued.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">b)
<U>New Warrants</U>. This Warrant may be divided or combined with other Warrants upon presentation hereof at the aforesaid office of
the Company, together with a written notice specifying the names and denominations in which new Warrants are to be issued, signed by
the Holder or its agent or attorney. Subject to compliance with Section 4(a), as to any transfer which may be involved in such division
or combination, the Company shall execute and deliver a new Warrant or Warrants in exchange for the Warrant or Warrants to be divided
or combined in accordance with such notice. All Warrants issued on transfers or exchanges shall be dated the initial issuance date of
this Warrant and shall be identical with this Warrant except as to the number of Warrant Shares issuable pursuant thereto.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">c)
<U>Warrant Register</U>. The Company shall register this Warrant, upon records to be maintained by the Company for that purpose (the
&ldquo;<U>Warrant Register</U>&rdquo;), in the name of the record Holder hereof from time to time. The Company may deem and treat the
registered Holder of this Warrant as the absolute owner hereof for the purpose of any exercise hereof or any distribution to the Holder,
and for all other purposes, absent actual notice to the contrary.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">d)
<U>Transfer Restrictions</U>. If, at the time of the surrender of this Warrant in connection with any transfer of this Warrant, the transfer
of this Warrant shall not be either (i) registered pursuant to an effective registration statement under the Securities Act and under
applicable state securities or blue sky laws or (ii) eligible for resale without volume or manner-of-sale restrictions or current public
information requirements pursuant to Rule 144, the Company may require, as a condition of allowing such transfer, that the Holder or
transferee of this Warrant, as the case may be, provides to the Company an opinion of counsel, the form and substance of which opinion
shall be reasonably satisfactory to the Company, to the effect that the transfer of this Warrant does not require registration under
the Securities Act.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">e)
<U>Representation by the Holder</U>. The Holder, by the acceptance hereof, represents and warrants that it is acquiring this Warrant
and, upon any exercise hereof, will acquire the Warrant Shares issuable upon such exercise, for its own account and not with a view to
or for distributing or reselling such Warrant Shares or any part thereof in violation of the Securities Act or any applicable state securities
law, except pursuant to sales registered or exempted under the Securities Act.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 12 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->12<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Section
5</U>. <U>Miscellaneous</U>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">a)
<U>No Rights as Stockholder Until Exercise; No Settlement in Cash</U>. This Warrant does not entitle the Holder to any voting rights,
dividends or other rights as a stockholder of the Company prior to the exercise hereof as set forth in Section 2(d)(i), except as expressly
set forth in Section 3. Without limiting any rights of a Holder to receive Warrant Shares on a &ldquo;cashless exercise&rdquo; pursuant
to Section 2(c) or to receive cash payments pursuant to Section 2(d)(i) and Section 2(d)(iv) herein, in no event shall the Company be
required to net cash settle an exercise of this Warrant.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">b)
<U>Loss, Theft, Destruction or Mutilation of Warrant</U>. The Company covenants that upon receipt by the Company of evidence reasonably
satisfactory to it of the loss, theft, destruction or mutilation of this Warrant or any stock certificate relating to the Warrant Shares,
and in case of loss, theft or destruction, of indemnity or security reasonably satisfactory to it (which, in the case of the Warrant,
shall not include the posting of any bond), and upon surrender and cancellation of such Warrant or stock certificate, if mutilated, the
Company will make and deliver a new Warrant or stock certificate of like tenor and dated as of such cancellation, in lieu of such Warrant
or stock certificate.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">c)
<U>Saturdays, Sundays, Holidays, etc</U>. If the last or appointed day for the taking of any action or the expiration of any right required
or granted herein shall not be a Trading Day, then such action may be taken or such right may be exercised on the next succeeding Trading
Day.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">d)
<U>Authorized Shares</U>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1in; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company covenants that during the period the Warrant is outstanding, it will reserve from its authorized and unissued Common Stock a
sufficient number of shares to provide for the issuance of the Warrant Shares upon the exercise of any purchase rights under this Warrant.
The Company further covenants that its issuance of this Warrant shall constitute full authority to its officers who are charged with
the duty of issuing the necessary Warrant Shares upon the exercise of the purchase rights under this Warrant. The Company will take such
reasonable action as may be necessary to assure that such Warrant Shares may be issued as provided herein without violation of any applicable
law or regulation, or of any requirements of the Trading Market upon which the Common Stock may be listed. The Company covenants that
all Warrant Shares which may be issued upon the exercise of the purchase rights represented by this Warrant will, upon exercise of the
purchase rights represented by this Warrant and payment for such Warrant Shares in accordance herewith, be duly authorized, validly issued,
fully paid and nonassessable and free from all taxes, liens and charges created by the Company in respect of the issue thereof (other
than taxes in respect of any transfer occurring contemporaneously with such issue).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 13 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->13<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Except
and to the extent as waived or consented to by the Holder, the Company shall not by any action, including, without limitation, amending
its certificate of incorporation or through any reorganization, transfer of assets, consolidation, merger, dissolution, issue or sale
of securities or any other voluntary action, avoid or seek to avoid the observance or performance of any of the terms of this Warrant,
but will at all times in good faith assist in the carrying out of all such terms and in the taking of all such actions as may be necessary
or appropriate to protect the rights of Holder as set forth in this Warrant against impairment. Without limiting the generality of the
foregoing, the Company will (i) not increase the par value of any Warrant Shares above the amount payable therefor upon such exercise
immediately prior to such increase in par value, (ii) take such action as may be necessary or appropriate in order that the Company may
validly and legally issue fully paid and nonassessable Warrant Shares upon the exercise of this Warrant and (iii) use commercially reasonable
efforts to obtain all such authorizations, exemptions or consents from any public regulatory body having jurisdiction thereof, as may
be, necessary to enable the Company to perform its obligations under this Warrant.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Before
taking any action which would result in an adjustment in the number of Warrant Shares for which this Warrant is exercisable or in the
Exercise Price, the Company shall obtain all such authorizations or exemptions thereof, or consents thereto, as may be necessary from
any public regulatory body or bodies having jurisdiction thereof.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">e)
<U>Jurisdiction</U>. All questions concerning the construction, validity, enforcement and interpretation of this Warrant shall be governed
by and construed and enforced in accordance with the internal laws of the State of New York, without regard to the principles of conflicts
of law thereof. The Company and, by accepting this Warrant, the Holder each agrees that all legal proceedings concerning the interpretations,
enforcement and defense of the transactions contemplated by this Warrant (whether brought against the Company or the Holder or their
respective affiliates, directors, officers, shareholders, partners, members, employees or agents) shall be commenced exclusively in the
state and federal courts sitting in the City of New York. The Company and, by accepting this Warrant, the Holder each hereby irrevocably
submits to the exclusive jurisdiction of the state and federal courts sitting in the City of New York, Borough of Manhattan for the adjudication
of any dispute hereunder or in connection herewith or with any transaction contemplated hereby or discussed herein, and hereby irrevocably
waives, and agrees not to assert in any suit, action or proceeding, any claim that it is not personally subject to the jurisdiction of
any such court, that such suit, action or proceeding is improper or is an inconvenient venue for such proceeding. The Company and, by
accepting this Warrant, the Holder each hereby irrevocably waives personal service of process and consents to process being served in
any such suit, action or proceeding by mailing a copy thereof via registered or certified mail or overnight delivery (with evidence of
delivery) to it at the address in effect for notices to it under this Warrant and agrees that such service shall constitute good and
sufficient service of process and notice thereof. Nothing contained herein shall be deemed to limit in any way any right to serve process
in any other manner permitted by law. If the Company or the Holder shall commence an action, suit or proceeding to enforce any provisions
of this Warrant, the prevailing party in such action, suit or proceeding shall be reimbursed by the other party for their reasonable
attorneys&rsquo; fees and other costs and expenses incurred with the investigation, preparation and prosecution of such action or proceeding.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 14 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->14<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">f)
<U>Restrictions</U>. The Holder acknowledges that the Warrant Shares acquired upon the exercise of this Warrant, if not registered, and
the Holder does not utilize cashless exercise, will have restrictions upon resale imposed by state and federal securities laws.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">g)
<U>Nonwaiver and Expenses</U>. No course of dealing or any delay or failure to exercise any right hereunder on the part of Holder shall
operate as a waiver of such right or otherwise prejudice the Holder&rsquo;s rights, powers or remedies. Without limiting any other provision
of this Warrant, if the Company willfully and knowingly fails to comply with any provision of this Warrant or the Letter Agreement, which
results in any material damages to the Holder, the Company shall pay to the Holder such amounts as shall be sufficient to cover any costs
and expenses including, but not limited to, reasonable attorneys&rsquo; fees, including those of appellate proceedings, incurred by the
Holder in collecting any amounts due pursuant hereto or in otherwise enforcing any of its rights, powers or remedies hereunder.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">h)
<U>Notices</U>. Any and all notices or other communications or deliveries to be provided by the Holder hereunder including, without limitation,
any Notice of Exercise, shall be in writing and delivered personally, by email or sent by a nationally recognized overnight courier service,
addressed to the Company, at 1901 W. 47th Place, Kansas City, KS 66205, Attention: Shane J. Schaffer, CEO, email address: sschaffer@cingulate.com,
or such other email address or address as the Company may specify for such purposes by notice to the Holder. Any and all notices or other
communications or deliveries to be provided by the Company hereunder shall be in writing and delivered personally, by email, or sent
by a nationally recognized overnight courier service addressed to the Holder at the email address or address of the Holder appearing
on the books of the Company. Any notice or other communication or deliveries hereunder shall be deemed given and effective on the earliest
of (i) the time of transmission, if such notice or communication is delivered via email at the email address set forth in this Section
prior to 5:30 p.m. (New York City time) on any date, (ii) the next Trading Day after the time of transmission, if such notice or communication
is delivered via email at the email address set forth in this Section on a day that is not a Trading Day or later than 5:30 p.m. (New
York City time) on any Trading Day, (iii) the second Trading Day following the date of mailing, if sent by U.S. nationally recognized
overnight courier service, or (iv) upon actual receipt by the party to whom such notice is required to be given. To the extent that any
notice provided by the Company hereunder constitutes, or contains, material, non-public information regarding the Company or any subsidiaries,
the Company shall simultaneously file such notice with the Commission pursuant to a Current Report on Form 8-K.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">i)
<U>Limitation of Liability</U>. No provision hereof, in the absence of any affirmative action by the Holder to exercise this Warrant
to purchase Warrant Shares, and no enumeration herein of the rights or privileges of the Holder, shall give rise to any liability of
the Holder for the purchase price of any Common Stock or as a stockholder of the Company, whether such liability is asserted by the Company
or by creditors of the Company.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 15 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->15<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">j)
<U>Remedies</U>. The Holder, in addition to being entitled to exercise all rights granted by law, including recovery of damages, will
be entitled to specific performance of its rights under this Warrant. The Company agrees that monetary damages would not be adequate
compensation for any loss incurred by reason of a breach by it of the provisions of this Warrant and hereby agrees to waive and not to
assert the defense in any action for specific performance that a remedy at law would be adequate.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">k)
<U>Successors and Assigns</U>. Subject to applicable securities laws, this Warrant and the rights and obligations evidenced hereby shall
inure to the benefit of and be binding upon the successors and permitted assigns of the Company and the successors and permitted assigns
of Holder. The provisions of this Warrant are intended to be for the benefit of any Holder from time to time of this Warrant and shall
be enforceable by such Holder or holder of Warrant Shares.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">l)
<U>Amendment</U>. This Warrant may be modified or amended or the provisions hereof waived with the written consent of the Company, on
the one hand and the Holder, on the other hand.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">m)
<U>Severability</U>. Wherever possible, each provision of this Warrant shall be interpreted in such manner as to be effective and valid
under applicable law, but if any provision of this Warrant shall be prohibited by or invalid under applicable law, such provision shall
be ineffective to the extent of such prohibition or invalidity, without invalidating the remainder of such provisions or the remaining
provisions of this Warrant.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">n)
<U>Headings</U>. The headings used in this Warrant are for the convenience of reference only and shall not, for any purpose, be deemed
a part of this Warrant.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">o)
<U>Electronic Signatures</U>. Electronically scanned and transmitted signatures, including by email attachment, shall be deemed originals
for all purposes of this Warrant.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">********************</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>(Signature
Page Follows)</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>&nbsp;</I></FONT></P>


<!-- Field: Page; Sequence: 16 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->16<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">IN
WITNESS WHEREOF, the Company has caused this Warrant to be executed by its officer thereunto duly authorized as of the date first above
indicated.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>CINGULATE
    INC.</B></FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 50%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 5%; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 45%; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">By:</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; border-bottom: Black 1.5pt solid; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Name:</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Shane
    J. Schaffer</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Title:</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Chief
    Executive Officer</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>


<!-- Field: Page; Sequence: 17 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->17<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><U>Annex
A</U></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>NOTICE
OF EXERCISE</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase">To:</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase"><B>CINGULATE
    INC.</B></FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(1)
The undersigned hereby elects to purchase ________ Warrant Shares of the Company pursuant to the terms of the attached Warrant (only
if exercised in full), and tenders herewith payment of the exercise price in full, together with all applicable transfer taxes, if any.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(2)
Payment shall take the form of (check applicable box):</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1.5in; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9744;
in lawful money of the United States; or</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1.5in; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9744;
if permitted the cancellation of such number of Warrant Shares as is necessary, in accordance with the formula set forth in subsection
2(c), to exercise this Warrant with respect to the maximum number of Warrant Shares purchasable pursuant to the cashless exercise procedure
set forth in subsection 2(c).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(3)
Please issue said Warrant Shares in the name of the undersigned or in such other name as is specified below:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(4)
<U>Accredited Investor</U>. The undersigned is an &ldquo;accredited investor&rdquo; as defined in Regulation D promulgated under the
Securities Act of 1933, as amended.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">_______________________________</FONT></P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Warrant Shares shall be delivered to the following DWAC Account Number:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">_______________________________</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">_______________________________</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">_______________________________</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase">[SIGNATURE
OF HOLDER]</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Name
of Investing Entity: ________________________________________________________________________</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>Signature
of Authorized Signatory of Investing Entity</I>: _________________________________________________</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Name
of Authorized Signatory: ___________________________________________________________________</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Title
of Authorized Signatory: ____________________________________________________________________</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Date:
________________________________________________________________________________________</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 18 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%">&nbsp;</TD><TD STYLE="width: 33%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><U>Annex
B</U></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-weight: normal">ASSIGNMENT
FORM</FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>(To
assign the foregoing Warrant, execute this form and supply required information. Do not use this form to exercise the Warrant to purchase
shares.)</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>&nbsp;</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">FOR
VALUE RECEIVED, the foregoing Warrant and all rights evidenced thereby are hereby assigned to</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 50%; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Name:</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; border-bottom: Black 1.5pt solid; width: 50%; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(Please
    Print)</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Address:</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; border-bottom: Black 1.5pt solid; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(Please
    Print)</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Phone
    Number:</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; border-bottom: Black 1.5pt solid; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Email
    Address:</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; border-bottom: Black 1.5pt solid; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
</TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 50%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Dated:
    ___________________ __ , __________</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 50%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
</TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 18%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Holder&rsquo;s
    Signature:</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; border-bottom: Black 1.5pt solid; width: 32%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 50%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Holder&rsquo;s
    Address:</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; border-bottom: Black 1.5pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 19; Options: Last -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%">&nbsp;</TD><TD STYLE="width: 33%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-10.1
<SEQUENCE>4
<FILENAME>ex10-1.htm
<TEXT>
<HTML>
<HEAD>
<TITLE></TITLE>
</HEAD>
<BODY>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Exhibit
10.1</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase"><B>cingulate
Inc.</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 4.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 328.5pt; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">June
28, 2024</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Holder
of Common Stock Purchase Warrants</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.4in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Re:</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Inducement
    Offer to Exercise Common Stock Purchase Warrants</U></FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Dear
Holder:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Cingulate
Inc. (the &ldquo;<U>Company</U>&rdquo;) is pleased to offer to you (&ldquo;<U>Holder</U>&rdquo;, &ldquo;<U>you</U>&rdquo; or similar
terminology) the opportunity to receive (i) new warrants to purchase shares of the Company&rsquo;s common stock, par value $0.0001 per
share (the &ldquo;<U>Common Stock</U>&rdquo;), and (ii) a reduction in the Exercise Price (as defined in the respective Existing Warrants)
of the Series A Common Stock purchase warrants of the Company (the &ldquo;<U>Series A Warrants</U>&rdquo;) and the Series B Common Stock
Purchase Warrants of the Company (the &ldquo;<U>Series B Warrants</U>&rdquo;) set forth on the Holder&rsquo;s signature page hereto (collectively,
the &ldquo;<U>Existing Warrants</U>&rdquo;) held by you in consideration for exercising by you for cash all of the Existing Warrants,
as set forth on the signature page hereto. The issuance of the shares of Common Stock underlying the Existing Warrants (the &ldquo;<U>Existing
Warrant Shares</U>&rdquo;) has been registered pursuant to the registration statement on Form S-1 (File No. 333-276502) (as amended to
date, the &ldquo;<U>Registration Statement</U>&rdquo;). The Registration Statement is currently effective and, upon exercise of the Existing
Warrants pursuant to this letter agreement, will be effective for the issuance of the Existing Warrant Shares. Capitalized terms not
otherwise defined herein shall have the meanings set forth in the New Warrants (as defined herein).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company desires to reduce the Exercise Price (as defined in the respective Existing Warrants) of the Existing Warrants to $0.585 per
share (the &ldquo;<U>Reduced Exercise Price</U>&rdquo;). In consideration for the exercise in full for cash all of the Existing Warrants
held by the Holder as set forth on the Holder&rsquo;s signature page hereto (the &ldquo;<U>Warrant Exercise</U>&rdquo;) on or before
the Execution Time (as defined below), the Company hereby offers to sell and issue you (i) new unregistered Series C Common Stock purchase
warrants (the &ldquo;<U>Series C New Warrants</U>&rdquo;) pursuant to Section 4(a)(2) of the Securities Act of 1933, as amended (&ldquo;<U>Securities
Act</U>&rdquo;), to purchase up to a number of shares of Common Stock (the &ldquo;<U>Series C New Warrant Shares</U>&rdquo;) equal to
200% of the number of Existing Warrant Shares issued upon the exercise of the Series A Warrants held by you in the Warrant Exercise hereunder
and (ii) new unregistered Series D Common Stock purchase warrants (the &ldquo;<U>Series D New Warrants</U>&rdquo; and, collectively with
the Series C New Warrants, the &ldquo;<U>New Warrants</U>&rdquo;) pursuant to Section 4(a)(2) of the Securities Act, to purchase up to
a number of shares of Common Stock (the &ldquo;<U>Series D New Warrant Shares</U>&rdquo; and collectively with the Series C New Warrant
Shares, the &ldquo;<U>New Warrant Shares</U>&rdquo;) equal to 200% of the number of Existing Warrant Shares issued upon the exercise
of the Series B Warrants held by you in the Warrant Exercise hereunder. The New Warrants shall have an exercise price per share equal
to $0.585, subject to adjustment as provided in the New Warrants, and will be exercisable at any time on or after the Stockholder Approval
Date, and the Series C New Warrants have a term of exercise of five (5) years from the Stockholder Approval Date, provided that, if such
date is not a Trading Day, the immediately following Trading Day, which Series C New Warrants shall be in the form as set forth in <U>Exhibit
A</U> hereto, and the Series D New Warrants have a term of exercise of two (2) years from the Stockholder Approval Date, provided that,
if such date is not a Trading Day, the immediately following Trading Day, which Series D New Warrants shall be in the form as set forth
in <U>Exhibit A</U> hereto.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
New Warrant certificate(s) will be delivered at Closing (as defined below), and such New Warrants, together with any underlying shares
of Common Stock issued upon exercise of the New Warrants, will, unless and until their sales are registered under the Securities Act,
contain customary restrictive legends and other language typical for an unregistered warrant and unregistered shares. Notwithstanding
anything herein to the contrary, in the event that any Warrant Exercise would otherwise cause the Holder to exceed the beneficial ownership
limitations (&ldquo;<U>Beneficial Ownership Limitation</U>&rdquo;) set forth in Section 2(e) of the Existing Warrants (or, if applicable
and at the Holder&rsquo;s election, 9.99%), the Company shall only issue such number of Existing Warrant Shares to the Holder that would
not cause the Holder to exceed the maximum number of Existing Warrant Shares permitted thereunder, as directed by the Holder, with the
balance to be held in abeyance until notice from the Holder that the balance (or portion thereof) may be issued in compliance with such
limitations, which abeyance shall be evidenced through the Existing Warrants which shall be deemed prepaid thereafter (including the
cash payment in full of the exercise price), and exercised pursuant to a Notice of Exercise in the Existing Warrants (provided no additional
exercise price shall be due and payable). The parties hereby agree that the Beneficial Ownership Limitation for purposes of the Existing
Warrants is as set forth on the Holder&rsquo;s signature page hereto.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Expressly
subject to the paragraph immediately following this paragraph below, Holder may accept this offer by signing this letter agreement below,
with such acceptance constituting Holder&rsquo;s exercise in full of the Existing Warrants for an aggregate exercise price set forth
on the Holder&rsquo;s signature page hereto (the &ldquo;<U>Warrant Exercise Price</U>&rdquo;) on or before 9:00 a.m., Eastern Time, on
June 28, 2024 (the &ldquo;<U>Execution Time</U>&rdquo;).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Additionally,
the Company agrees to the representations, warranties and covenants set forth on <U>Annex A</U> attached hereto. Holder represents and
warrants that, as of the date hereof it is, and on each date on which it exercises any New Warrants it will be, an &ldquo;accredited
investor&rdquo; as defined in Rule 501 of Regulation D promulgated under the Securities Act, and agrees that the New Warrants will contain
restrictive legends when issued, and neither the New Warrants nor the shares of Common Stock issuable upon exercise of the New Warrants
will be registered under the Securities Act, except as provided in <U>Annex A</U> attached hereto. Also, Holder represents and warrants
that it is acquiring the New Warrants as principal for its own account and has no direct or indirect arrangement or understandings with
any other persons to distribute or regarding the distribution of the New Warrants or the New Warrant Shares (this representation is not
limiting Holder&rsquo;s right to sell the New Warrant Shares pursuant to an effective registration statement under the Securities Act
or otherwise in compliance with applicable federal and state securities laws).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Holder understands that the issuance of the New Warrants and the New Warrant Shares are not, and may never be, registered under the Securities
Act, or the securities laws of any state and, accordingly, each certificate, if any, representing such securities shall bear a legend
substantially similar to the following:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;THE
OFFER AND SALE OF THIS SECURITY HAS NOT BEEN REGISTERED WITH THE SECURITIES AND EXCHANGE COMMISSION OR THE SECURITIES COMMISSION OF ANY
STATE IN RELIANCE UPON AN EXEMPTION FROM REGISTRATION UNDER THE SECURITIES ACT OF 1933, AS AMENDED (THE &ldquo;SECURITIES ACT&rdquo;),
AND, ACCORDINGLY, THIS SECURITY MAY NOT BE OFFERED OR SOLD EXCEPT PURSUANT TO AN EFFECTIVE REGISTRATION STATEMENT UNDER THE SECURITIES
ACT OR PURSUANT TO AN AVAILABLE EXEMPTION FROM, OR IN A TRANSACTION NOT SUBJECT TO, THE REGISTRATION REQUIREMENTS OF THE SECURITIES ACT
AND IN ACCORDANCE WITH APPLICABLE STATE SECURITIES LAWS.&rdquo;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Certificates
evidencing the New Warrant Shares shall not contain any legend (including the legend set forth above), (i) while a registration statement
covering the resale of such New Warrant Shares is effective under the Securities Act, (ii) following any sale of such New Warrant Shares
pursuant to Rule 144 under the Securities Act, (iii) if such New Warrant Shares are eligible for sale under Rule 144 (assuming cashless
exercise of the New Warrants), without the requirement for the Company to be in compliance with the current public information required
under Rule 144 as to such New Warrant Shares and without volume or manner-of-sale restrictions, (iv) if such New Warrant Shares may be
sold under Rule 144 (assuming cashless exercise of the New Warrants) and the Company is then in compliance with the current public information
required under Rule 144 as to such New Warrant Shares, or (v) if such legend is not required under applicable requirements of the Securities
Act (including judicial interpretations and pronouncements issued by the staff of the Securities and Exchange Commission (the &ldquo;<U>Commission</U>&rdquo;)
and the earliest of clauses (i) through (v), the &ldquo;<U>Delegend Date</U>&rdquo;)). The Company shall cause its counsel to issue a
legal opinion to the Transfer Agent promptly after the Delegend Date if required by the Company and/or the Transfer Agent to effect the
removal of the legend hereunder, or at the request of the Holder, which opinion shall be in form and substance reasonably acceptable
to the Holder. From and after the Delegend Date, such New Warrant Shares shall be issued free of all legends. The Company agrees that
following the Delegend Date or at such time as such legend is no longer required under this Section, it will, no later than one (1) Trading
Day following the delivery by the Holder to the Company or the Transfer Agent of a certificate representing the New Warrant Shares issued
with a restrictive legend (such first (1<SUP>st</SUP>) Trading Day, the &ldquo;<U>Legend Removal Date</U>&rdquo;), deliver or cause to
be delivered to the Holder a certificate representing such shares that is free from all restrictive and other legends or, at the request
of the Holder shall credit the account of the Holder&rsquo;s prime broker with the Depository Trust Company System as directed by the
Holder.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
addition to the Holder&rsquo;s other available remedies, the Company shall pay to a Holder, in cash, (i) as partial liquidated damages
and not as a penalty, for each $1,000 of New Warrant Shares (based on the VWAP of the Common Stock on the date such New Warrant Shares
are submitted to the Transfer Agent) delivered for removal of the restrictive legend, $10 per Trading Day (increasing to $20 per Trading
Day five (5) Trading Days after such damages have begun to accrue) for each Trading Day after the Legend Removal Date until such certificate
is delivered without a legend and (ii) if the Company fails to (a) issue and deliver (or cause to be delivered) to the Holder by the
Legend Removal Date a certificate representing the New Warrant Shares that is free from all restrictive and other legends and (b) if
after the Legend Removal Date the Holder purchases (in an open market transaction or otherwise) shares of Common Stock to deliver in
satisfaction of a sale by the Holder of all or any portion of the number of shares of Common Stock, or a sale of a number of shares of
Common Stock equal to all or any portion of the number of shares of Common Stock that the Holder anticipated receiving from the Company
without any restrictive legend, then, an amount equal to the excess of the Holder&rsquo;s total purchase price (including brokerage commissions
and other out-of-pocket expenses, if any) for the shares of Common Stock so purchased (including brokerage commissions and other out-of-pocket
expenses, if any) over the product of (A) such number of New Warrant Shares that the Company was required to deliver to the Holder by
the Legend Removal Date and for which the Holder was required to purchase shares to timely satisfy delivery requirements, multiplied
by (B) the weighted average price at which the Holder sold that number of shares of Common Stock.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 3 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">If
this offer is accepted and the transaction documents are executed by the Execution Time, then as promptly as possible following the Execution
Time, but in any event no later than 9:00 a.m., Eastern Time, on the date hereof, the Company shall issue a press release disclosing
the material terms of the transactions contemplated hereby and shall file a Current Report on Form 8-K with the Commission disclosing
all material terms of the transactions contemplated hereunder, including the filing with the Commission of this letter agreement as an
exhibit thereto within the time required by the Exchange Act. From and after the dissemination of such press release, the Company represents
to you that it shall have publicly disclosed all material, non-public information delivered to you by the Company, or any of its respective
officers, directors, employees or agents in connection with the transactions contemplated hereunder. In addition, effective upon the
dissemination of such press release, the Company acknowledges and agrees that any and all confidentiality or similar obligations under
any agreement, whether written or oral, between the Company, any of its Subsidiaries or any of their respective officers, directors,
agents, employees or Affiliates on the one hand, and you and your Affiliates on the other hand, shall terminate. The Company represents,
warrants and covenants that, upon acceptance of this offer, the Existing Warrant Shares shall be issued at Closing free of any legends
or restrictions on resale by Holder.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">No
later than the first (1<SUP>st</SUP>) Trading Day following the date of the public disclosure of the transactions hereunder, the closing
(&ldquo;<U>Closing</U>&rdquo;) shall occur at such location as the parties shall mutually agree. Unless otherwise directed by H.C. Wainwright
&amp; Co., LLC (the &ldquo;<U>Placement Agent</U>&rdquo;), settlement of the Existing Warrant Shares shall occur via &ldquo;Delivery
Versus Payment&rdquo; (&ldquo;<U>DVP</U>&rdquo;) (i.e., on the Closing Date (as defined below), the Company shall issue the Existing
Warrant Shares registered in the Holder&rsquo;s name and address provided to the Company in writing and released by the Transfer Agent
directly to the account(s) at the Placement Agent identified by the Holder; upon receipt of such Existing Warrant Shares, the Placement
Agent shall promptly electronically deliver such Existing Warrant Shares to the Holder, and payment therefor shall concurrently be made
to the Company by the Placement Agent (or its clearing firm) by wire transfer to the Company). The date of the Closing of the Warrant
Exercise shall be referred to as the &ldquo;<U>Closing Date</U>&rdquo;.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company acknowledges and agrees that the obligations of the Holders under this letter agreement are several and not joint with the obligations
of any other holder or holders of Existing Warrants or other warrants of the Company (each, an &ldquo;<U>Other Holder</U>&rdquo;) under
any other agreement related to the exercise of such warrants (&ldquo;<U>Other Warrant Exercise Agreement</U>&rdquo;), and the Holder
shall not be responsible in any way for the performance of the obligations of any Other Holder or under any such Other Warrant Exercise
Agreement. Nothing contained in this letter agreement, and no action taken by the Holders pursuant hereto, shall be deemed to constitute
the Holder and the Other Holders as a partnership, an association, a joint venture or any other kind of entity, or create a presumption
that the Holder and the Other Holders are in any way acting in concert or as a group with respect to such obligations or the transactions
contemplated by this letter agreement and the Company acknowledges that the Holder and the Other Holders are not acting in concert or
as a group with respect to such obligations or the transactions contemplated by this letter agreement or any Other Warrant Exercise Agreement.
The Company and the Holder confirm that the Holder has independently participated in the negotiation of the transactions contemplated
hereby with the advice of its own counsel and advisors. The Holder shall be entitled to independently protect and enforce its rights,
including, without limitation, the rights arising out of this letter agreement, and it shall not be necessary for any Other Holder to
be joined as an additional party in any proceeding for such purpose.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company shall pay all transfer agent fees, stamp taxes and other taxes and duties levied in connection with the delivery of any Existing
Warrant Shares. This letter agreement shall be construed and enforced in accordance with the laws of the State of New York, without regards
to conflicts of laws principles. Each party hereby irrevocably submits to the exclusive jurisdiction of the state and federal courts
sitting in the City of New York, Borough of Manhattan for the adjudication of any dispute hereunder or in connection herewith or with
any transaction contemplated hereby.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 5 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Sincerely
    yours,</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase">cingulate
    inc.</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="padding-bottom: 1.5pt; font: 10pt Times New Roman, Times, Serif; width: 50%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 5%; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">By:</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; width: 45%; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Name:</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Title:</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">[Holder
Signature Page Follows]</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 6 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Accepted
and Agreed to:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Name
of Holder: ________________________________________________________</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>Signature
of Authorized Signatory of Holder</I>: _________________________________</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Name
of Authorized Signatory: _______________________________________________</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Title
of Authorized Signatory: ________________________________________________</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Existing
Warrants:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Number
of Series A Warrants:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Number
of Series B Warrants:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Aggregate
Warrant Exercise Price at the Reduced Exercise Price being exercised contemporaneously with signing this letter agreement: _________________</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Existing
Warrants Beneficial Ownership Blocker: &#9744; 4.99% or &#9744; 9.99%</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Series
C New Warrants: _______________ (200% of the total Series A Warrants being exercised)</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Series
D New Warrants: _______________ (200% of the total Series B Warrants being exercised)</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">New
Warrants Beneficial Ownership Blocker: &#9744; 4.99% or &#9744; 9.99%</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">DTC
Instructions:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">[Holder
signature page to CING Inducement Offer]</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>


<!-- Field: Page; Sequence: 7 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><U>Annex
A</U></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Representations,
Warranties and Covenants of the Company</U>. The Company hereby makes the following representations and warranties to the Holder:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">a)</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>SEC
    Reports</U>. The Company has filed all reports, schedules, forms, statements and other documents required to be filed by the Company
    under the Exchange Act, including pursuant to Section 13(a) or 15(d) thereof, for the one year preceding the date hereof (or such
    shorter period as the Company was required by law or regulation to file such material) (the foregoing materials, including the exhibits
    thereto and documents incorporated by reference therein &ldquo;<U>SEC Reports</U>&rdquo;). As of their respective dates, the SEC
    Reports complied in all material respects with the requirements of the Exchange Act and none of the SEC Reports, when filed, contained
    any untrue statement of a material fact or omitted to state a material fact required to be stated therein or necessary in order to
    make the statements therein, in the light of the circumstances under which they were made, not misleading. The Company is not currently
    an issuer identified in Rule 144(i) under the Securities Act.</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">b)</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Authorization;
    Enforcement</U>. The Company has the requisite corporate power and authority to enter into and to consummate the transactions contemplated
    by this letter agreement and otherwise to carry out its obligations hereunder. The execution and delivery of this letter agreement
    by the Company and the consummation by the Company of the transactions contemplated hereby have been duly authorized by all necessary
    action on the part of the Company and no further action is required by the Company, its board of directors or its stockholders in
    connection herewith other than the Stockholder Approval. This letter agreement has been duly executed by the Company and, when delivered
    in accordance with the terms hereof, will constitute the valid and binding obligation of the Company enforceable against the Company
    in accordance with its terms, except (i) as limited by general equitable principles and applicable bankruptcy, insolvency, reorganization,
    moratorium and other laws of general application affecting enforcement of creditors&rsquo; rights generally, (ii) as limited by laws
    relating to the availability of specific performance, injunctive relief or other equitable remedies and (iii) insofar as indemnification
    and contribution provisions may be limited by applicable law.</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">c)</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>No
    Conflicts</U>. The execution, delivery and performance of this letter agreement by the Company and the consummation by the Company
    of the transactions contemplated hereby do not and will not: (i) conflict with or violate any provision of the Company&rsquo;s certificate
    or articles of incorporation, bylaws or other organizational or charter documents; or (ii) conflict with, or constitute a default
    (or an event that with notice or lapse of time or both would become a default) under, result in the creation of any liens, claims,
    security interests, other encumbrances or defects upon any of the properties or assets of the Company in connection with, or give
    to others any rights of termination, amendment, acceleration or cancellation (with or without notice, lapse of time or both) of,
    any material agreement, credit facility, debt or other material instrument (evidencing Company debt or otherwise) or other material
    understanding to which such Company is a party or by which any property or asset of the Company is bound or affected; or (iii) conflict
    with or result in a violation of any law, rule, regulation, order, judgment, injunction, decree or other restriction of any court
    or governmental authority to which the Company is subject (including federal and state securities laws and regulations), or by which
    any property or asset of the Company is bound or affected, except, in the case of each of clauses (ii) and (iii), such as could not
    have or reasonably be expected to result in a material adverse effect upon the business, prospects, properties, operations, condition
    (financial or otherwise) or results of operations of the Company, taken as a whole, or in its ability to perform its obligations
    under this letter agreement.</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">d)</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Registration
    Obligations</U>. As soon as reasonably practicable (and in any event within 30 calendar days of the date of this letter agreement),
    the Company shall file a registration statement on Form S-3 (or other appropriate form if the Company is not then S-3 eligible) providing
    for the resale of the New Warrant Shares by the holders of the New Warrants (the &ldquo;<U>Resale Registration Statement</U>&rdquo;).
    The Company shall use commercially reasonable efforts to cause the Resale Registration Statement to become effective within sixty
    (60) calendar days following the date hereof (or within 90 calendar days following the date hereof in case of &ldquo;full review&rdquo;
    of such registration statement by the Commission) and to keep the Resale Registration Statement effective at all times until no holder
    of the New Warrants owns any New Warrants or New Warrant Shares. </FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">e)</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Trading
    Market</U>. Except for as related to the Stockholder Approval, the transactions contemplated under this letter agreement comply with
    all the rules and regulations of the Nasdaq Capital Market.</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">f)</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Filings,
    Consents and Approvals</U>. The Company is not required to obtain any consent, waiver, authorization or order of, give any notice
    to, or make any filing or registration with, any court or other federal, state, local or other governmental authority or other Person
    in connection with the execution, delivery and performance by the Company of this letter agreement, other than: (i) the filings required
    pursuant to this letter agreement, (ii) application(s) or notice to each applicable Trading Market for the listing of the New Warrants
    and New Warrant Shares for trading thereon in the time and manner required thereby, (iii) the filing of Form D with the Commission,
    (iv) such filings as are required to be made under applicable state securities laws, and (v) Stockholder Approval.</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 9 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">g)</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Listing
    of Common Stock</U>. The Company hereby agrees to use best efforts to maintain the listing or quotation of the Common Stock on the
    Trading Market on which it is currently listed, and concurrently with the Closing, the Company shall apply to list or quote all of
    the New Warrant Shares on such Trading Market and promptly secure the listing of all of the New Warrant Shares on such Trading Market.
    The Company further agrees, if the Company applies to have the Common Stock traded on any other Trading Market, it will then include
    in such application all of the New Warrant Shares, and will take such other action as is necessary to cause all of the New Warrant
    Shares to be listed or quoted on such other Trading Market as promptly as possible. The Company will then take all action reasonably
    necessary to continue the listing and trading of its Common Stock on a Trading Market and will comply in all respects with the Company&rsquo;s
    reporting, filing and other obligations under the bylaws or rules of the Trading Market. The Company agrees to maintain the eligibility
    of the Common Stock for electronic transfer through the Depository Trust Company or another established clearing corporation, including,
    without limitation, by timely payment of fees to the Depository Trust Company or such other established clearing corporation in connection
    with such electronic transfer. In addition, the Company shall hold an annual or special meeting of stockholders on or prior to the
    date that is ninety (90) days following the Closing Date for the purpose of obtaining Stockholder Approval, with the recommendation
    of the Company&rsquo;s Board of Directors that such proposals are approved, and the Company shall solicit proxies from its stockholders
    in connection therewith in the same manner as all other management proposals in such proxy statement and all management-appointed
    proxyholders shall vote their proxies in favor of such proposals. If the Company does not obtain Stockholder Approval at the first
    meeting, the Company shall call a meeting every ninety (90) days thereafter to seek Stockholder Approval until the earlier of the
    date on which Stockholder Approval is obtained or the New Warrants are no longer outstanding. The Company shall set the record date
    for Stockholder Approval prior to the Closing Date.</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">h)</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Subsequent
                                            Equity Sales</U>.</FONT></P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(i)
    From the date hereof until twenty (20) days after the Closing Date, neither the Company nor any Subsidiary shall (A) issue, enter
    into any agreement to issue or announce the issuance or proposed issuance of any Common Stock or Common Stock Equivalents or (B)
    file any registration statement or any amendment or supplement to any existing registration statement (other than (x) the Resale
    Registration Statement referred to herein or (y) a registration statement on Form S-8 in connection with any employee benefit plan).
    Notwithstanding the foregoing, this Section (h)(i) shall not apply in respect of an Exempt Issuance. &ldquo;<U>Exempt Issuance</U>&rdquo;
    means the issuance of (a) shares of Common Stock or options to employees, officers, directors or consultants of the Company pursuant
    to any stock or option plan duly adopted for such purpose, by a majority of the non-employee members of the Board of Directors or
    a majority of the members of a committee of non-employee directors established for such purpose for services rendered to the Company,
    provided that any shares of Common Stock or options issued to consultants of the Company are issued as &ldquo;restricted securities&rdquo;
    (as defined in Rule 144) and carry no registration rights that require or permit the filing of any registration statement in connection
    therewith during the prohibition period in this Section (h)(i), (b) warrants to the Placement Agent in connection with the transactions
    pursuant to this letter agreement and any shares of Common Stock upon exercise of the warrants to the Placement Agent, if applicable,
    and/or shares of Common Stock upon the exercise or exchange of or conversion of any securities issued hereunder and/or other securities
    exercisable or exchangeable for or convertible into shares of Common Stock issued and outstanding on the date of this letter agreement,
    provided that such securities have not been amended since the date of this letter agreement to increase the number of such securities
    or to decrease the exercise price, exchange price or conversion price of such securities (other than in connection with stock splits
    or combinations) or to extend the term of such securities, and (c) securities issued pursuant to acquisitions or strategic transactions
    approved by a majority of the disinterested directors of the Company, provided that such securities are issued as &ldquo;restricted
    securities&rdquo; (as defined in Rule 144) and carry no registration rights that require or permit the filing of any registration
    statement in connection therewith during the prohibition period in this Section (h)(i), and provided that any such issuance shall
    only be to a Person (or to the equityholders of a Person) which is, itself or through its subsidiaries, an operating company or an
    owner of an asset in a business synergistic with the business of the Company and shall provide to the Company additional benefits
    in addition to the investment of funds, but shall not include a transaction in which the Company is issuing securities primarily
    for the purpose of raising capital or to an entity whose primary business is investing in securities.</FONT></P></TD></TR>
</TABLE>

<P STYLE="margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>



<P STYLE="margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="padding-left: 0.5in; font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(ii)
    From the date hereof until one (1) year following the Closing Date, the Company shall be prohibited from effecting or entering into
    an agreement to effect any issuance by the Company or any of its Subsidiaries of Common Stock or Common Stock Equivalents (or a combination
    of units thereof) involving a Variable Rate Transaction. &ldquo;<U>Variable Rate Transaction</U>&rdquo; means a transaction in which
    the Company (i) issues or sells any debt or equity securities that are convertible into, exchangeable or exercisable for, or include
    the right to receive additional shares of Common Stock either (A) at a conversion price, exercise price or exchange rate or other
    price that is based upon and/or varies with the trading prices of or quotations for the shares of Common Stock at any time after
    the initial issuance of such debt or equity securities, or (B) with a conversion, exercise or exchange price that is subject to being
    reset at some future date after the initial issuance of such debt or equity security or upon the occurrence of specified or contingent
    events directly or indirectly related to the business of the Company or the market for the Common Stock or (ii) enters into, or effects
    a transaction under, any agreement, including, but not limited to, an equity line of credit or an &ldquo;at-the-market offering&rdquo;,
    whereby the Company may issue securities at a future determined price regardless of whether shares pursuant to such agreement have
    actually been issued and regardless of whether such agreement is subsequently canceled; <U>provided</U>, <U>however</U>, that, after
    the expiration of the prohibition period set forth in Section (h)(i) above, the issuance of shares of Common Stock pursuant to the
    &ldquo;at the market&rdquo; offering with the Placement Agent as sales agent and issuances of shares of Common Stock pursuant to
    that existing Purchase Agreement, by and between the Company and Lincoln Park Capital Fund, LLC shall not be deemed a Variable Rate
    Transaction. The Holder shall be entitled to obtain injunctive relief against the Company to preclude any such issuance, which remedy
    shall be in addition to any right to collect damages.</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">i)</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Form
    D; Blue Sky Filings</U>. If required, the Company agrees to timely file a Form D with respect to the New Warrants and New Warrant
    Shares as required under Regulation D and to provide a copy thereof, promptly upon request of any Holder. The Company shall take
    such action as the Company shall reasonably determine is necessary in order to obtain an exemption for, or to qualify the New Warrants
    and New Warrant Shares for, sale to the Holder at Closing under applicable securities or &ldquo;Blue Sky&rdquo; laws of the states
    of the United States, and shall provide evidence of such actions promptly upon request of any Holder.</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 12; Options: Last -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-99.1
<SEQUENCE>5
<FILENAME>ex99-1.htm
<TEXT>
<HTML>
<HEAD>
<TITLE></TITLE>
</HEAD>
<BODY>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Exhibit
99.1</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Cingulate
Announces Exercise of Warrants for $1.86 Million Gross Proceeds</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Kansas
City, Kan., June 28, 2024 &mdash; Cingulate Inc. (the &ldquo;Company&rdquo;) (NASDAQ: CING), a biopharmaceutical company utilizing its
proprietary Precision Timed Release&trade; (PTR&trade;) drug delivery platform technology to build and advance a pipeline of next-generation
pharmaceutical products, today announced the entry into definitive agreements for the immediate exercise of certain outstanding Series
A warrants to purchase up to an aggregate of 2,125,000 shares of common stock of the Company and Series B warrants to purchase up to
an aggregate of 1,062,500 shares of common stock of the Company originally issued in February 2023, having an exercise price of $2.00
per share, at a reduced exercise price of $0.585 per share. The shares of common stock issuable upon exercise of the warrants are registered
pursuant to an effective registration statement on Form S-1 (No. 333-276502). The offering is expected to close on or about July 1, 2024,
subject to satisfaction of customary closing conditions.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">H.C.
Wainwright &amp; Co. is acting as the exclusive placement agent for the offering.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
consideration for the immediate exercise of the warrants for cash, the Company will issue new unregistered Series C warrants to purchase
up to 4,250,000 shares of common stock and new unregistered Series D warrants to purchase up to 2,125,000 shares of common stock. The
new warrants will have an exercise price of $0.585 per share and will be exercisable beginning on the effective date of stockholder approval
of the issuance of the shares issuable upon exercise of the new warrants. The Series C warrants will expire five years from the effective
date of stockholder approval, and the Series D warrants will expire two years from the effective date of stockholder approval.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
gross proceeds to the Company from the exercise of the warrants are expected to be approximately $1,860,000, prior to deducting placement
agent fees and estimated offering expenses. The Company intends to use the net proceeds from the offering for continued research and
development and commercialization activities of CTx-1301, and for working capital, capital expenditures and general corporate purposes.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
new warrants described above were offered in a private placement pursuant to an applicable exemption from the registration requirements
of the Securities Act of 1933, as amended (the &ldquo;1933 Act&rdquo;) and, along with the shares of common stock issuable upon their
exercise, have not been registered under the 1933 Act, and may not be offered or sold in the United States absent registration with the
Securities and Exchange Commission (the &ldquo;SEC&rdquo;) or an applicable exemption from such registration requirements. The Company
has agreed to file a registration statement with the SEC covering the resale of the shares of common stock issuable upon exercise of
the new warrants.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">This
press release shall not constitute an offer to sell or a solicitation of an offer to buy nor shall there be any sale of these securities
in any state or jurisdiction in which such offer, solicitation or sale would be unlawful prior to the registration or qualification under
the securities laws of any such state or other jurisdiction.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>About
Cingulate<SUP>&reg;</SUP></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Cingulate
is a clinical-stage biopharmaceutical company utilizing its proprietary Precision Timed Release&trade; (PTR&trade;) drug delivery platform
technology to build and advance a pipeline of next-generation pharmaceutical products, designed to improve the lives of patients suffering
from frequently diagnosed conditions characterized by burdensome daily dosing regimens and suboptimal treatment outcomes. With an initial
focus on the treatment of Attention Deficit/Hyperactivity Disorder (ADHD), Cingulate is identifying and evaluating additional therapeutic
areas where PTR technology may be employed to develop future product candidates, including to treat anxiety disorders. Cingulate is headquartered
in Kansas City, KS.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Forward
Looking Statements</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">This
press release contains &ldquo;forward-looking statements&rdquo; within the meaning of Section 27A of the Securities Act of 1933, as amended,
and Section 21E of the Securities Exchange Act of 1934, as amended. These forward-looking statements include all statements, other than
statements of historical fact, regarding our current views and assumptions with respect to future events regarding our business, including
statements with respect to our plans, assumptions, expectations, beliefs and objectives with respect to the completion of the offering,
the satisfaction of customary closing conditions related to the offering, the expected gross proceeds from the offering, the intended
use of proceeds from the offering, product development, clinical studies, clinical and regulatory timelines, market opportunity, competitive
position, business strategies, potential growth opportunities, market and other conditions and other statements that are predictive in
nature. These statements are generally identified by the use of such words as &ldquo;may,&rdquo; &ldquo;could,&rdquo; &ldquo;should,&rdquo;
&ldquo;would,&rdquo; &ldquo;believe,&rdquo; &ldquo;anticipate,&rdquo; &ldquo;forecast,&rdquo; &ldquo;estimate,&rdquo; &ldquo;expect,&rdquo;
&ldquo;intend,&rdquo; &ldquo;plan,&rdquo; &ldquo;continue,&rdquo; &ldquo;outlook,&rdquo; &ldquo;will,&rdquo; &ldquo;potential&rdquo;
and similar statements of a future or forward-looking nature. Readers are cautioned that any forward-looking information provided by
us or on our behalf is not a guarantee of future performance. Actual results may differ materially from those contained in these forward-looking
statements as a result of various factors disclosed in our filings with the SEC, including the &ldquo;Risk Factors&rdquo; section of
our Annual Report on Form 10-K filed with the SEC on April 1, 2024. All forward-looking statements speak only as of the date on which
they are made, and we undertake no duty to update or revise any forward-looking statements, whether as a result of new information, future
events or otherwise, except to the extent required by law.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Investor
Relations</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Thomas
Dalton</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Vice
President, Investor &amp; Public Relations, Cingulate</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><U>tdalton@cingulate.com</U></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(913)
942-2301</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Matt
Kreps</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Darrow
Associates</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><U>mkreps@darrowir.com</U></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(214)
597-8200</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 2; Options: Last -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.SCH
<SEQUENCE>6
<FILENAME>cing-20240628.xsd
<DESCRIPTION>XBRL SCHEMA FILE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII" ?>
    <!-- Field: Doc-Info; Name: Generator; Value: GoFiler Complete; Version: 5.22c -->
    <!-- Field: Doc-Info; Name: VendorURI; Value: https://www.novaworks.com -->
    <!-- Field: Doc-Info; Name: Status; Value: 0x00000000 -->
    <!-- Field: Doc-Info; Name: Misc; Value: 96Mps7xRiXgen8uDanwsWayP6bP9z5Z8mekhvWB3bdmKbyQuijpIGSbx+ikmgZIF -->
<schema xmlns="http://www.w3.org/2001/XMLSchema" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xmlns:xbrldi="http://xbrl.org/2006/xbrldi" xmlns:dei="http://xbrl.sec.gov/dei/2024" xmlns:us-gaap="http://fasb.org/us-gaap/2024" xmlns:srt="http://fasb.org/srt/2024" xmlns:srt-types="http://fasb.org/srt-types/2024" xmlns:dtr-types="http://www.xbrl.org/dtr/type/2022-03-31" xmlns:CING="http://cingulate.com/20240628" elementFormDefault="qualified" targetNamespace="http://cingulate.com/20240628">
    <annotation>
      <appinfo>
        <link:roleType roleURI="http://cingulate.com/role/Cover" id="Cover">
          <link:definition>00000001 - Document - Cover</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:linkbaseRef xlink:type="simple" xlink:href="cing-20240628_pre.xml" xlink:role="http://www.xbrl.org/2003/role/presentationLinkbaseRef" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:title="Presentation Links" />
        <link:linkbaseRef xlink:type="simple" xlink:href="cing-20240628_lab.xml" xlink:role="http://www.xbrl.org/2003/role/labelLinkbaseRef" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:title="Label Links" />
        <link:linkbaseRef xlink:type="simple" xlink:href="cing-20240628_def.xml" xlink:role="http://www.xbrl.org/2003/role/definitionLinkbaseRef" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:title="Definition Links" />
      </appinfo>
    </annotation>
    <import namespace="http://www.xbrl.org/2003/instance" schemaLocation="http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd" />
    <import namespace="http://www.xbrl.org/2003/linkbase" schemaLocation="http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd" />
    <import namespace="http://xbrl.sec.gov/dei/2024" schemaLocation="https://xbrl.sec.gov/dei/2024/dei-2024.xsd" />
    <import namespace="http://fasb.org/us-gaap/2024" schemaLocation="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd" />
    <import namespace="http://fasb.org/us-types/2024" schemaLocation="https://xbrl.fasb.org/us-gaap/2024/elts/us-types-2024.xsd" />
    <import namespace="http://www.xbrl.org/dtr/type/2022-03-31" schemaLocation="https://www.xbrl.org/dtr/type/2022-03-31/types.xsd" />
    <import namespace="http://xbrl.sec.gov/country/2024" schemaLocation="https://xbrl.sec.gov/country/2024/country-2024.xsd" />
    <import namespace="http://fasb.org/srt/2024" schemaLocation="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd" />
    <import namespace="http://fasb.org/srt-types/2024" schemaLocation="https://xbrl.fasb.org/srt/2024/elts/srt-types-2024.xsd" />
    <element id="CING_CommonStockParValue0.0001PerShareMember" name="CommonStockParValue0.0001PerShareMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="CING_WarrantsExercisableForOneShareOfCommonStockMember" name="WarrantsExercisableForOneShareOfCommonStockMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
</schema>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.DEF
<SEQUENCE>7
<FILENAME>cing-20240628_def.xml
<DESCRIPTION>XBRL DEFINITION FILE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII" standalone="no"?>
    <!-- Field: Doc-Info; Name: Generator; Value: GoFiler Complete; Version: 5.22c -->
    <!-- Field: Doc-Info; Name: VendorURI; Value: https://www.novaworks.com -->
    <!-- Field: Doc-Info; Name: Status; Value: 0x00000000 -->
<link:linkbase xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xmlns:xbrli="http://www.xbrl.org/2003/instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
    <link:roleRef roleURI="http://cingulate.com/role/Cover" xlink:href="cing-20240628.xsd#Cover" xlink:type="simple" />
    <link:arcroleRef xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#hypercube-dimension" arcroleURI="http://xbrl.org/int/dim/arcrole/hypercube-dimension" />
    <link:arcroleRef xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#dimension-domain" arcroleURI="http://xbrl.org/int/dim/arcrole/dimension-domain" />
    <link:arcroleRef xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#domain-member" arcroleURI="http://xbrl.org/int/dim/arcrole/domain-member" />
    <link:arcroleRef xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#all" arcroleURI="http://xbrl.org/int/dim/arcrole/all" />
    <link:arcroleRef xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#notAll" arcroleURI="http://xbrl.org/int/dim/arcrole/notAll" />
    <link:arcroleRef xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#dimension-default" arcroleURI="http://xbrl.org/int/dim/arcrole/dimension-default" />
    <link:definitionLink xlink:type="extended" xlink:role="http://cingulate.com/role/Cover" xlink:title="00000001 - Document - Cover">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaapStatementLineItems" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaapStatementTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStatementTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementClassOfStockAxis" xlink:label="loc_us-gaapStatementClassOfStockAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapStatementClassOfStockAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ClassOfStockDomain" xlink:label="loc_us-gaapClassOfStockDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapStatementClassOfStockAxis" xlink:to="loc_us-gaapClassOfStockDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ClassOfStockDomain" xlink:label="loc_us-gaapClassOfStockDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapStatementClassOfStockAxis" xlink:to="loc_us-gaapClassOfStockDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="cing-20240628.xsd#CING_CommonStockParValue0.0001PerShareMember" xlink:label="loc_CINGCommonStockParValue0.0001PerShareMember_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapClassOfStockDomain" xlink:to="loc_CINGCommonStockParValue0.0001PerShareMember_10" xlink:type="arc" order="11" />
      <link:loc xlink:type="locator" xlink:href="cing-20240628.xsd#CING_WarrantsExercisableForOneShareOfCommonStockMember" xlink:label="loc_CINGWarrantsExercisableForOneShareOfCommonStockMember_20" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapClassOfStockDomain" xlink:to="loc_CINGWarrantsExercisableForOneShareOfCommonStockMember_20" xlink:type="arc" order="21" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentType" xlink:label="loc_deiDocumentType_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiDocumentType_40" xlink:type="arc" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_AmendmentFlag" xlink:label="loc_deiAmendmentFlag_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiAmendmentFlag_40" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_AmendmentDescription" xlink:label="loc_deiAmendmentDescription_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiAmendmentDescription_40" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentRegistrationStatement" xlink:label="loc_deiDocumentRegistrationStatement_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiDocumentRegistrationStatement_40" xlink:type="arc" order="3" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentAnnualReport" xlink:label="loc_deiDocumentAnnualReport_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiDocumentAnnualReport_40" xlink:type="arc" order="4" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentQuarterlyReport" xlink:label="loc_deiDocumentQuarterlyReport_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiDocumentQuarterlyReport_40" xlink:type="arc" order="5" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentTransitionReport" xlink:label="loc_deiDocumentTransitionReport_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiDocumentTransitionReport_40" xlink:type="arc" order="6" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentShellCompanyReport" xlink:label="loc_deiDocumentShellCompanyReport_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiDocumentShellCompanyReport_40" xlink:type="arc" order="7" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentShellCompanyEventDate" xlink:label="loc_deiDocumentShellCompanyEventDate_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiDocumentShellCompanyEventDate_40" xlink:type="arc" order="8" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentPeriodStartDate" xlink:label="loc_deiDocumentPeriodStartDate_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiDocumentPeriodStartDate_40" xlink:type="arc" order="9" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentPeriodEndDate" xlink:label="loc_deiDocumentPeriodEndDate_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiDocumentPeriodEndDate_40" xlink:type="arc" order="10" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentFiscalPeriodFocus" xlink:label="loc_deiDocumentFiscalPeriodFocus_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiDocumentFiscalPeriodFocus_40" xlink:type="arc" order="11" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentFiscalYearFocus" xlink:label="loc_deiDocumentFiscalYearFocus_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiDocumentFiscalYearFocus_40" xlink:type="arc" order="12" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_CurrentFiscalYearEndDate" xlink:label="loc_deiCurrentFiscalYearEndDate_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiCurrentFiscalYearEndDate_40" xlink:type="arc" order="13" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityFileNumber" xlink:label="loc_deiEntityFileNumber_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityFileNumber_40" xlink:type="arc" order="14" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityRegistrantName" xlink:label="loc_deiEntityRegistrantName_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityRegistrantName_40" xlink:type="arc" order="15" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityCentralIndexKey" xlink:label="loc_deiEntityCentralIndexKey_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityCentralIndexKey_40" xlink:type="arc" order="16" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityPrimarySicNumber" xlink:label="loc_deiEntityPrimarySicNumber_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityPrimarySicNumber_40" xlink:type="arc" order="17" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityTaxIdentificationNumber" xlink:label="loc_deiEntityTaxIdentificationNumber_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityTaxIdentificationNumber_40" xlink:type="arc" order="18" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityIncorporationStateCountryCode" xlink:label="loc_deiEntityIncorporationStateCountryCode_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityIncorporationStateCountryCode_40" xlink:type="arc" order="19" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressAddressLine1" xlink:label="loc_deiEntityAddressAddressLine1_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityAddressAddressLine1_40" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressAddressLine2" xlink:label="loc_deiEntityAddressAddressLine2_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityAddressAddressLine2_40" xlink:type="arc" order="21" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressAddressLine3" xlink:label="loc_deiEntityAddressAddressLine3_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityAddressAddressLine3_40" xlink:type="arc" order="22" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressCityOrTown" xlink:label="loc_deiEntityAddressCityOrTown_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityAddressCityOrTown_40" xlink:type="arc" order="23" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressStateOrProvince" xlink:label="loc_deiEntityAddressStateOrProvince_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityAddressStateOrProvince_40" xlink:type="arc" order="24" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressCountry" xlink:label="loc_deiEntityAddressCountry_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityAddressCountry_40" xlink:type="arc" order="25" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressPostalZipCode" xlink:label="loc_deiEntityAddressPostalZipCode_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityAddressPostalZipCode_40" xlink:type="arc" order="26" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_CountryRegion" xlink:label="loc_deiCountryRegion_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiCountryRegion_40" xlink:type="arc" order="27" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_CityAreaCode" xlink:label="loc_deiCityAreaCode_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiCityAreaCode_40" xlink:type="arc" order="28" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_LocalPhoneNumber" xlink:label="loc_deiLocalPhoneNumber_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiLocalPhoneNumber_40" xlink:type="arc" order="29" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_Extension" xlink:label="loc_deiExtension_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiExtension_40" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_WrittenCommunications" xlink:label="loc_deiWrittenCommunications_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiWrittenCommunications_40" xlink:type="arc" order="31" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_SolicitingMaterial" xlink:label="loc_deiSolicitingMaterial_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiSolicitingMaterial_40" xlink:type="arc" order="32" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_PreCommencementTenderOffer" xlink:label="loc_deiPreCommencementTenderOffer_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiPreCommencementTenderOffer_40" xlink:type="arc" order="33" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_PreCommencementIssuerTenderOffer" xlink:label="loc_deiPreCommencementIssuerTenderOffer_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiPreCommencementIssuerTenderOffer_40" xlink:type="arc" order="34" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_Security12bTitle" xlink:label="loc_deiSecurity12bTitle_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiSecurity12bTitle_40" xlink:type="arc" order="35" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_NoTradingSymbolFlag" xlink:label="loc_deiNoTradingSymbolFlag_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiNoTradingSymbolFlag_40" xlink:type="arc" order="36" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_TradingSymbol" xlink:label="loc_deiTradingSymbol_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiTradingSymbol_40" xlink:type="arc" order="37" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_SecurityExchangeName" xlink:label="loc_deiSecurityExchangeName_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiSecurityExchangeName_40" xlink:type="arc" order="38" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_Security12gTitle" xlink:label="loc_deiSecurity12gTitle_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiSecurity12gTitle_40" xlink:type="arc" order="39" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_SecurityReportingObligation" xlink:label="loc_deiSecurityReportingObligation_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiSecurityReportingObligation_40" xlink:type="arc" order="40" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_AnnualInformationForm" xlink:label="loc_deiAnnualInformationForm_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiAnnualInformationForm_40" xlink:type="arc" order="41" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_AuditedAnnualFinancialStatements" xlink:label="loc_deiAuditedAnnualFinancialStatements_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiAuditedAnnualFinancialStatements_40" xlink:type="arc" order="42" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityWellKnownSeasonedIssuer" xlink:label="loc_deiEntityWellKnownSeasonedIssuer_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityWellKnownSeasonedIssuer_40" xlink:type="arc" order="43" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityVoluntaryFilers" xlink:label="loc_deiEntityVoluntaryFilers_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityVoluntaryFilers_40" xlink:type="arc" order="44" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityCurrentReportingStatus" xlink:label="loc_deiEntityCurrentReportingStatus_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityCurrentReportingStatus_40" xlink:type="arc" order="45" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityInteractiveDataCurrent" xlink:label="loc_deiEntityInteractiveDataCurrent_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityInteractiveDataCurrent_40" xlink:type="arc" order="46" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityFilerCategory" xlink:label="loc_deiEntityFilerCategory_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityFilerCategory_40" xlink:type="arc" order="47" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntitySmallBusiness" xlink:label="loc_deiEntitySmallBusiness_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntitySmallBusiness_40" xlink:type="arc" order="48" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityEmergingGrowthCompany" xlink:label="loc_deiEntityEmergingGrowthCompany_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityEmergingGrowthCompany_40" xlink:type="arc" order="49" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityExTransitionPeriod" xlink:label="loc_deiEntityExTransitionPeriod_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityExTransitionPeriod_40" xlink:type="arc" order="50" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentAccountingStandard" xlink:label="loc_deiDocumentAccountingStandard_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiDocumentAccountingStandard_40" xlink:type="arc" order="51" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_OtherReportingStandardItemNumber" xlink:label="loc_deiOtherReportingStandardItemNumber_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiOtherReportingStandardItemNumber_40" xlink:type="arc" order="52" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityShellCompany" xlink:label="loc_deiEntityShellCompany_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityShellCompany_40" xlink:type="arc" order="53" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityPublicFloat" xlink:label="loc_deiEntityPublicFloat_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityPublicFloat_40" xlink:type="arc" order="54" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityBankruptcyProceedingsReportingCurrent" xlink:label="loc_deiEntityBankruptcyProceedingsReportingCurrent_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityBankruptcyProceedingsReportingCurrent_40" xlink:type="arc" order="55" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityCommonStockSharesOutstanding" xlink:label="loc_deiEntityCommonStockSharesOutstanding_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityCommonStockSharesOutstanding_40" xlink:type="arc" order="56" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentsIncorporatedByReferenceTextBlock" xlink:label="loc_deiDocumentsIncorporatedByReferenceTextBlock_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiDocumentsIncorporatedByReferenceTextBlock_40" xlink:type="arc" order="57" />
    </link:definitionLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.LAB
<SEQUENCE>8
<FILENAME>cing-20240628_lab.xml
<DESCRIPTION>XBRL LABEL FILE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII" standalone="no"?>
    <!-- Field: Doc-Info; Name: Generator; Value: GoFiler Complete; Version: 5.22c -->
    <!-- Field: Doc-Info; Name: VendorURI; Value: https://www.novaworks.com -->
    <!-- Field: Doc-Info; Name: Status; Value: 0x00000000 -->
<link:linkbase xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrli="http://www.xbrl.org/2003/instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedLabel" roleURI="http://www.xbrl.org/2009/role/negatedLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodEndLabel" roleURI="http://www.xbrl.org/2009/role/negatedPeriodEndLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodStartLabel" roleURI="http://www.xbrl.org/2009/role/negatedPeriodStartLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTotalLabel" roleURI="http://www.xbrl.org/2009/role/negatedTotalLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedNetLabel" roleURI="http://www.xbrl.org/2009/role/negatedNetLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTerseLabel" roleURI="http://www.xbrl.org/2009/role/negatedTerseLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/net-2009-12-16.xsd#netLabel" roleURI="http://www.xbrl.org/2009/role/netLabel" />
    <link:labelLink xlink:type="extended" xlink:role="http://www.xbrl.org/2003/role/link">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementClassOfStockAxis" xlink:label="us-gaap_StatementClassOfStockAxis" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StatementClassOfStockAxis" xlink:to="us-gaap_StatementClassOfStockAxis_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StatementClassOfStockAxis_lbl" xml:lang="en-US">Class of Stock [Axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="cing-20240628.xsd#CING_CommonStockParValue0.0001PerShareMember" xlink:label="CING_CommonStockParValue0.0001PerShareMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="CING_CommonStockParValue0.0001PerShareMember" xlink:to="CING_CommonStockParValue0.0001PerShareMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="CING_CommonStockParValue0.0001PerShareMember_lbl" xml:lang="en-US">Common Stock, par value $0.0001 per share</link:label>
      <link:loc xlink:type="locator" xlink:href="cing-20240628.xsd#CING_WarrantsExercisableForOneShareOfCommonStockMember" xlink:label="CING_WarrantsExercisableForOneShareOfCommonStockMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="CING_WarrantsExercisableForOneShareOfCommonStockMember" xlink:to="CING_WarrantsExercisableForOneShareOfCommonStockMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="CING_WarrantsExercisableForOneShareOfCommonStockMember_lbl" xml:lang="en-US">Warrants, exercisable for one share of common stock</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementTable" xlink:label="us-gaap_StatementTable" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_StatementTable_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StatementTable_lbl" xml:lang="en-US">Statement [Table]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementLineItems" xlink:label="us-gaap_StatementLineItems" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StatementLineItems_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StatementLineItems_lbl" xml:lang="en-US">Statement [Line Items]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentType" xlink:label="dei_DocumentType" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentType" xlink:to="dei_DocumentType_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentType_lbl" xml:lang="en-US">Document Type</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_AmendmentFlag" xlink:label="dei_AmendmentFlag" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AmendmentFlag" xlink:to="dei_AmendmentFlag_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_AmendmentFlag_lbl" xml:lang="en-US">Amendment Flag</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_AmendmentDescription" xlink:label="dei_AmendmentDescription" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AmendmentDescription" xlink:to="dei_AmendmentDescription_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_AmendmentDescription_lbl" xml:lang="en-US">Amendment Description</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentRegistrationStatement" xlink:label="dei_DocumentRegistrationStatement" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentRegistrationStatement" xlink:to="dei_DocumentRegistrationStatement_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentRegistrationStatement_lbl" xml:lang="en-US">Document Registration Statement</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentAnnualReport" xlink:label="dei_DocumentAnnualReport" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentAnnualReport" xlink:to="dei_DocumentAnnualReport_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentAnnualReport_lbl" xml:lang="en-US">Document Annual Report</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentQuarterlyReport" xlink:label="dei_DocumentQuarterlyReport" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentQuarterlyReport" xlink:to="dei_DocumentQuarterlyReport_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentQuarterlyReport_lbl" xml:lang="en-US">Document Quarterly Report</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentTransitionReport" xlink:label="dei_DocumentTransitionReport" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentTransitionReport" xlink:to="dei_DocumentTransitionReport_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentTransitionReport_lbl" xml:lang="en-US">Document Transition Report</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentShellCompanyReport" xlink:label="dei_DocumentShellCompanyReport" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentShellCompanyReport" xlink:to="dei_DocumentShellCompanyReport_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentShellCompanyReport_lbl" xml:lang="en-US">Document Shell Company Report</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentShellCompanyEventDate" xlink:label="dei_DocumentShellCompanyEventDate" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentShellCompanyEventDate" xlink:to="dei_DocumentShellCompanyEventDate_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentShellCompanyEventDate_lbl" xml:lang="en-US">Document Shell Company Event Date</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentPeriodStartDate" xlink:label="dei_DocumentPeriodStartDate" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentPeriodStartDate" xlink:to="dei_DocumentPeriodStartDate_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentPeriodStartDate_lbl" xml:lang="en-US">Document Period Start Date</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentPeriodEndDate" xlink:label="dei_DocumentPeriodEndDate" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentPeriodEndDate" xlink:to="dei_DocumentPeriodEndDate_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentPeriodEndDate_lbl" xml:lang="en-US">Document Period End Date</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentFiscalPeriodFocus" xlink:label="dei_DocumentFiscalPeriodFocus" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentFiscalPeriodFocus" xlink:to="dei_DocumentFiscalPeriodFocus_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentFiscalPeriodFocus_lbl" xml:lang="en-US">Document Fiscal Period Focus</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentFiscalYearFocus" xlink:label="dei_DocumentFiscalYearFocus" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentFiscalYearFocus" xlink:to="dei_DocumentFiscalYearFocus_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentFiscalYearFocus_lbl" xml:lang="en-US">Document Fiscal Year Focus</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_CurrentFiscalYearEndDate" xlink:label="dei_CurrentFiscalYearEndDate" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CurrentFiscalYearEndDate" xlink:to="dei_CurrentFiscalYearEndDate_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_CurrentFiscalYearEndDate_lbl" xml:lang="en-US">Current Fiscal Year End Date</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityFileNumber" xlink:label="dei_EntityFileNumber" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityFileNumber" xlink:to="dei_EntityFileNumber_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityFileNumber_lbl" xml:lang="en-US">Entity File Number</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityRegistrantName" xlink:label="dei_EntityRegistrantName" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityRegistrantName" xlink:to="dei_EntityRegistrantName_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityRegistrantName_lbl" xml:lang="en-US">Entity Registrant Name</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityCentralIndexKey" xlink:label="dei_EntityCentralIndexKey" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityCentralIndexKey" xlink:to="dei_EntityCentralIndexKey_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityCentralIndexKey_lbl" xml:lang="en-US">Entity Central Index Key</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityPrimarySicNumber" xlink:label="dei_EntityPrimarySicNumber" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityPrimarySicNumber" xlink:to="dei_EntityPrimarySicNumber_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityPrimarySicNumber_lbl" xml:lang="en-US">Entity Primary SIC Number</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityTaxIdentificationNumber" xlink:label="dei_EntityTaxIdentificationNumber" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityTaxIdentificationNumber" xlink:to="dei_EntityTaxIdentificationNumber_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityTaxIdentificationNumber_lbl" xml:lang="en-US">Entity Tax Identification Number</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityIncorporationStateCountryCode" xlink:label="dei_EntityIncorporationStateCountryCode" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityIncorporationStateCountryCode" xlink:to="dei_EntityIncorporationStateCountryCode_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityIncorporationStateCountryCode_lbl" xml:lang="en-US">Entity Incorporation, State or Country Code</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressAddressLine1" xlink:label="dei_EntityAddressAddressLine1" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressAddressLine1" xlink:to="dei_EntityAddressAddressLine1_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressAddressLine1_lbl" xml:lang="en-US">Entity Address, Address Line One</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressAddressLine2" xlink:label="dei_EntityAddressAddressLine2" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressAddressLine2" xlink:to="dei_EntityAddressAddressLine2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressAddressLine2_lbl" xml:lang="en-US">Entity Address, Address Line Two</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressAddressLine3" xlink:label="dei_EntityAddressAddressLine3" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressAddressLine3" xlink:to="dei_EntityAddressAddressLine3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressAddressLine3_lbl" xml:lang="en-US">Entity Address, Address Line Three</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressCityOrTown" xlink:label="dei_EntityAddressCityOrTown" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressCityOrTown" xlink:to="dei_EntityAddressCityOrTown_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressCityOrTown_lbl" xml:lang="en-US">Entity Address, City or Town</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressStateOrProvince" xlink:label="dei_EntityAddressStateOrProvince" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressStateOrProvince" xlink:to="dei_EntityAddressStateOrProvince_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressStateOrProvince_lbl" xml:lang="en-US">Entity Address, State or Province</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressCountry" xlink:label="dei_EntityAddressCountry" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressCountry" xlink:to="dei_EntityAddressCountry_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressCountry_lbl" xml:lang="en-US">Entity Address, Country</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressPostalZipCode" xlink:label="dei_EntityAddressPostalZipCode" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressPostalZipCode" xlink:to="dei_EntityAddressPostalZipCode_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressPostalZipCode_lbl" xml:lang="en-US">Entity Address, Postal Zip Code</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_CountryRegion" xlink:label="dei_CountryRegion" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CountryRegion" xlink:to="dei_CountryRegion_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_CountryRegion_lbl" xml:lang="en-US">Country Region</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_CityAreaCode" xlink:label="dei_CityAreaCode" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CityAreaCode" xlink:to="dei_CityAreaCode_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_CityAreaCode_lbl" xml:lang="en-US">City Area Code</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_LocalPhoneNumber" xlink:label="dei_LocalPhoneNumber" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_LocalPhoneNumber" xlink:to="dei_LocalPhoneNumber_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_LocalPhoneNumber_lbl" xml:lang="en-US">Local Phone Number</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_Extension" xlink:label="dei_Extension" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_Extension" xlink:to="dei_Extension_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_Extension_lbl" xml:lang="en-US">Extension</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_WrittenCommunications" xlink:label="dei_WrittenCommunications" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_WrittenCommunications" xlink:to="dei_WrittenCommunications_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_WrittenCommunications_lbl" xml:lang="en-US">Written Communications</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_SolicitingMaterial" xlink:label="dei_SolicitingMaterial" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_SolicitingMaterial" xlink:to="dei_SolicitingMaterial_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_SolicitingMaterial_lbl" xml:lang="en-US">Soliciting Material</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_PreCommencementTenderOffer" xlink:label="dei_PreCommencementTenderOffer" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_PreCommencementTenderOffer" xlink:to="dei_PreCommencementTenderOffer_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_PreCommencementTenderOffer_lbl" xml:lang="en-US">Pre-commencement Tender Offer</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_PreCommencementIssuerTenderOffer" xlink:label="dei_PreCommencementIssuerTenderOffer" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_PreCommencementIssuerTenderOffer" xlink:to="dei_PreCommencementIssuerTenderOffer_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_PreCommencementIssuerTenderOffer_lbl" xml:lang="en-US">Pre-commencement Issuer Tender Offer</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_Security12bTitle" xlink:label="dei_Security12bTitle" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_Security12bTitle" xlink:to="dei_Security12bTitle_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_Security12bTitle_lbl" xml:lang="en-US">Title of 12(b) Security</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_NoTradingSymbolFlag" xlink:label="dei_NoTradingSymbolFlag" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_NoTradingSymbolFlag" xlink:to="dei_NoTradingSymbolFlag_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_NoTradingSymbolFlag_lbl" xml:lang="en-US">No Trading Symbol Flag</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_TradingSymbol" xlink:label="dei_TradingSymbol" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_TradingSymbol" xlink:to="dei_TradingSymbol_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_TradingSymbol_lbl" xml:lang="en-US">Trading Symbol</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_SecurityExchangeName" xlink:label="dei_SecurityExchangeName" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_SecurityExchangeName" xlink:to="dei_SecurityExchangeName_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_SecurityExchangeName_lbl" xml:lang="en-US">Security Exchange Name</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_Security12gTitle" xlink:label="dei_Security12gTitle" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_Security12gTitle" xlink:to="dei_Security12gTitle_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_Security12gTitle_lbl" xml:lang="en-US">Title of 12(g) Security</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_SecurityReportingObligation" xlink:label="dei_SecurityReportingObligation" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_SecurityReportingObligation" xlink:to="dei_SecurityReportingObligation_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_SecurityReportingObligation_lbl" xml:lang="en-US">Security Reporting Obligation</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_AnnualInformationForm" xlink:label="dei_AnnualInformationForm" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AnnualInformationForm" xlink:to="dei_AnnualInformationForm_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_AnnualInformationForm_lbl" xml:lang="en-US">Annual Information Form</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_AuditedAnnualFinancialStatements" xlink:label="dei_AuditedAnnualFinancialStatements" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AuditedAnnualFinancialStatements" xlink:to="dei_AuditedAnnualFinancialStatements_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_AuditedAnnualFinancialStatements_lbl" xml:lang="en-US">Audited Annual Financial Statements</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityWellKnownSeasonedIssuer" xlink:label="dei_EntityWellKnownSeasonedIssuer" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityWellKnownSeasonedIssuer" xlink:to="dei_EntityWellKnownSeasonedIssuer_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityWellKnownSeasonedIssuer_lbl" xml:lang="en-US">Entity Well-known Seasoned Issuer</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityVoluntaryFilers" xlink:label="dei_EntityVoluntaryFilers" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityVoluntaryFilers" xlink:to="dei_EntityVoluntaryFilers_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityVoluntaryFilers_lbl" xml:lang="en-US">Entity Voluntary Filers</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityCurrentReportingStatus" xlink:label="dei_EntityCurrentReportingStatus" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityCurrentReportingStatus" xlink:to="dei_EntityCurrentReportingStatus_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityCurrentReportingStatus_lbl" xml:lang="en-US">Entity Current Reporting Status</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityInteractiveDataCurrent" xlink:label="dei_EntityInteractiveDataCurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityInteractiveDataCurrent" xlink:to="dei_EntityInteractiveDataCurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityInteractiveDataCurrent_lbl" xml:lang="en-US">Entity Interactive Data Current</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityFilerCategory" xlink:label="dei_EntityFilerCategory" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityFilerCategory" xlink:to="dei_EntityFilerCategory_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityFilerCategory_lbl" xml:lang="en-US">Entity Filer Category</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntitySmallBusiness" xlink:label="dei_EntitySmallBusiness" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntitySmallBusiness" xlink:to="dei_EntitySmallBusiness_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntitySmallBusiness_lbl" xml:lang="en-US">Entity Small Business</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityEmergingGrowthCompany" xlink:label="dei_EntityEmergingGrowthCompany" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityEmergingGrowthCompany" xlink:to="dei_EntityEmergingGrowthCompany_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityEmergingGrowthCompany_lbl" xml:lang="en-US">Entity Emerging Growth Company</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityExTransitionPeriod" xlink:label="dei_EntityExTransitionPeriod" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityExTransitionPeriod" xlink:to="dei_EntityExTransitionPeriod_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityExTransitionPeriod_lbl" xml:lang="en-US">Elected Not To Use the Extended Transition Period</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentAccountingStandard" xlink:label="dei_DocumentAccountingStandard" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentAccountingStandard" xlink:to="dei_DocumentAccountingStandard_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentAccountingStandard_lbl" xml:lang="en-US">Document Accounting Standard</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_OtherReportingStandardItemNumber" xlink:label="dei_OtherReportingStandardItemNumber" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_OtherReportingStandardItemNumber" xlink:to="dei_OtherReportingStandardItemNumber_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_OtherReportingStandardItemNumber_lbl" xml:lang="en-US">Other Reporting Standard Item Number</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityShellCompany" xlink:label="dei_EntityShellCompany" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityShellCompany" xlink:to="dei_EntityShellCompany_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityShellCompany_lbl" xml:lang="en-US">Entity Shell Company</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityPublicFloat" xlink:label="dei_EntityPublicFloat" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityPublicFloat" xlink:to="dei_EntityPublicFloat_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityPublicFloat_lbl" xml:lang="en-US">Entity Public Float</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityBankruptcyProceedingsReportingCurrent" xlink:label="dei_EntityBankruptcyProceedingsReportingCurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityBankruptcyProceedingsReportingCurrent" xlink:to="dei_EntityBankruptcyProceedingsReportingCurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityBankruptcyProceedingsReportingCurrent_lbl" xml:lang="en-US">Entity Bankruptcy Proceedings, Reporting Current</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityCommonStockSharesOutstanding" xlink:label="dei_EntityCommonStockSharesOutstanding" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityCommonStockSharesOutstanding" xlink:to="dei_EntityCommonStockSharesOutstanding_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityCommonStockSharesOutstanding_lbl" xml:lang="en-US">Entity Common Stock, Shares Outstanding</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentsIncorporatedByReferenceTextBlock" xlink:label="dei_DocumentsIncorporatedByReferenceTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentsIncorporatedByReferenceTextBlock" xlink:to="dei_DocumentsIncorporatedByReferenceTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentsIncorporatedByReferenceTextBlock_lbl" xml:lang="en-US">Documents Incorporated by Reference [Text Block]</link:label>
    </link:labelLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.PRE
<SEQUENCE>9
<FILENAME>cing-20240628_pre.xml
<DESCRIPTION>XBRL PRESENTATION FILE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII" standalone="no"?>
    <!-- Field: Doc-Info; Name: Generator; Value: GoFiler Complete; Version: 5.22c -->
    <!-- Field: Doc-Info; Name: VendorURI; Value: https://www.novaworks.com -->
    <!-- Field: Doc-Info; Name: Status; Value: 0x00000000 -->
<link:linkbase xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrli="http://www.xbrl.org/2003/instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
    <link:roleRef roleURI="http://cingulate.com/role/Cover" xlink:href="cing-20240628.xsd#Cover" xlink:type="simple" />
    <link:presentationLink xlink:type="extended" xlink:role="http://cingulate.com/role/Cover" xlink:title="00000001 - Document - Cover">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_CoverAbstract" xlink:label="loc_deiCoverAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaapStatementTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_us-gaapStatementTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaapStatementLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapStatementLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementClassOfStockAxis" xlink:label="loc_us-gaapStatementClassOfStockAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapStatementClassOfStockAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ClassOfStockDomain" xlink:label="loc_us-gaapClassOfStockDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementClassOfStockAxis" xlink:to="loc_us-gaapClassOfStockDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="cing-20240628.xsd#CING_CommonStockParValue0.0001PerShareMember" xlink:label="loc_CINGCommonStockParValue0.0001PerShareMember" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapClassOfStockDomain" xlink:to="loc_CINGCommonStockParValue0.0001PerShareMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="cing-20240628.xsd#CING_WarrantsExercisableForOneShareOfCommonStockMember" xlink:label="loc_CINGWarrantsExercisableForOneShareOfCommonStockMember" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapClassOfStockDomain" xlink:to="loc_CINGWarrantsExercisableForOneShareOfCommonStockMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentType" xlink:label="loc_deiDocumentType" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiDocumentType" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_AmendmentFlag" xlink:label="loc_deiAmendmentFlag" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiAmendmentFlag" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_AmendmentDescription" xlink:label="loc_deiAmendmentDescription" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiAmendmentDescription" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentRegistrationStatement" xlink:label="loc_deiDocumentRegistrationStatement" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiDocumentRegistrationStatement" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentAnnualReport" xlink:label="loc_deiDocumentAnnualReport" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiDocumentAnnualReport" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentQuarterlyReport" xlink:label="loc_deiDocumentQuarterlyReport" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiDocumentQuarterlyReport" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentTransitionReport" xlink:label="loc_deiDocumentTransitionReport" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiDocumentTransitionReport" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentShellCompanyReport" xlink:label="loc_deiDocumentShellCompanyReport" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiDocumentShellCompanyReport" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentShellCompanyEventDate" xlink:label="loc_deiDocumentShellCompanyEventDate" />
      <link:presentationArc order="80" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiDocumentShellCompanyEventDate" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentPeriodStartDate" xlink:label="loc_deiDocumentPeriodStartDate" />
      <link:presentationArc order="90" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiDocumentPeriodStartDate" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentPeriodEndDate" xlink:label="loc_deiDocumentPeriodEndDate" />
      <link:presentationArc order="100" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiDocumentPeriodEndDate" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentFiscalPeriodFocus" xlink:label="loc_deiDocumentFiscalPeriodFocus" />
      <link:presentationArc order="110" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiDocumentFiscalPeriodFocus" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentFiscalYearFocus" xlink:label="loc_deiDocumentFiscalYearFocus" />
      <link:presentationArc order="120" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiDocumentFiscalYearFocus" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_CurrentFiscalYearEndDate" xlink:label="loc_deiCurrentFiscalYearEndDate" />
      <link:presentationArc order="130" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiCurrentFiscalYearEndDate" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityFileNumber" xlink:label="loc_deiEntityFileNumber" />
      <link:presentationArc order="140" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityFileNumber" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityRegistrantName" xlink:label="loc_deiEntityRegistrantName" />
      <link:presentationArc order="150" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityRegistrantName" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityCentralIndexKey" xlink:label="loc_deiEntityCentralIndexKey" />
      <link:presentationArc order="160" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityCentralIndexKey" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityPrimarySicNumber" xlink:label="loc_deiEntityPrimarySicNumber" />
      <link:presentationArc order="170" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityPrimarySicNumber" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityTaxIdentificationNumber" xlink:label="loc_deiEntityTaxIdentificationNumber" />
      <link:presentationArc order="180" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityTaxIdentificationNumber" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityIncorporationStateCountryCode" xlink:label="loc_deiEntityIncorporationStateCountryCode" />
      <link:presentationArc order="190" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityIncorporationStateCountryCode" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressAddressLine1" xlink:label="loc_deiEntityAddressAddressLine1" />
      <link:presentationArc order="200" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityAddressAddressLine1" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressAddressLine2" xlink:label="loc_deiEntityAddressAddressLine2" />
      <link:presentationArc order="210" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityAddressAddressLine2" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressAddressLine3" xlink:label="loc_deiEntityAddressAddressLine3" />
      <link:presentationArc order="220" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityAddressAddressLine3" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressCityOrTown" xlink:label="loc_deiEntityAddressCityOrTown" />
      <link:presentationArc order="230" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityAddressCityOrTown" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressStateOrProvince" xlink:label="loc_deiEntityAddressStateOrProvince" />
      <link:presentationArc order="240" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityAddressStateOrProvince" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressCountry" xlink:label="loc_deiEntityAddressCountry" />
      <link:presentationArc order="250" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityAddressCountry" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressPostalZipCode" xlink:label="loc_deiEntityAddressPostalZipCode" />
      <link:presentationArc order="260" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityAddressPostalZipCode" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_CountryRegion" xlink:label="loc_deiCountryRegion" />
      <link:presentationArc order="270" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiCountryRegion" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_CityAreaCode" xlink:label="loc_deiCityAreaCode" />
      <link:presentationArc order="280" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiCityAreaCode" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_LocalPhoneNumber" xlink:label="loc_deiLocalPhoneNumber" />
      <link:presentationArc order="290" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiLocalPhoneNumber" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_Extension" xlink:label="loc_deiExtension" />
      <link:presentationArc order="300" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiExtension" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_WrittenCommunications" xlink:label="loc_deiWrittenCommunications" />
      <link:presentationArc order="310" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiWrittenCommunications" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_SolicitingMaterial" xlink:label="loc_deiSolicitingMaterial" />
      <link:presentationArc order="320" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiSolicitingMaterial" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_PreCommencementTenderOffer" xlink:label="loc_deiPreCommencementTenderOffer" />
      <link:presentationArc order="330" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiPreCommencementTenderOffer" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_PreCommencementIssuerTenderOffer" xlink:label="loc_deiPreCommencementIssuerTenderOffer" />
      <link:presentationArc order="340" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiPreCommencementIssuerTenderOffer" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_Security12bTitle" xlink:label="loc_deiSecurity12bTitle" />
      <link:presentationArc order="350" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiSecurity12bTitle" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_NoTradingSymbolFlag" xlink:label="loc_deiNoTradingSymbolFlag" />
      <link:presentationArc order="360" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiNoTradingSymbolFlag" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_TradingSymbol" xlink:label="loc_deiTradingSymbol" />
      <link:presentationArc order="370" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiTradingSymbol" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_SecurityExchangeName" xlink:label="loc_deiSecurityExchangeName" />
      <link:presentationArc order="380" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiSecurityExchangeName" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_Security12gTitle" xlink:label="loc_deiSecurity12gTitle" />
      <link:presentationArc order="390" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiSecurity12gTitle" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_SecurityReportingObligation" xlink:label="loc_deiSecurityReportingObligation" />
      <link:presentationArc order="400" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiSecurityReportingObligation" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_AnnualInformationForm" xlink:label="loc_deiAnnualInformationForm" />
      <link:presentationArc order="410" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiAnnualInformationForm" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_AuditedAnnualFinancialStatements" xlink:label="loc_deiAuditedAnnualFinancialStatements" />
      <link:presentationArc order="420" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiAuditedAnnualFinancialStatements" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityWellKnownSeasonedIssuer" xlink:label="loc_deiEntityWellKnownSeasonedIssuer" />
      <link:presentationArc order="430" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityWellKnownSeasonedIssuer" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityVoluntaryFilers" xlink:label="loc_deiEntityVoluntaryFilers" />
      <link:presentationArc order="440" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityVoluntaryFilers" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityCurrentReportingStatus" xlink:label="loc_deiEntityCurrentReportingStatus" />
      <link:presentationArc order="450" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityCurrentReportingStatus" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityInteractiveDataCurrent" xlink:label="loc_deiEntityInteractiveDataCurrent" />
      <link:presentationArc order="460" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityInteractiveDataCurrent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityFilerCategory" xlink:label="loc_deiEntityFilerCategory" />
      <link:presentationArc order="470" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityFilerCategory" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntitySmallBusiness" xlink:label="loc_deiEntitySmallBusiness" />
      <link:presentationArc order="480" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntitySmallBusiness" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityEmergingGrowthCompany" xlink:label="loc_deiEntityEmergingGrowthCompany" />
      <link:presentationArc order="490" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityEmergingGrowthCompany" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityExTransitionPeriod" xlink:label="loc_deiEntityExTransitionPeriod" />
      <link:presentationArc order="500" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityExTransitionPeriod" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentAccountingStandard" xlink:label="loc_deiDocumentAccountingStandard" />
      <link:presentationArc order="510" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiDocumentAccountingStandard" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_OtherReportingStandardItemNumber" xlink:label="loc_deiOtherReportingStandardItemNumber" />
      <link:presentationArc order="520" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiOtherReportingStandardItemNumber" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityShellCompany" xlink:label="loc_deiEntityShellCompany" />
      <link:presentationArc order="530" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityShellCompany" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityPublicFloat" xlink:label="loc_deiEntityPublicFloat" />
      <link:presentationArc order="540" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityPublicFloat" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityBankruptcyProceedingsReportingCurrent" xlink:label="loc_deiEntityBankruptcyProceedingsReportingCurrent" />
      <link:presentationArc order="550" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityBankruptcyProceedingsReportingCurrent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityCommonStockSharesOutstanding" xlink:label="loc_deiEntityCommonStockSharesOutstanding" />
      <link:presentationArc order="560" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityCommonStockSharesOutstanding" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentsIncorporatedByReferenceTextBlock" xlink:label="loc_deiDocumentsIncorporatedByReferenceTextBlock" />
      <link:presentationArc order="570" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiDocumentsIncorporatedByReferenceTextBlock" xlink:type="arc" />
    </link:presentationLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>11
<FILENAME>R1.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.2</span><table class="report" border="0" cellspacing="2" id="idm140526092928752">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Cover<br></strong></div></th>
<th class="th"><div>Jun. 28, 2024</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentType', window );">Document Type</a></td>
<td class="text">8-K<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_AmendmentFlag', window );">Amendment Flag</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentPeriodEndDate', window );">Document Period End Date</a></td>
<td class="text">Jun. 28,  2024<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityFileNumber', window );">Entity File Number</a></td>
<td class="text">001-40874<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityRegistrantName', window );">Entity Registrant Name</a></td>
<td class="text">CINGULATE,
INC.<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityCentralIndexKey', window );">Entity Central Index Key</a></td>
<td class="text">0001862150<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityTaxIdentificationNumber', window );">Entity Tax Identification Number</a></td>
<td class="text">86-3825535<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityIncorporationStateCountryCode', window );">Entity Incorporation, State or Country Code</a></td>
<td class="text">DE<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressAddressLine1', window );">Entity Address, Address Line One</a></td>
<td class="text">1901
                                            W. 47th Place<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressCityOrTown', window );">Entity Address, City or Town</a></td>
<td class="text">Kansas
    City<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressStateOrProvince', window );">Entity Address, State or Province</a></td>
<td class="text">KS<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressPostalZipCode', window );">Entity Address, Postal Zip Code</a></td>
<td class="text">66205<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_CityAreaCode', window );">City Area Code</a></td>
<td class="text">(913)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_LocalPhoneNumber', window );">Local Phone Number</a></td>
<td class="text">942-2300<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_WrittenCommunications', window );">Written Communications</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_SolicitingMaterial', window );">Soliciting Material</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_PreCommencementTenderOffer', window );">Pre-commencement Tender Offer</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_PreCommencementIssuerTenderOffer', window );">Pre-commencement Issuer Tender Offer</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityEmergingGrowthCompany', window );">Entity Emerging Growth Company</a></td>
<td class="text">true<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityExTransitionPeriod', window );">Elected Not To Use the Extended Transition Period</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=CING_CommonStockParValue0.0001PerShareMember', window );">Common Stock, par value $0.0001 per share</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_Security12bTitle', window );">Title of 12(b) Security</a></td>
<td class="text">Common
    Stock, par value $0.0001 per share<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_TradingSymbol', window );">Trading Symbol</a></td>
<td class="text">CING<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_SecurityExchangeName', window );">Security Exchange Name</a></td>
<td class="text">NASDAQ<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=CING_WarrantsExercisableForOneShareOfCommonStockMember', window );">Warrants, exercisable for one share of common stock</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_Security12bTitle', window );">Title of 12(b) Security</a></td>
<td class="text">Warrants,
    exercisable for one share of common stock<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_TradingSymbol', window );">Trading Symbol</a></td>
<td class="text">CINGW<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_SecurityExchangeName', window );">Security Exchange Name</a></td>
<td class="text">NASDAQ<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AmendmentFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AmendmentFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CityAreaCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Area code of city</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CityAreaCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentPeriodEndDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period. The format of the date is YYYY-MM-DD.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentPeriodEndDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:dateItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentType">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentType</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:submissionTypeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressAddressLine1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Address Line 1 such as Attn, Building Name, Street Name</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressAddressLine1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressCityOrTown">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the City or Town</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressCityOrTown</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressPostalZipCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Code for the postal or zip code</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressPostalZipCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressStateOrProvince">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the state or province.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressStateOrProvince</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:stateOrProvinceItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCentralIndexKey">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCentralIndexKey</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:centralIndexKeyItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityEmergingGrowthCompany">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate if registrant meets the emerging growth company criteria.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityEmergingGrowthCompany</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityExTransitionPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate if an emerging growth company has elected not to use the extended transition period for complying with any new or revised financial accounting standards.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 7A<br> -Section B<br> -Subsection 2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityExTransitionPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityFileNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityFileNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:fileNumberItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityIncorporationStateCountryCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Two-character EDGAR code representing the state or country of incorporation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityIncorporationStateCountryCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarStateCountryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityRegistrantName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityRegistrantName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityTaxIdentificationNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityTaxIdentificationNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:employerIdItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LocalPhoneNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Local phone number for entity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LocalPhoneNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_PreCommencementIssuerTenderOffer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 13e<br> -Subsection 4c<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_PreCommencementIssuerTenderOffer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_PreCommencementTenderOffer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 14d<br> -Subsection 2b<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_PreCommencementTenderOffer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_Security12bTitle">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Title of a 12(b) registered security.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_Security12bTitle</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:securityTitleItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SecurityExchangeName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the Exchange on which a security is registered.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection d1-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SecurityExchangeName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarExchangeCodeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SolicitingMaterial">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 14a<br> -Subsection 12<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SolicitingMaterial</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_TradingSymbol">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Trading symbol of an instrument as listed on an exchange.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_TradingSymbol</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:tradingSymbolItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_WrittenCommunications">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br> -Section 425<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_WrittenCommunications</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=CING_CommonStockParValue0.0001PerShareMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=CING_CommonStockParValue0.0001PerShareMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=CING_WarrantsExercisableForOneShareOfCommonStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=CING_WarrantsExercisableForOneShareOfCommonStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EXCEL
<SEQUENCE>12
<FILENAME>Financial_Report.xlsx
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 Financial_Report.xlsx
M4$L#!!0    (  M X5@'04UB@0   +$    0    9&]C4')O<',O87!P+GAM
M;$V./0L",1!$_\IQO;=!P4)B0-!2L+(/>QLOD&1#LD)^OCG!CVX>;QA&WPIG
M*N*I#BV&5(_C(I(/ !47BK9.7:=N')=HI6-Y #OGD<Z,STA)8*O4'J@)I9GF
M3?X.CD:?<@X>K7A.YNJQ<&4GPZ4A!0W_<FW>J=0U[R;UEA_6\#MI7E!+ P04
M    "  +0.%8%&EM,>X    K @  $0   &1O8U!R;W!S+V-O<F4N>&ULS9+!
M2L0P$(9?17)O)^F*8NCFHGA2$%Q0O(5D=C=LTX1DI-VW-ZV[740?P&-F_GSS
M#4QKHC0AX4L*$1,YS%>C[_HL35RS/5&4 -GLT>M<ET1?FMN0O*;R3#N(VAST
M#J'A_ 8\DK::-$S *BY$IEIKI$FH*:03WIH%'S]3-\.L >S08T\91"V J6EB
M/(Y="Q? !"-,/G\7T"[$N?HG=NX .R7'[);4, SUL)IS90<![\]/K_.ZE>LS
MZ=Y@^96=I&/$-3M/?EO=/VP>F6IX<UWQVXJ+C6@DYU+<?4RN/_PNPCY8MW7_
MV/@LJ%KX=1?J"U!+ P04    "  +0.%8F5R<(Q &  "<)P  $P   'AL+W1H
M96UE+W1H96UE,2YX;6SM6EMSVC@4?N^OT'AG]FT+QC:!MK03<VEVV[29A.U.
M'X416(UL>621A'^_1S80RY8-[9)-NIL\!"SI^\Y%1^?H.'GS[BYBZ(:(E/)X
M8-DOV]:[MR_>X%<R)!%!,!FGK_# "J5,7K5::0##.'W)$Q+#W(*+"$MX%,O6
M7.!;&B\CUNJTV]U6A&ELH1A'9&!]7BQH0-!445IO7R"TY1\S^!7+5(UEHP$3
M5T$FN8BT\OELQ?S:WCYES^DZ'3*!;C ;6"!_SF^GY$Y:B.%4PL3 :F<_5FO'
MT=)(@(+)?90%NDGVH],5"#(-.SJ=6,YV?/;$[9^,RMIT-&T:X./Q>#BVR]*+
M<!P$X%&[GL*=]&R_I$$)M*-IT&38]MJND::JC5-/T_=]W^N;:)P*C5M/TVMW
MW=..B<:MT'@-OO%/A\.NB<:KT'3K:28G_:YKI.D6:$)&X^MZ$A6UY4#3( !8
M<';6S-(#EEXI^G64&MD=N]U!7/!8[CF)$?[&Q036:=(9EC1&<IV0!0X -\31
M3%!\KT&VBN#"DM)<D-;/*;50&@B:R('U1X(AQ=RO_?67N\FD,WJ=?3K.:Y1_
M::L!I^V[F\^3_'/HY)^GD]=-0LYPO"P)\?LC6V&')VX[$W(Z'&="?,_V]I&E
M)3+/[_D*ZTX\9Q]6EK!=S\_DGHQR([O=]EA]]D]';B/7J<"S(M>41B1%G\@M
MNN01.+5)#3(3/PB=AIAJ4!P"I DQEJ&&^+3&K!'@$WVWO@C(WXV(]ZMOFCU7
MH5A)VH3X$$8:XIQSYG/1;/L'I4;1]E6\W*.76!4!EQC?-*HU+,76>)7 \:V<
M/!T3$LV4"P9!AI<D)A*I.7Y-2!/^*Z7:_IS30/"4+R3Z2I&/:;,CIW0FS>@S
M&L%&KQMUAVC2/'K^!?F<-0H<D1L= F<;LT8AA&F[\!ZO)(Z:K<(1*T(^8ADV
M&G*U%H&V<:F$8%H2QM%X3M*T$?Q9K#63/F#([,V1=<[6D0X1DEXW0CYBSHN0
M$;\>ACA*FNVB<5@$_9Y>PTG!Z(++9OVX?H;5,VPLCO='U!=*Y \FIS_I,C0'
MHYI9";V$5FJ?JH<T/J@>,@H%\;D>/N5Z> HWEL:\4*Z">P'_T=HWPJOX@L Y
M?RY]SZ7ON?0]H=*W-R-]9\'3BUO>1FY;Q/NN,=K7-"XH8U=RS<C'5*^3*=@Y
MG\#L_6@^GO'M^MDDA*^:62TC%I!+@;-!)+C\B\KP*L0)Z&1;)0G+5--E-XH2
MGD(;;NE3]4J5U^6ON2BX/%ODZ:^A=#XLS_D\7^>TS0LS0[=R2^JVE+ZU)CA*
M]+',<$X>RPP[9SR2';9WH!TU^_9==N0CI3!3ET.X&D*^ VVZG=PZ.)Z8D;D*
MTU*0;\/YZ<5X&N(YV02Y?9A7;>?8T='[Y\%1L*/O/)8=QXCRHB'NH8:8S\-#
MAWE[7YAGE<90-!1M;*PD+$:W8+C7\2P4X&1@+: '@Z]1 O)256 Q6\8#*Y"B
M?$R,1>APYY=<7^/1DN/;IF6U;J\I=QEM(E(YPFF8$V>KRMYEL<%5'<]56_*P
MOFH]M!5.S_Y9K<B?#!%.%@L22&.4%Z9*HO,94[[G*TG$53B_13.V$I<8O./F
MQW%.4[@2=K8/ C*YNSFI>F4Q9Z;RWRT,"2Q;B%D2XDU=[=7GFYRN>B)V^I=W
MP6#R_7#)1P_E.^=?]%U#KG[VW>/Z;I,[2$R<><41 71% B.5' 86%S+D4.Z2
MD 83 <V4R43P H)DIAR F/H+O?(,N2D5SJT^.7]%+(.&3E[2)1(4BK ,!2$7
M<N/O[Y-J=XS7^BR!;814,F35%\I#B<$],W)#V%0E\Z[:)@N%V^)4S;L:OB9@
M2\-Z;ITM)__;7M0]M!<]1O.CF> >LX=SFWJXPD6L_UC6'ODRWSEPVSK> U[F
M$RQ#I'[!?8J*@!&K8KZZKT_Y)9P[M'OQ@2";_-;;I/;=X Q\U*M:I60K$3]+
M!WP?D@9CC%OT-%^/%&*MIK&MQMHQ#'F 6/,,H68XWX=%FAHSU8NL.8T*;T'5
M0.4_V]0-:/8--!R1!5XQF;8VH^1."CS<_N\-L,+$CN'MB[\!4$L#!!0    (
M  M X5CYPI,VUP0  "$4   8    >&PO=V]R:W-H965T<R]S:&5E=#$N>&UL
MG9C;<N(X$(;OYRE4[-;63%4"MC@$LD 5(626389A ]E4[9VP!:AB6QY)#N3M
MMV6(33*F3287P2?]_M3=[E]V=R/5DUYS;L@V#"+=JZR-B2]K->VM><AT5<8\
M@C-+J4)F8%>M:CI6G/GIH#"H4<=IU4(FHDJ_FQZ;JGY7)B80$9\JHI,P9.KE
MB@=RTZNXE=<#]V*U-O9 K=^-V8K/N'F(IPKV:IF*+T(>:2$CHOBR5QFXEU>T
M8P>D5_PK^$8?;!,[E8643W9G[/<JCB7B ?>,E6#P\\R'/ BL$G#\V(M6LGO:
M@8?;K^HWZ>1A,@NF^5 &C\(WZUZE72$^7[(D,/=R\Q??3ZAI]3P9Z/0_V>RN
M;=(*\1)M9+@?# 2AB':_;+L/Q,& 5OW( +H?0%/NW8U2RFMF6+^KY(8H>S6H
MV8UTJNEH@!.1S<K,*#@K8)SI#^4S5]V: 2E[H.;MAUWMAM$CP_Y.HBJA[3-"
M'=IX.[P&!!D&S3!HJE<_HG<MO01R;<C\)>9%./CP]ODM E'/(.JHR@ (_)3B
M)F"K(@I\_)(%FB,<C8RC<5HPIEP)Z9-1Y!-(;F%<<*4L365Y:F9H351P%!EA
M7LB-"#B9).&BN'9P#<=QSQM.^P+C:64\K5-X[OE*:*,8Q&S"PL) X3K#\>3K
MP]U@/CK[-)X,JPC9149V<0K9$/*H6$#&D<^WY):_%+'A2@X$K-VB;M-!L-H9
M5OL4K#G;DK$/;&(I/);VQ^/IQ!7;K?-ZFS:;]2:"U\GP.J?@C2-/JEBJE.R,
MS Q4/Y&*#&4"X82H2K\PR;CX]0@A=)V\8SJG, Y\7W&MSUXWR!U<1[Y'A6 E
MDF['<3^1#_P]5DGCPJS)-& >UG+< Q]P/S2KH=V#D,_E)BJ<$2YWRR+-=#HG
MJX0AYA[AXEW^/6)6%E,EGT7T/A![3ESS=H:AY<[AXJW_/=I4:@-/_7\B/EJK
M)8JM%G6P)\K-W<3%32#-Y "6;,=1<('/';?^!4/)W</%6_^=]" JT[6,,/LH
M$>DTZ#FM.U@W='/_</'&_ZB$,3R"T(1A$NU[H2ZDPH7*S-_-C</%^_U,!L(3
M1D0K\@T*7 D6%/+@*J4\N6.X>(.?*G[N07@X/&&[-1HLD[@BWY?+(_G#]4K)
M<K-P\8;^$]E8ZP3(2@%QV3) FEL%/<DJ1B%7*YO/KZ  71N*+691X5*@1-"H
M!"7+VSTM:??VM8C[9"(AGY(\:$[,FI/1UMC8^60.BRDMTH7!;A5:"(O?HS2.
M!V\'>)>V3R>0S(STGLY(S!1Y9D'"R>].U:Z.2 S9UFNFBE\=4&W[VGNI8[#1
M7@7>:S57S[S2_^,WM^7\B;'GUD#Q1CX7!A;+<DE<^GGQA<RXEZB?''%/BBOM
MHI!ZZD<C\98]MPZ*=WZH M_6[>PE7,C"+E0B8-?5&$GN'!1O^J]A@PKUUBQ:
M\:,+_1*AR6!V/?@'8\J]@Y9X!U/VE0/LGF^Y\H1F"\CT$A8DUM_2+-B\>[OB
MU39EA<#H77ZU/G.[H;A1?*0^<:4L'FF)_F),WLXB-RF*F\H)E8H+V$I]Q%!R
M5Z*X?7R@5'&AXZ5:._C@8S^>?6/67S0)^!*4G.H%/ -J]SUJMV-DG'X#6DAC
M9)ANKCD#D[07P/FEE.9UQWY6RKX*]O\'4$L#!!0    (  M X5C@]#J)J@(
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M':5_'<?VD-/IKV,BM'I;Z/EQ:%0*CMQC)8QQ8K3^-8+)#^Q^ %!+ P04
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MEG!:(.+)(&UI5GVP3TZTYWD7-_=%KLWC":[?#'!X=/X!4$L#!!0    (  M
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M;64O=&AE;64Q+GAM;%!+ 0(4 Q0    (  M X5CYPI,VUP0  "$4   8
M          " @0T(  !X;"]W;W)K<VAE971S+W-H965T,2YX;6Q02P$"% ,4
M    "  +0.%8X/0ZB:H"   P#   #0              @ $:#0  >&PO<W1Y
M;&5S+GAM;%!+ 0(4 Q0    (  M X5B7BKL<P    !,"   +
M  "  >\/  !?<F5L<R\N<F5L<U!+ 0(4 Q0    (  M X5BJQ"(6,P$  "("
M   /              "  =@0  !X;"]W;W)K8F]O:RYX;6Q02P$"% ,4
M"  +0.%8)!Z;HJT   #X 0  &@              @ $X$@  >&PO7W)E;',O
M=V]R:V)O;VLN>&UL+G)E;'-02P$"% ,4    "  +0.%899!YDAD!  #/ P
M$P              @ $=$P  6T-O;G1E;G1?5'EP97-=+GAM;%!+!08
.."0 ) #X"  !G%      !

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>13
<FILENAME>Show.js
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
// Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission.  Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105.
var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0);
e.removeAttribute('id');a.parentNode.appendChild(e)}}
if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'}
e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>14
<FILENAME>report.css
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
/* Updated 2009-11-04 */
/* v2.2.0.24 */

/* DefRef Styles */
..report table.authRefData{
	background-color: #def;
	border: 2px solid #2F4497;
	font-size: 1em;
	position: absolute;
}

..report table.authRefData a {
	display: block;
	font-weight: bold;
}

..report table.authRefData p {
	margin-top: 0px;
}

..report table.authRefData .hide {
	background-color: #2F4497;
	padding: 1px 3px 0px 0px;
	text-align: right;
}

..report table.authRefData .hide a:hover {
	background-color: #2F4497;
}

..report table.authRefData .body {
	height: 150px;
	overflow: auto;
	width: 400px;
}

..report table.authRefData table{
	font-size: 1em;
}

/* Report Styles */
..pl a, .pl a:visited {
	color: black;
	text-decoration: none;
}

/* table */
..report {
	background-color: white;
	border: 2px solid #acf;
	clear: both;
	color: black;
	font: normal 8pt Helvetica, Arial, san-serif;
	margin-bottom: 2em;
}

..report hr {
	border: 1px solid #acf;
}

/* Top labels */
..report th {
	background-color: #acf;
	color: black;
	font-weight: bold;
	text-align: center;
}

..report th.void	{
	background-color: transparent;
	color: #000000;
	font: bold 10pt Helvetica, Arial, san-serif;
	text-align: left;
}

..report .pl {
	text-align: left;
	vertical-align: top;
	white-space: normal;
	width: 200px;
	white-space: normal; /* word-wrap: break-word; */
}

..report td.pl a.a {
	cursor: pointer;
	display: block;
	width: 200px;
	overflow: hidden;
}

..report td.pl div.a {
	width: 200px;
}

..report td.pl a:hover {
	background-color: #ffc;
}

/* Header rows... */
..report tr.rh {
	background-color: #acf;
	color: black;
	font-weight: bold;
}

/* Calendars... */
..report .rc {
	background-color: #f0f0f0;
}

/* Even rows... */
..report .re, .report .reu {
	background-color: #def;
}

..report .reu td {
	border-bottom: 1px solid black;
}

/* Odd rows... */
..report .ro, .report .rou {
	background-color: white;
}

..report .rou td {
	border-bottom: 1px solid black;
}

..report .rou table td, .report .reu table td {
	border-bottom: 0px solid black;
}

/* styles for footnote marker */
..report .fn {
	white-space: nowrap;
}

/* styles for numeric types */
..report .num, .report .nump {
	text-align: right;
	white-space: nowrap;
}

..report .nump {
	padding-left: 2em;
}

..report .nump {
	padding: 0px 0.4em 0px 2em;
}

/* styles for text types */
..report .text {
	text-align: left;
	white-space: normal;
}

..report .text .big {
	margin-bottom: 1em;
	width: 17em;
}

..report .text .more {
	display: none;
}

..report .text .note {
	font-style: italic;
	font-weight: bold;
}

..report .text .small {
	width: 10em;
}

..report sup {
	font-style: italic;
}

..report .outerFootnotes {
	font-size: 1em;
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>16
<FILENAME>FilingSummary.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version='1.0' encoding='utf-8'?>
<FilingSummary>
  <Version>3.24.2</Version>
  <ProcessingTime/>
  <ReportFormat>html</ReportFormat>
  <ContextCount>3</ContextCount>
  <ElementCount>23</ElementCount>
  <EntityCount>1</EntityCount>
  <FootnotesReported>false</FootnotesReported>
  <SegmentCount>2</SegmentCount>
  <ScenarioCount>0</ScenarioCount>
  <TuplesReported>false</TuplesReported>
  <UnitCount>3</UnitCount>
  <MyReports>
    <Report instance="form8-k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R1.htm</HtmlFileName>
      <LongName>00000001 - Document - Cover</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://cingulate.com/role/Cover</Role>
      <ShortName>Cover</ShortName>
      <MenuCategory>Cover</MenuCategory>
      <Position>1</Position>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <LongName>All Reports</LongName>
      <ReportType>Book</ReportType>
      <ShortName>All Reports</ShortName>
    </Report>
  </MyReports>
  <InputFiles>
    <File>cing-20240628.xsd</File>
    <File>cing-20240628_def.xml</File>
    <File>cing-20240628_lab.xml</File>
    <File>cing-20240628_pre.xml</File>
    <File doctype="8-K" isOnlyDei="true" isUsgaap="true" original="form8-k.htm">form8-k.htm</File>
  </InputFiles>
  <SupplementalFiles/>
  <BaseTaxonomies>
    <BaseTaxonomy items="26">http://xbrl.sec.gov/dei/2024</BaseTaxonomy>
  </BaseTaxonomies>
  <HasPresentationLinkbase>true</HasPresentationLinkbase>
  <HasCalculationLinkbase>false</HasCalculationLinkbase>
</FilingSummary>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>JSON
<SEQUENCE>18
<FILENAME>MetaLinks.json
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
{
 "version": "2.2",
 "instance": {
  "form8-k.htm": {
   "nsprefix": "CING",
   "nsuri": "http://cingulate.com/20240628",
   "dts": {
    "schema": {
     "local": [
      "cing-20240628.xsd"
     ],
     "remote": [
      "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xl-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xlink-2003-12-31.xsd",
      "http://www.xbrl.org/2005/xbrldt-2005.xsd",
      "http://www.xbrl.org/2006/ref-2006-02-27.xsd",
      "http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd",
      "http://www.xbrl.org/lrr/role/net-2009-12-16.xsd",
      "https://www.xbrl.org/2020/extensible-enumerations-2.0.xsd",
      "https://www.xbrl.org/dtr/type/2020-01-21/types.xsd",
      "https://www.xbrl.org/dtr/type/2022-03-31/types.xsd",
      "https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd",
      "https://xbrl.fasb.org/srt/2024/elts/srt-roles-2024.xsd",
      "https://xbrl.fasb.org/srt/2024/elts/srt-types-2024.xsd",
      "https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd",
      "https://xbrl.fasb.org/us-gaap/2024/elts/us-roles-2024.xsd",
      "https://xbrl.fasb.org/us-gaap/2024/elts/us-types-2024.xsd",
      "https://xbrl.sec.gov/country/2024/country-2024.xsd",
      "https://xbrl.sec.gov/dei/2024/dei-2024.xsd",
      "https://xbrl.sec.gov/stpr/2024/stpr-2024.xsd"
     ]
    },
    "definitionLink": {
     "local": [
      "cing-20240628_def.xml"
     ]
    },
    "labelLink": {
     "local": [
      "cing-20240628_lab.xml"
     ]
    },
    "presentationLink": {
     "local": [
      "cing-20240628_pre.xml"
     ]
    },
    "inline": {
     "local": [
      "form8-k.htm"
     ]
    }
   },
   "keyStandard": 23,
   "keyCustom": 0,
   "axisStandard": 1,
   "axisCustom": 0,
   "memberStandard": 0,
   "memberCustom": 2,
   "hidden": {
    "total": 2,
    "http://xbrl.sec.gov/dei/2024": 2
   },
   "contextCount": 3,
   "entityCount": 1,
   "segmentCount": 2,
   "elementCount": 65,
   "unitCount": 3,
   "baseTaxonomies": {
    "http://xbrl.sec.gov/dei/2024": 26
   },
   "report": {
    "R1": {
     "role": "http://cingulate.com/role/Cover",
     "longName": "00000001 - Document - Cover",
     "shortName": "Cover",
     "isDefault": "true",
     "groupType": "document",
     "subGroupType": "",
     "menuCat": "Cover",
     "order": "1",
     "firstAnchor": {
      "contextRef": "AsOf2024-06-28",
      "name": "dei:DocumentType",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "b",
       "span",
       "p",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "form8-k.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "AsOf2024-06-28",
      "name": "dei:DocumentType",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "b",
       "span",
       "p",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "form8-k.htm",
      "first": true,
      "unique": true
     }
    }
   },
   "tag": {
    "dei_AmendmentDescription": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "AmendmentDescription",
     "presentation": [
      "http://cingulate.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Amendment Description",
        "documentation": "Description of changes contained within amended document."
       }
      }
     },
     "auth_ref": []
    },
    "dei_AmendmentFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "AmendmentFlag",
     "presentation": [
      "http://cingulate.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Amendment Flag",
        "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission."
       }
      }
     },
     "auth_ref": []
    },
    "dei_AnnualInformationForm": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "AnnualInformationForm",
     "presentation": [
      "http://cingulate.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Annual Information Form",
        "documentation": "Boolean flag with value true on a form if it is an annual report containing an annual information form."
       }
      }
     },
     "auth_ref": [
      "r14"
     ]
    },
    "dei_AuditedAnnualFinancialStatements": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "AuditedAnnualFinancialStatements",
     "presentation": [
      "http://cingulate.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Audited Annual Financial Statements",
        "documentation": "Boolean flag with value true on a form if it is an annual report containing audited financial statements."
       }
      }
     },
     "auth_ref": [
      "r14"
     ]
    },
    "dei_CityAreaCode": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "CityAreaCode",
     "presentation": [
      "http://cingulate.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "City Area Code",
        "documentation": "Area code of city"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ClassOfStockDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ClassOfStockDomain",
     "presentation": [
      "http://cingulate.com/role/Cover"
     ],
     "auth_ref": []
    },
    "CING_CommonStockParValue0.0001PerShareMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://cingulate.com/20240628",
     "localname": "CommonStockParValue0.0001PerShareMember",
     "presentation": [
      "http://cingulate.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Common Stock, par value $0.0001 per share"
       }
      }
     },
     "auth_ref": []
    },
    "dei_CountryRegion": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "CountryRegion",
     "presentation": [
      "http://cingulate.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Country Region",
        "documentation": "Region code of country"
       }
      }
     },
     "auth_ref": []
    },
    "dei_CoverAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "CoverAbstract",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Cover page."
       }
      }
     },
     "auth_ref": []
    },
    "dei_CurrentFiscalYearEndDate": {
     "xbrltype": "gMonthDayItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "CurrentFiscalYearEndDate",
     "presentation": [
      "http://cingulate.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Current Fiscal Year End Date",
        "documentation": "End date of current fiscal year in the format --MM-DD."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentAccountingStandard": {
     "xbrltype": "accountingStandardItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "DocumentAccountingStandard",
     "presentation": [
      "http://cingulate.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Accounting Standard",
        "documentation": "The basis of accounting the registrant has used to prepare the financial statements included in this filing This can either be 'U.S. GAAP', 'International Financial Reporting Standards', or 'Other'."
       }
      }
     },
     "auth_ref": [
      "r13"
     ]
    },
    "dei_DocumentAnnualReport": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "DocumentAnnualReport",
     "presentation": [
      "http://cingulate.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Annual Report",
        "documentation": "Boolean flag that is true only for a form used as an annual report."
       }
      }
     },
     "auth_ref": [
      "r11",
      "r13",
      "r14"
     ]
    },
    "dei_DocumentFiscalPeriodFocus": {
     "xbrltype": "fiscalPeriodItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "DocumentFiscalPeriodFocus",
     "presentation": [
      "http://cingulate.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Fiscal Period Focus",
        "documentation": "Fiscal period values are FY, Q1, Q2, and Q3. 1st, 2nd and 3rd quarter 10-Q or 10-QT statements have value Q1, Q2, and Q3 respectively, with 10-K, 10-KT or other fiscal year statements having FY."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentFiscalYearFocus": {
     "xbrltype": "gYearItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "DocumentFiscalYearFocus",
     "presentation": [
      "http://cingulate.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Fiscal Year Focus",
        "documentation": "This is focus fiscal year of the document report in YYYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentPeriodEndDate": {
     "xbrltype": "dateItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "DocumentPeriodEndDate",
     "presentation": [
      "http://cingulate.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Period End Date",
        "documentation": "For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period. The format of the date is YYYY-MM-DD."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentPeriodStartDate": {
     "xbrltype": "dateItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "DocumentPeriodStartDate",
     "presentation": [
      "http://cingulate.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Period Start Date",
        "documentation": "The start date of the period covered in the document, in YYYY-MM-DD format."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentQuarterlyReport": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "DocumentQuarterlyReport",
     "presentation": [
      "http://cingulate.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Quarterly Report",
        "documentation": "Boolean flag that is true only for a form used as an quarterly report."
       }
      }
     },
     "auth_ref": [
      "r12"
     ]
    },
    "dei_DocumentRegistrationStatement": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "DocumentRegistrationStatement",
     "presentation": [
      "http://cingulate.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Registration Statement",
        "documentation": "Boolean flag that is true only for a form used as a registration statement."
       }
      }
     },
     "auth_ref": [
      "r0"
     ]
    },
    "dei_DocumentShellCompanyEventDate": {
     "xbrltype": "dateItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "DocumentShellCompanyEventDate",
     "presentation": [
      "http://cingulate.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Shell Company Event Date",
        "documentation": "Date of event requiring a shell company report."
       }
      }
     },
     "auth_ref": [
      "r13"
     ]
    },
    "dei_DocumentShellCompanyReport": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "DocumentShellCompanyReport",
     "presentation": [
      "http://cingulate.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Shell Company Report",
        "documentation": "Boolean flag that is true for a Shell Company Report pursuant to section 13 or 15(d) of the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r13"
     ]
    },
    "dei_DocumentTransitionReport": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "DocumentTransitionReport",
     "presentation": [
      "http://cingulate.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Transition Report",
        "documentation": "Boolean flag that is true only for a form used as a transition report."
       }
      }
     },
     "auth_ref": [
      "r15"
     ]
    },
    "dei_DocumentType": {
     "xbrltype": "submissionTypeItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "DocumentType",
     "presentation": [
      "http://cingulate.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Type",
        "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentsIncorporatedByReferenceTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "DocumentsIncorporatedByReferenceTextBlock",
     "presentation": [
      "http://cingulate.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Documents Incorporated by Reference [Text Block]",
        "documentation": "Documents incorporated by reference."
       }
      }
     },
     "auth_ref": [
      "r3"
     ]
    },
    "dei_EntityAddressAddressLine1": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityAddressAddressLine1",
     "presentation": [
      "http://cingulate.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, Address Line One",
        "documentation": "Address Line 1 such as Attn, Building Name, Street Name"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressAddressLine2": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityAddressAddressLine2",
     "presentation": [
      "http://cingulate.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, Address Line Two",
        "documentation": "Address Line 2 such as Street or Suite number"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressAddressLine3": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityAddressAddressLine3",
     "presentation": [
      "http://cingulate.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, Address Line Three",
        "documentation": "Address Line 3 such as an Office Park"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressCityOrTown": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityAddressCityOrTown",
     "presentation": [
      "http://cingulate.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, City or Town",
        "documentation": "Name of the City or Town"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressCountry": {
     "xbrltype": "countryCodeItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityAddressCountry",
     "presentation": [
      "http://cingulate.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, Country",
        "documentation": "ISO 3166-1 alpha-2 country code."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressPostalZipCode": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityAddressPostalZipCode",
     "presentation": [
      "http://cingulate.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, Postal Zip Code",
        "documentation": "Code for the postal or zip code"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressStateOrProvince": {
     "xbrltype": "stateOrProvinceItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityAddressStateOrProvince",
     "presentation": [
      "http://cingulate.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, State or Province",
        "documentation": "Name of the state or province."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityBankruptcyProceedingsReportingCurrent": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityBankruptcyProceedingsReportingCurrent",
     "presentation": [
      "http://cingulate.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Bankruptcy Proceedings, Reporting Current",
        "documentation": "For registrants involved in bankruptcy proceedings during the preceding five years, the value Yes indicates that the registrant has filed all documents and reports required to be filed by Section 12, 13 or 15(d) of the Securities Exchange Act of 1934 subsequent to the distribution of securities under a plan confirmed by a court; the value No indicates the registrant has not. Registrants not involved in bankruptcy proceedings during the preceding five years should not report this element."
       }
      }
     },
     "auth_ref": [
      "r6"
     ]
    },
    "dei_EntityCentralIndexKey": {
     "xbrltype": "centralIndexKeyItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityCentralIndexKey",
     "presentation": [
      "http://cingulate.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Central Index Key",
        "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK."
       }
      }
     },
     "auth_ref": [
      "r2"
     ]
    },
    "dei_EntityCommonStockSharesOutstanding": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityCommonStockSharesOutstanding",
     "presentation": [
      "http://cingulate.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Common Stock, Shares Outstanding",
        "documentation": "Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityCurrentReportingStatus": {
     "xbrltype": "yesNoItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityCurrentReportingStatus",
     "presentation": [
      "http://cingulate.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Current Reporting Status",
        "documentation": "Indicate 'Yes' or 'No' whether registrants (1) have filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that registrants were required to file such reports), and (2) have been subject to such filing requirements for the past 90 days. This information should be based on the registrant's current or most recent filing containing the related disclosure."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityEmergingGrowthCompany": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityEmergingGrowthCompany",
     "presentation": [
      "http://cingulate.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Emerging Growth Company",
        "documentation": "Indicate if registrant meets the emerging growth company criteria."
       }
      }
     },
     "auth_ref": [
      "r2"
     ]
    },
    "dei_EntityExTransitionPeriod": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityExTransitionPeriod",
     "presentation": [
      "http://cingulate.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Elected Not To Use the Extended Transition Period",
        "documentation": "Indicate if an emerging growth company has elected not to use the extended transition period for complying with any new or revised financial accounting standards."
       }
      }
     },
     "auth_ref": [
      "r19"
     ]
    },
    "dei_EntityFileNumber": {
     "xbrltype": "fileNumberItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityFileNumber",
     "presentation": [
      "http://cingulate.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity File Number",
        "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityFilerCategory": {
     "xbrltype": "filerCategoryItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityFilerCategory",
     "presentation": [
      "http://cingulate.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Filer Category",
        "documentation": "Indicate whether the registrant is one of the following: Large Accelerated Filer, Accelerated Filer, Non-accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure."
       }
      }
     },
     "auth_ref": [
      "r2"
     ]
    },
    "dei_EntityIncorporationStateCountryCode": {
     "xbrltype": "edgarStateCountryItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityIncorporationStateCountryCode",
     "presentation": [
      "http://cingulate.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Incorporation, State or Country Code",
        "documentation": "Two-character EDGAR code representing the state or country of incorporation."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityInteractiveDataCurrent": {
     "xbrltype": "yesNoItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityInteractiveDataCurrent",
     "presentation": [
      "http://cingulate.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Interactive Data Current",
        "documentation": "Boolean flag that is true when the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files)."
       }
      }
     },
     "auth_ref": [
      "r16"
     ]
    },
    "dei_EntityPrimarySicNumber": {
     "xbrltype": "sicNumberItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityPrimarySicNumber",
     "presentation": [
      "http://cingulate.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Primary SIC Number",
        "documentation": "Primary Standard Industrial Classification (SIC) Number for the Entity."
       }
      }
     },
     "auth_ref": [
      "r14"
     ]
    },
    "dei_EntityPublicFloat": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityPublicFloat",
     "crdr": "credit",
     "presentation": [
      "http://cingulate.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Public Float",
        "documentation": "The aggregate market value of the voting and non-voting common equity held by non-affiliates computed by reference to the price at which the common equity was last sold, or the average bid and asked price of such common equity, as of the last business day of the registrant's most recently completed second fiscal quarter."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityRegistrantName": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityRegistrantName",
     "presentation": [
      "http://cingulate.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Registrant Name",
        "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC."
       }
      }
     },
     "auth_ref": [
      "r2"
     ]
    },
    "dei_EntityShellCompany": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityShellCompany",
     "presentation": [
      "http://cingulate.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Shell Company",
        "documentation": "Boolean flag that is true when the registrant is a shell company as defined in Rule 12b-2 of the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r2"
     ]
    },
    "dei_EntitySmallBusiness": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntitySmallBusiness",
     "presentation": [
      "http://cingulate.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Small Business",
        "documentation": "Indicates that the company is a Smaller Reporting Company (SRC)."
       }
      }
     },
     "auth_ref": [
      "r2"
     ]
    },
    "dei_EntityTaxIdentificationNumber": {
     "xbrltype": "employerIdItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityTaxIdentificationNumber",
     "presentation": [
      "http://cingulate.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Tax Identification Number",
        "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS."
       }
      }
     },
     "auth_ref": [
      "r2"
     ]
    },
    "dei_EntityVoluntaryFilers": {
     "xbrltype": "yesNoItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityVoluntaryFilers",
     "presentation": [
      "http://cingulate.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Voluntary Filers",
        "documentation": "Indicate 'Yes' or 'No' if the registrant is not required to file reports pursuant to Section 13 or Section 15(d) of the Act."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityWellKnownSeasonedIssuer": {
     "xbrltype": "yesNoItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityWellKnownSeasonedIssuer",
     "presentation": [
      "http://cingulate.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Well-known Seasoned Issuer",
        "documentation": "Indicate 'Yes' or 'No' if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act. Is used on Form Type: 10-K, 10-Q, 8-K, 20-F, 6-K, 10-K/A, 10-Q/A, 20-F/A, 6-K/A, N-CSR, N-Q, N-1A."
       }
      }
     },
     "auth_ref": [
      "r17"
     ]
    },
    "dei_Extension": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "Extension",
     "presentation": [
      "http://cingulate.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Extension",
        "documentation": "Extension number for local phone number."
       }
      }
     },
     "auth_ref": []
    },
    "dei_LocalPhoneNumber": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "LocalPhoneNumber",
     "presentation": [
      "http://cingulate.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Local Phone Number",
        "documentation": "Local phone number for entity."
       }
      }
     },
     "auth_ref": []
    },
    "dei_NoTradingSymbolFlag": {
     "xbrltype": "trueItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "NoTradingSymbolFlag",
     "presentation": [
      "http://cingulate.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "No Trading Symbol Flag",
        "documentation": "Boolean flag that is true only for a security having no trading symbol."
       }
      }
     },
     "auth_ref": []
    },
    "dei_OtherReportingStandardItemNumber": {
     "xbrltype": "otherReportingStandardItemNumberItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "OtherReportingStandardItemNumber",
     "presentation": [
      "http://cingulate.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Other Reporting Standard Item Number",
        "documentation": "\"Item 17\" or \"Item 18\" specified when the basis of accounting is neither US GAAP nor IFRS."
       }
      }
     },
     "auth_ref": [
      "r13"
     ]
    },
    "dei_PreCommencementIssuerTenderOffer": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "PreCommencementIssuerTenderOffer",
     "presentation": [
      "http://cingulate.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Pre-commencement Issuer Tender Offer",
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r7"
     ]
    },
    "dei_PreCommencementTenderOffer": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "PreCommencementTenderOffer",
     "presentation": [
      "http://cingulate.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Pre-commencement Tender Offer",
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r9"
     ]
    },
    "dei_Security12bTitle": {
     "xbrltype": "securityTitleItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "Security12bTitle",
     "presentation": [
      "http://cingulate.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Title of 12(b) Security",
        "documentation": "Title of a 12(b) registered security."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "dei_Security12gTitle": {
     "xbrltype": "securityTitleItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "Security12gTitle",
     "presentation": [
      "http://cingulate.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Title of 12(g) Security",
        "documentation": "Title of a 12(g) registered security."
       }
      }
     },
     "auth_ref": [
      "r5"
     ]
    },
    "dei_SecurityExchangeName": {
     "xbrltype": "edgarExchangeCodeItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "SecurityExchangeName",
     "presentation": [
      "http://cingulate.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Security Exchange Name",
        "documentation": "Name of the Exchange on which a security is registered."
       }
      }
     },
     "auth_ref": [
      "r4"
     ]
    },
    "dei_SecurityReportingObligation": {
     "xbrltype": "securityReportingObligationItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "SecurityReportingObligation",
     "presentation": [
      "http://cingulate.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Security Reporting Obligation",
        "documentation": "15(d), indicating whether the security has a reporting obligation under that section of the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r10"
     ]
    },
    "dei_SolicitingMaterial": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "SolicitingMaterial",
     "presentation": [
      "http://cingulate.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Soliciting Material",
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r8"
     ]
    },
    "us-gaap_StatementClassOfStockAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "StatementClassOfStockAxis",
     "presentation": [
      "http://cingulate.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Class of Stock [Axis]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_StatementLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "StatementLineItems",
     "presentation": [
      "http://cingulate.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Statement [Line Items]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_StatementTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "StatementTable",
     "presentation": [
      "http://cingulate.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Statement [Table]"
       }
      }
     },
     "auth_ref": []
    },
    "dei_TradingSymbol": {
     "xbrltype": "tradingSymbolItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "TradingSymbol",
     "presentation": [
      "http://cingulate.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Trading Symbol",
        "documentation": "Trading symbol of an instrument as listed on an exchange."
       }
      }
     },
     "auth_ref": []
    },
    "CING_WarrantsExercisableForOneShareOfCommonStockMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://cingulate.com/20240628",
     "localname": "WarrantsExercisableForOneShareOfCommonStockMember",
     "presentation": [
      "http://cingulate.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Warrants, exercisable for one share of common stock"
       }
      }
     },
     "auth_ref": []
    },
    "dei_WrittenCommunications": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "WrittenCommunications",
     "presentation": [
      "http://cingulate.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Written Communications",
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act."
       }
      }
     },
     "auth_ref": [
      "r18"
     ]
    }
   }
  }
 },
 "std_ref": {
  "r0": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12"
  },
  "r1": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "b"
  },
  "r2": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "b-2"
  },
  "r3": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "b-23"
  },
  "r4": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "d1-1"
  },
  "r5": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "g"
  },
  "r6": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12, 13, 15d"
  },
  "r7": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "13e",
   "Subsection": "4c"
  },
  "r8": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "14a",
   "Subsection": "12"
  },
  "r9": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "14d",
   "Subsection": "2b"
  },
  "r10": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "15",
   "Subsection": "d"
  },
  "r11": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 10-K",
   "Number": "249",
   "Section": "310"
  },
  "r12": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 10-Q",
   "Number": "240",
   "Section": "308",
   "Subsection": "a"
  },
  "r13": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Number": "249",
   "Section": "220",
   "Subsection": "f"
  },
  "r14": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 40-F",
   "Number": "249",
   "Section": "240",
   "Subsection": "f"
  },
  "r15": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Forms 10-K, 10-Q, 20-F",
   "Number": "240",
   "Section": "13",
   "Subsection": "a-1"
  },
  "r16": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-T",
   "Number": "232",
   "Section": "405"
  },
  "r17": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "405"
  },
  "r18": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "425"
  },
  "r19": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "7A",
   "Section": "B",
   "Subsection": "2"
  }
 }
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>ZIP
<SEQUENCE>19
<FILENAME>0001493152-24-025724-xbrl.zip
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 0001493152-24-025724-xbrl.zip
M4$L#!!0    (  M X5BJ3.+!SP,  .0.   1    8VEN9RTR,#(T,#8R."YX
M<V2]5]MRVS80?>],_P'A:X>D+K5K,5(RJ5U[-+5CU4KB3%XR(+F24)$ "X"6
MW*_/ KQ8=TM*'#V!N^?L!5@L5MVW\S0A#R 5$[SG-+V&0X!'(F9\W',^#MUW
MP_-^WR%OW_SZ"\%?]Y7KDDL&21R0"Q&Y?3X2K\E[FD) KH"#I%K(U^0337(C
M$9<L 4G.19HEH $5A:> G'BM5D1<=P^[GX#'0GZ\Z]=V)UIG*O#]V6SF<?%
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MCXMQ-3P66E;&:9_$<Q11]>Q.F14O8M:'"2,FTGW17PNX\4;I@0>'&7)38>W
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M4?X+H1L<)\&@E1(,RB5PE/]"Z$Z/D^"TE1*<EDO@* LNH!OICQ-QRQ^!I^^
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MMV;K.A")]JP:S;L5+,BSHS3S&[\5R+QK9[I=S3B%M_!8#!O--H07)-Q11EE
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M@V !,&4RH&5(ZI 6>FGYXE<"FLGE)V!U3)E; NPFZQ34-0&18#4&T+#3JM5
M7H@X%ST3Q\F$SLGV-_(,UJNA<\L$8+,.A2$*B J[,P"+7(R4&@FY%S!N>;S"
M_'D:1QU#15/H%@W(:)T-4Q40'( U@(Y<C::3<Y\CR1W>3N8"U'@1ZY5\'92
M>K>P=-BN,P.( T*GW2% D A"]2B?($UHQ/B:51YW.&<;T0$^G[,Y/$/IB'(+
M5:\JU-%J#0D(L#X^ <QJH0?ZF13$Y IL50"2)7@A[FP^%R<JS?^YBBDY!NMO
MU;JEJ\5NG2F+,""28'< /[GRH/B 9 RZH:% ,WY!5<?^H1GWA68<-#3C?:"Y
M>V*!0'/R@JJ>^(?FI"\T)T%#<[(7-*+AO?8UY^+C#;]C3[:'LT&E%V2:5JW
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M>W]Y==.5^"0V%YO$7S.<$K'E_U!+ P04    "  +0.%8X+YR:$<(   U8P
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MS'%\7,L>B8,--2/$6=D7"4P(=__>3DCW>]%7"QT#Y9T4^6SE9(KGLCNK+F+
MV@0PLQY=L&"*HB1(9##9>1&/\6SWX@5C33*;Z7$"SP"R30#S\BO\.7CLZB(9
M7:S8 Y_04!MXHNLB9&[P PGLXEH:("H*,UL"T-ZM 51= 2M\^O7PZ78$0.J.
MX;/WA?"!A?@ 4CY\OHUT>^^2+"S\WS8VU+L$J,$K=0+"S&L8X(]:@VH!+ZJ-
M#6.!W3OXU2R#U[TQS*LJG[U2?T'OS3 OX&#M=SMI#(1V&ST[JLS39 P[<>9Q
MWQS>-)?+'#(>$MQX7L):S%^!/;S-+.N,XRTF[Q#*J9[0&]:X')C:#<",8=88
M9=\\ 5BT@&58Z/C3!HMTKT@P-$>\ 3,3G&"RDQ"*=/INKI-P=.]LGN#A\'D\
M5 7DL>E2/B\?(:Y- -LJW0-%R'"JL4Z!7: \!GQJ-\W)K-,FVB.U)9K7$)WR
MJ49-G84-9'2>.8;%FV7WFB\--"7.<'A<9@1#IKHL:0EU5B4I/I@  X_A:X5,
MW!,K:?HV6:S; <6LBM&D!4< 0"P6J"Q6( ^0MICJ*<CW/ L9'U0:9],:D;I:
MS/&:DLH&LD0@QHJ<*HOS?BC%OG&45PB;LH(GR+X"0*HN$#QBT!!K$JZN@$5%
MAMSK2Y0[D.,07)>$GZN\3F6I9"<9Q76I?3T1!M:?1UHSFQSJ#(YTE, ^\JL,
M=+*+9-[MI,DLJ4A3+7W%9L<]?&P>5H?VV14F2EBXD8N?]O0UVG8O+TC*B.?S
M%" +8A)K"G'5ILSJE >-U,O-ER__W- SF4OF&?!85BP)2V\6207L!E8(9H)H
MMX/<_ 9@SN+/R:R>W6*:.1KKJXK?$VF5U,EQ4L"V=$.YCZS4WNT,XY0L:##U
M4+,\#!".AWI!7_-5@,6B0&NE&'\_=.PR"(!<H9<@80F\T/FD#]M8D'S!]Y&L
MO3,X$7J!UL%BH(<D1F*QJ[!"BD8)*1O11HN\GEZL.'M^W[XV1E/B&"0L/8\3
M 1(+R+TD&Z7U6.RZ<'W16#*/%VS?%"N*H%@HW@NY,E^&EML8;V3"ALE]SRBS
M E.MZ)>A.C!.$ HHI#<4"K>?FJRLN%#$:['2SN."")$81<B"ZL[HAMM&= >V
M,,]+Y[%IL=>"(/JUIJ%'(BT^3%Z]_QFPORS31;?CZ9X5HPV@2CR_6*%*D%7>
M/42\.C(D "]W/!KI><7/L1L2L \QP+[=M.G+(-V.O?\R"-UVM&U62573)6F2
MZ::%<R7Y%SX:3V'2*:I0S<OD%)P[-&\NFVL#(Z=Z^6IK2\6;L\U([<?(Q-G0
M&<%3W0[&9RD3GK7L4?(MHX%!>'VOOM^]&EAR;9V@1F@@="^=(P\O("S"\CA&
M':38;%4#48Q5<I^XPLD/LDQ_%KT[KJIX="'^)?1ARCVTH]-@GOV:C2VQ)>ED
M36#6K!)TX3$;0R$Y-L8&^, ,%!XPMZ8D^3 P'<"O(N'C& 95X2*#9)J T(&6
M@TL0?O/"6@\#3\IIG6KU8FL;EW:J*?P!T7L/+2&S.L5+>XVH3<LV(#9,+E@?
M+4[D\6ZG30R_NM"9""8\7J83DLJ7QLK$P[+"F$J.2#3$W:AN(,UC)GX;?8+$
MP?F28? FI!BD91ZUHX:U>2.N M0(!X#Z_E$GA?%N!SNGJ4%*2N:BG"08;7"5
M(<7.:U%*T),-L@N+FTCNX+[QWS3,5)S6!>_4J"FE6,T1LU@; D&V1"VAPK'P
MO(8UXB-N8AH71DQSOR&^M !9Y4M':$3E'C&D\#**=4UDT!:N0Y&XUKVT8N1
M_LL\;_4*%_ZJ0P=^5'@:5XO [#0:-='H!&27%PT-2[2#I?%5N?9 _VA;(:N)
MW$UW'3PBUHQJ"*^C&*1;$!"-%(#&3,E0,,M NR^(/-] :\BQ&)E;T\ @7 ;I
MP(1>Y/G"JT^W$7@>\PW/\L-*=[:(W"TC.PU*>=[01IF)04P3@DRB*4*C2I"=
MFF TPT&M2'KGD8K?V<+\=&UA?J069O[OYM-'F++R/7?%DN;Y^_UNY_C=N_U3
M-3@"W!H VA^_4^?O#\[4V?[NQ].#\]_4^\&9.CH^5SO[^T?J=/_O!V?G^Z?[
M>^H?!^?OX=%]\^3!_AF-LO]?N^\'1W^'"W3\X</!V=G!\9$Z/FT^Z?_X#M[[
MK=LY.Q^<[ZL#G.3P8'"TNZ\^GL#/@R,8<O_#R3D^^^[T^(,LXG1 WWP\VMM?
M&GVP>X[#<E (K'_P81\>VU,]?$XV'SYN T* DA_MP4N[N\>G>/</?XL: /DP
M^$T H@AV,"[L[^SXD/:^?W*N3CZ>GGT<P%F=']/RX:G=\X-?]\.5TWYA8>>M
M>X!UX"9.FX,-?AT<'!*!"J$2X;, O(&"\8_.X&7\!==Y]G'GWV%^>#^B.8)%
MG.[_Y\>#4UK&&9]]$Y $$!J90$('0V<_.#DY/-BEI?#1>>\=#OYQMBDP?10R
MQR,2GW:=I %RBQB$6S07(Q6QG$'F=G'-H### D?#_&N^=0IX/ 2MO!]1#!FH
MQ!AIL4*<1\\/,$(S$LP<IR3!-?U9+EK%4Q%6*X 4U^2,<22(73]RM^-K(J1D
M;S]_?OT4,$>R>JD4P@*'G)#&D;-33 :TX_=B$%MGN$:TH:,OS;-?MTBR??9"
MY'4E $,-E#4C$\YH#"GLFVA1A,BEQ1'(H'X-02F"IS""@0]'Q@2YLK'6F&,%
M5VV7@FQX:9=Y6L]( P7<S$!2RB<;M'MK3B!;3B^YO!:"[ ,!^1;$_IL!=ZT!
MP>4&&/ DJ#OH[,L!A$81AE!S3=<"B!2%GK=AN382H](8TU-6O3,NEX/92 GQ
M;^3O\ _Y*Q+,9 95PO@0R?51Y%E>9R,93;Q+XN:"6SF9M(3+X8O[GT<7:)$@
M PZ\AHC2DE["O_AF5O8>DB,H+E(8CB(W1RDZ\4JB$,8G!;!I1KSM:0$2QOKX
MHXKO)G0TLF,0#2UH8BDU!<.QXS'N=F D]*_.DXS\;*P<G5->-D853>FP"Q@0
MP_)='%BP!#P[>U "-6NWS,9/Y 8V1D7_)-$L=I;!45+\D@!:AO<\D&B"=]=;
M(!;X(<G,:+;BQR)Q'!+% Y!*.,(QXC+/ ).,RX%]NH&/=5.]0R<EV0;;=QZM
MO*1N>D:F"?K/4/F%;\5B&!Z69WWL=GR'21/8# >:ET+TT(/6O#@JS0$KB^;U
M(7/5F?%-B\DUHN=CWE^<J3S3JK?=-U%?&-T7>G!L#,:B$>8MP#,[:C]VA(&O
MX8>*_0J^RT 4%T_<$@6A>@2#25( 7O2VWYQ]/'E;5F^>X+_]Y3@W=Y<.^?53
MP;[FC8K,7A4%OY.+/>]V@CB4T"]_S>;8:B'.?+*7EHP7Y M'S/ WYH5UB(49
M8Q#"*V"C465RN?%D,Z?OC5TU>,R:(N<%(M"PR#^9>!A&MWE>)E4.YWM>@!QF
M#_1L48)\TA(*8$Q0:_/@#[:5 V#+)@8@Q%.+ XQB\66<I,)7T6]KPJQ#5C*/
M%QR08$@N2@D@9[!,&Y<<-0#7*$V [HS)YS*.9_$4&3*Y1')R/\1JKK,XK> V
M4GX>&OW^M!UM;6TAHK89VH>4FBJ^U5__,3CQ<A2=YT1^)[_32H$6!5#@ R;&
MI8WC];W;/2&'0<";ELE/!,O?HAAMC]20^(%\A@A;KO[T-'A$"*N)??9>+(7=
M2,0NP8_#@X=Z6M-!HF.LUGT'/G]>QZQ:J)M$X=#8'J7J=I+2V[4168TUU>7"
M)F%NZ 3PAN2[7MPW4@4\:JAFSR.;0?1>OT$V#2%I6_&7\XNOH:ZTPR%N$'#D
M6@AZRS:Y$BBSH3((X@<(SW#Q/X':1^5M8@XO\]TP_56>/_14">#0RUB"B%I.
MS #(-TE;")FNR!04H+"P 5-+>0[M,[)4997 UDP/RG!S:[3Y%%\_J_-.&)X)
MAXD^0;R0G N.9VLCQ 37F/T35F9MD9!$L3)R'\<SXGIVK1QQ-4)UJ)T35GD%
M3]K,%X[J\-0'YI%HS1U9>5YH&F,1+ O5N3EL3Z.C&]"@1"+*[HN^54-70*1T
M:3?C&^=5*Z9%';DY+]H1.#*GR#&%'6?N#?K-F,-5=\B_ZE=QZ01*#U6;%YD#
M%UHO<L;TE"5U[Z7FT,VD?YP".!VZ<>A.+)P(ZNN!D9K5:96 CHC"(MR3W@[7
M&[C2Z'3%F.%+AB8?,$90-I="6C7M_28T?B2A,M>[DYZMW4F/U)VTEJW_1=EZ
M@H3.ABE2X L:$O38&M5\ 6"<CVHV+Y$%E +PG+DD#,AC3B:!.F)Z@;]S(/]L
M-?65<?MJM\/O#FN*-D:2S1'YH7Y_3=1@,ZBK30<0&4]1!"A07ZH:@T$T(\[%
M8.H_P_E0$^ ""<)T/7B49$'7LWE*7-^$&6=CF6;"]O%=L3>>:I0Q;*6*7S;^
MP^FKGNW-7P:.\C7+$'-3:,R'Y>"?;7/2H&UQJ:CH9,B3.=>MDJ!/'$.BM\E^
MT[2<69OB8%2U6J!@DZ6>)5EL9"[BY<%YA ?G@K;(P(7YJ29<R\LY99,NH)H
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M4AL=L7>*N$M1B]5:[@[7[:#$K##^T^1PX=]4N]<X#W_+BT_N:G&&)9L;D=B
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MW2!"35R%+@<KTV3%M-7 OAH F$E,Y9!0(YQEW.^"BBTQXV?OLVU53H4'N1\
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M@8;$G>.]W\BB^/[\PR'\\;]02P,$%     @ "T#A6)%Z0@AO4P  :2,"  D
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M_JR$^"Q,WC" YH]/X<?X#?;S],/>W^'UV)F0WN%UXN3P?SX<G5 W3EEF&IW
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M72BM?[_\H(7[Y7<?7FG]&R0.-NHD@9Y4%U$5PFN+X#)*YRHHU%@EERJVPA_
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M^)3S='TFSF#U8.9Q&1J3$(SF%;VOPO6AF8<.P43 0I?C(ADIDC"<J=F\&%_
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MC0^NYI2/P#C^^'BDP!B&MF>TC.[A^CT-_;V_0K)?M5R\]UMW._6PSL4'J5'
M%H,M=0Z*:Q;CMLB+%\'515(I5SG>2^)^CTQ_1SLFFZX,Q9&R(#</6X'L>HA5
M11X:5FW).DR*LM).)&LJCM,(=%?V_ 71;)8FZ.W>B@9!PH^Z3@LP(,DWE05I
M4J(5"6^'WM#?,L>]]#8J/BJQ2D=);-TA]0:I_V3HHJL.]&?81R4[>>2+3*'K
MI8(FU%A1XSC40;\G;C/_E=@-F$!4S>MOZNPY*/.%FN5%Q7.UE^;Y=*2*\^#-
M]OOM8$L6PGQL/$!;HPB4?NJ(YUAC7]8/+Y[N!%&GTP_L^V<O=IYTNP4'(;R
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M"IUC,WD0C>'-!:B1+JK!5?0PDC].YZAGA0%&*D#Q<E 4(1N(:E0A2D!-5%&
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MAD30B#('O?39G#A^)Z7F:M2^OV!(?]IE]S#>$#FQ ND;K.Y70QQ:5:GIC/(
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MZ"*I>"O!>6^3Y^NSUXCE"FFFY_VMQQ$U\[(>EVQ<BN]B*+!C;":PU3HX"W,
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MD2ENTM3%6IJR#E+OA_&<7[5&]AJ4%_D:,OID@ @57G$IAHPE#W#EB6@?B19
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MA6%@9XTO$= [G)B;!7RO_N_]H]>T*OZLA'@M3%X_@-L?G\*/\1L<Y^G[_7_
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MY8L@F] %C:,) WRE>*S&W0XO:#R!&1Y=\ /@WFD&LQ.<Y=$X3L_A-PNX)"U
M"NBF\72JQC%<"FIADB4P"WB5<W5U3LY@'6$-<$%JTQ$,Y^ \XP-+7"I:A!"G
M!):\&.7Q4)&XX9S-YOGH @[48))G4YB>]'R>X("/TM$V+&APJ)+H"I0H+'\^
MRW)^7F4H!]ET!NONC@ %#A]H!1@$A90Q+;<C>M$8]_$4))7$:@[;&,?:M']$
MG7MO"FL"CY_"H$C P"F 7YJ7 ED8*;PF2U5 S^]V*K\(Z(GP0%@B_1RX,DE
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M7SOG$ID?12@^RX+,6C98V+X?JY*<(3Y4V(?+BU+[:]:J&241G!KL<0?1;);
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MZASJHY[/"^1*@V=Q@4?L6*;60?/;#;@@ 3PM#/!)@PS;2-!7G1[NN$R:$HL
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M#(OS*=QF6-$<%' >_ZG&RU* > ./U>\K=7VZ,PCB9T"C=W<VV.@[P4;O[FS
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MU1<18*CEJ&@NHP,S&4:1Z9<9:Y>VUG'$I!^P#21NX"3!YB"ME;[BO=4*?FO
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M^.U@YW[<?WOX!_D3OYV]>?WR_P-02P,$%     @ "T#A6-9<AYMJ#   4S8
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M*$<H_2F]1]6/%4_T(OL[B_56:303L-^94FYF<5FV,1NYL_Z1";Z]OZ#Y%)<
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MBR;?_U\VRPX,;NK;K,F]=^Q,[?%M-M2'[UBC3K_<YHOUV^OFG\7ZX>[N!?Q
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MS>_5H8V<-:&XM5G? 38P^JK)^)!KOF<\H!D>4 -WU]@JS"K#:5V;!'X+AQE
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M+$.+-#771W>XI&HI#-Y&&(3WK0U3?!QS*0;>(G.KV+F!B8G\W7UO%C3)3$J
M%,238=*[9O>#\!VR"XG&\!(>&\#O]!DO^+VO.AZYOW5N(L"A;\,Q'0.)Q*<D
MXP&4ENT1G-'$E3X#8=T(??\2=# TMH:&] CQ3#&$!1Y.G6"/0IL_[&M5>@NE
M42BPZHJ  I.[;E044:;A:K[KAC@SQW;EB$$$)B+L#(%+@-=!]KAKL.HCLF&%
M_FX4>?C=,CEY1)5H*HP"3:R!7$"ZF!AS;LK>![9OZF3?[:$XA-<6*^>JU3_1
MC!VN%5UVC'U42RZ64L62X8U#V_?HHB*N46(BC5Z/ZX8(HA)0-QA-TNE*Z!*
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M2P$"% ,4    "  +0.%8'JHITI!2  #1) ( "0              @ $;HP
M97@T+3(N:'1M4$L! A0#%     @ "T#A6-9<AYMJ#   4S8   H
M     ( !TO4  &5X.3DM,2YH=&U02P$"% ,4    "  +0.%8]2)TEW@C  #;
M 0$ "P              @ %D @$ 9F]R;3@M:RYH=&U02P4&      D "0 ?
) @  !28!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>20
<FILENAME>form8-k_htm.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version="1.0" encoding="utf-8"?>
<xbrl
  xmlns="http://www.xbrl.org/2003/instance"
  xmlns:CING="http://cingulate.com/20240628"
  xmlns:dei="http://xbrl.sec.gov/dei/2024"
  xmlns:iso4217="http://www.xbrl.org/2003/iso4217"
  xmlns:link="http://www.xbrl.org/2003/linkbase"
  xmlns:us-gaap="http://fasb.org/us-gaap/2024"
  xmlns:xbrldi="http://xbrl.org/2006/xbrldi"
  xmlns:xlink="http://www.w3.org/1999/xlink">
    <link:schemaRef xlink:href="cing-20240628.xsd" xlink:type="simple"/>
    <context id="AsOf2024-06-28">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001862150</identifier>
        </entity>
        <period>
            <startDate>2024-06-28</startDate>
            <endDate>2024-06-28</endDate>
        </period>
    </context>
    <context id="From2024-06-282024-06-28_custom_CommonStockParValue0.0001PerShareMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001862150</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">CING:CommonStockParValue0.0001PerShareMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-06-28</startDate>
            <endDate>2024-06-28</endDate>
        </period>
    </context>
    <context id="From2024-06-282024-06-28_custom_WarrantsExercisableForOneShareOfCommonStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001862150</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">CING:WarrantsExercisableForOneShareOfCommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-06-28</startDate>
            <endDate>2024-06-28</endDate>
        </period>
    </context>
    <unit id="USD">
        <measure>iso4217:USD</measure>
    </unit>
    <unit id="Shares">
        <measure>shares</measure>
    </unit>
    <unit id="USDPShares">
        <divide>
            <unitNumerator>
                <measure>iso4217:USD</measure>
            </unitNumerator>
            <unitDenominator>
                <measure>shares</measure>
            </unitDenominator>
        </divide>
    </unit>
    <dei:AmendmentFlag contextRef="AsOf2024-06-28" id="Fact000003">false</dei:AmendmentFlag>
    <dei:EntityCentralIndexKey contextRef="AsOf2024-06-28" id="Fact000004">0001862150</dei:EntityCentralIndexKey>
    <dei:DocumentType contextRef="AsOf2024-06-28" id="Fact000009">8-K</dei:DocumentType>
    <dei:DocumentPeriodEndDate contextRef="AsOf2024-06-28" id="Fact000010">2024-06-28</dei:DocumentPeriodEndDate>
    <dei:EntityRegistrantName contextRef="AsOf2024-06-28" id="Fact000011">CINGULATE, INC.</dei:EntityRegistrantName>
    <dei:EntityIncorporationStateCountryCode contextRef="AsOf2024-06-28" id="Fact000012">DE</dei:EntityIncorporationStateCountryCode>
    <dei:EntityFileNumber contextRef="AsOf2024-06-28" id="Fact000013">001-40874</dei:EntityFileNumber>
    <dei:EntityTaxIdentificationNumber contextRef="AsOf2024-06-28" id="Fact000014">86-3825535</dei:EntityTaxIdentificationNumber>
    <dei:EntityAddressAddressLine1 contextRef="AsOf2024-06-28" id="Fact000015">1901                                             W. 47th Place</dei:EntityAddressAddressLine1>
    <dei:EntityAddressCityOrTown contextRef="AsOf2024-06-28" id="Fact000016">Kansas     City</dei:EntityAddressCityOrTown>
    <dei:EntityAddressStateOrProvince contextRef="AsOf2024-06-28" id="Fact000017">KS</dei:EntityAddressStateOrProvince>
    <dei:EntityAddressPostalZipCode contextRef="AsOf2024-06-28" id="Fact000018">66205</dei:EntityAddressPostalZipCode>
    <dei:CityAreaCode contextRef="AsOf2024-06-28" id="Fact000019">(913)</dei:CityAreaCode>
    <dei:LocalPhoneNumber contextRef="AsOf2024-06-28" id="Fact000020">942-2300</dei:LocalPhoneNumber>
    <dei:WrittenCommunications contextRef="AsOf2024-06-28" id="Fact000021">false</dei:WrittenCommunications>
    <dei:SolicitingMaterial contextRef="AsOf2024-06-28" id="Fact000022">false</dei:SolicitingMaterial>
    <dei:PreCommencementTenderOffer contextRef="AsOf2024-06-28" id="Fact000023">false</dei:PreCommencementTenderOffer>
    <dei:PreCommencementIssuerTenderOffer contextRef="AsOf2024-06-28" id="Fact000024">false</dei:PreCommencementIssuerTenderOffer>
    <dei:Security12bTitle
      contextRef="From2024-06-282024-06-28_custom_CommonStockParValue0.0001PerShareMember"
      id="Fact000025">Common     Stock, par value $0.0001 per share</dei:Security12bTitle>
    <dei:TradingSymbol
      contextRef="From2024-06-282024-06-28_custom_CommonStockParValue0.0001PerShareMember"
      id="Fact000026">CING</dei:TradingSymbol>
    <dei:SecurityExchangeName
      contextRef="From2024-06-282024-06-28_custom_CommonStockParValue0.0001PerShareMember"
      id="Fact000027">NASDAQ</dei:SecurityExchangeName>
    <dei:Security12bTitle
      contextRef="From2024-06-282024-06-28_custom_WarrantsExercisableForOneShareOfCommonStockMember"
      id="Fact000028">Warrants,     exercisable for one share of common stock</dei:Security12bTitle>
    <dei:TradingSymbol
      contextRef="From2024-06-282024-06-28_custom_WarrantsExercisableForOneShareOfCommonStockMember"
      id="Fact000029">CINGW</dei:TradingSymbol>
    <dei:SecurityExchangeName
      contextRef="From2024-06-282024-06-28_custom_WarrantsExercisableForOneShareOfCommonStockMember"
      id="Fact000030">NASDAQ</dei:SecurityExchangeName>
    <dei:EntityEmergingGrowthCompany contextRef="AsOf2024-06-28" id="Fact000031">true</dei:EntityEmergingGrowthCompany>
    <dei:EntityExTransitionPeriod contextRef="AsOf2024-06-28" id="Fact000032">false</dei:EntityExTransitionPeriod>
</xbrl>
</XML>
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
